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Children born with hypoplastic left heart syndrome (HLHS) have a LV too small
to support the circulation. They undergo surgery resulting in the right ventricle
(RV) supporting the systemic circulation. Accurately assessing systemic RV
function is challenging but important as patients experience early circulatory
failure. MRI is well established as a tool for assessing congenital heart disease.
The technology is advancing allowing us to study the impact of energy, motion
and shape on ventricular function. Characterising these factors in relation to
HLHS might provide new insights into this condition.
Methods
A stepwise approach was used:
1. Ventricular work and function were studied at varying heart rates using MRI
catheterisation techniques to study the work of the heart and understand
the causes of exercise intolerance.
2. Continuing the energetic theme; a non-invasive 4D flow MRI sequence was
translated into a tool to study intra-cardiac kinetic energy (KE) a measure of
the useful work of the heart. This metric was used to devise a new biomark-
er based on the ratio of ejected to total systolic KE -the particle energy
ejection fraction (PE EF). 
3. Finally, computational processing tools were employed to study how differ-
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ent operations effect the shape and motion of the RV.
Results
The major findings were:
1. The systemic RV displayed good contractility and relaxation but preload (p
<0.008) and stroke volume fell at higher heart rates indicating a limitation of
blood flow due to the absence of a sub-pulmonary ventricle.
2. Early diastolic KE was adversely affected in HLHS by the presence of a
larger left ventricle (LV) remnant which acts as a stiff non-compliant struc-
ture impeding relaxation. Altered KE indices meant we attempted to study a
new metric of function based on KE - PE EF - which was lower in those
with single ventricles (p <0.001) and LV dysfunction (p =0.01).
3. HLHS subjects receiving RV-to-pulmonary artery conduits compared to
those receiving shunts demonstrated ventricular dilatation (p =0.001), in-
creased sphericity (p =0.006) and reduced multi-axial strain which is a sen-
sitive measure of function. 
Conclusions
Novel MRI approaches were used to assess energy, shape and motion in the
systemic RV. Characterising ventricular function in these terms provided new
insights into HLHS pathophysiology. Refining and implementing these MRI
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ANOVA Analysis of Variance
ccTGA congenitally corrected Transposition of the Great Arteries 
CHD congenital heart disease
CI cardiac index
CO cardiac output
CMR cardiac magnetic resonance
DCM dilated cardiomyopathy
Ea arterial elastance or afterload
ECG electrocardiogram
Ees ventricular elastance or contractility
EF Ejection Fraction
EDPVR end diastolic pressure volume relationship
EDV end diastolic volume
ESV end systolic volume
ESPVR end systolic pressure volume relationship
HLHS hypoplastic left heart syndrome 
KE kinetic energy 
kt-PCA kt-principal component analysis
LAD left anterior descending artery
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LV left ventricle 
mBT shunt modified Blalock-Taussig shunt 
MRI magnetic resonance imaging
PC phase contrast
PE particle energy
PV loop pressure-volume loop
PVR pulmonary vascular resistance
Qp:Qs pulmonary to systemic blood flow ratio 
RCA right coronary artery
rf radiofrequency
RV right ventricle
RV-PA conduit right ventricle to pulmonary artery conduit
SV stroke volume
SVC superior vena cava
SSFP steady state free precession 
TCPC total cavo-pulmonary connection 
TGA  transposition of the great arteries
TR tricuspid regurgitation
VENC velocity encoding
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verb: characterise; 3rd person present: characterises; past tense: charac-
terised; past participle: characterised; gerund or present participle:
characterising;
1 describe the distinctive nature or features of.
2 (of a feature or quality) be typical or characteristic of.
The modern usage of the verb "to characterise" arose in the late 16th century
from French caractériser or medieval Latin characterizare meaning ‘engrave' or
'inscribe’. Its true origin may extend as far back as the ancient Greek kharak-
tērizein, from kharaktēr ‘a stamping tool’
This thesis sets out to characterise the distinctive patterns and features that
predominate in systemic right ventricles. Using a translational approach the




Single ventricle hearts are a rare but serious form of congenital heart disease
(CHD). A healthy heart has two ventricles but patients with this condition have
a heart that contains only one normal sized ventricle typically because the oth-
er is underdeveloped. One of the severest forms is hypoplastic left heart syn-
drome (HLHS) in which the left sided heart structures are too small to support
the systemic circulation.1 Underlying the severity of the condition is that it is
uniformly fatal unless patients undergo a series of surgical operations starting
soon after birth resulting in the right ventricle (RV) being used to support the
systemic circulation, in place of the under-developed left ventricle (LV).2 3 
As our experience of looking after children with this condition has improved in-
creasing numbers of these children are surviving into early adulthood. However
despite improvements in care they still experience a higher morbidity and a
lower life expectancy compared to healthy children. This is even more pro-
nounced in those with single RV hearts compared to single LV hearts where
outcomes are markedly worse 4 and children with HLHS have the highest re-
ported incidence of exercise intolerance. 5, 6 The adverse prognosis of patients
with HLHS makes accurate characterisation of cardiac function and detection
of early deterioration especially important in order to  plan treatment strategies.
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Many of our methods of functional assessment in this group of patients are in-
sensitive to early dysfunction.7 Patients experience significant symptoms in-
cluding reduced exercise tolerance, fatigue and breathlessness before cardiac
dysfunction is detected. In HLHS the absence of one ventricle combined with
the necessary surgical procedures2, 8 that are performed to save the lives of
these children has the unintended consequence of altering the shape and mo-
tion of the heart.9 Changes in cardiac shape and motion alter the normal path
of blood through the chambers of the heart which in turn affect how the heart
transfers its energy to the flowing blood. Energetic inefficiencies accumulate
over thousands of heart beats. Studying the function of the heart in terms of
shape, motion, blood flow and energy transfer and linking it to established
methods of assessment may provide new insights into the pathophysiology
underpinning this condition. This premise led to the development of this thesis
to investigate the interplay of energy, motion and shape on ventricular function
in those with hypoplastic left heart syndrome (HLHS) through the application of
CMR techniques.  
1.2 Structure of the thesis
The thesis is divided into 6 chapters.
Chapter 1 covers the necessary background to understanding this piece of
work. It starts with the context of the research outlining the role of the healthy
RV and how it differs to the LV and the physiological alterations and complica-
tions following surgical palliation for HLHS. The challenges of assessing RV
Introduction
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function are described and this leads onto how CMR techniques could be ap-
plied towards our understanding of cardiac shape, motion and energy. There is
a critical appraisal of the application of these technique and their relationship
to this thesis.
Chapter 2 outlines the research methodology. It provides justification for the
techniques chosen including assumptions and limitations of the chosen meth-
ods. It links back into the background covered in the previous chapter.
Chapters 3, 4 and 5 are based around a number of published pieces of work or
work in progress. Chapter 3 covers the assessment of ventricular work using
XMR techniques and the unmasking of dysfunction through the use of pharma-
cological stress. The theme of cardiac energetics is further explored in Chapter
4. It outlines the validation of a new accelerated 4D flow MRI sequence, its ap-
plication towards measuring intra-cardiac kinetic energy in HLHS, and the ra-
tionale for developing a new measure of function based around KE. Chapter 5
utilises computational processing and modelling techniques to build a cardiac
atlas of ventricular shape in HLHS. Single institution datasets for rare condi-
tions such as HLHS are often small in size. Through a collaboration with
Boston Children's Hospital, the effects of the choice of surgical Norwood palli-




Chapter 6 brings together the individual concepts discussed in earlier chap-
ters. It outlines: the contribution this thesis makes towards our understanding
of the constraints imposed upon the systemic RV; contextualises the limita-
tions of the data and; makes suggestions for future directions.
1.3 Background
This section provides an overview of the normal heart and the morphological
differences between the right and left ventricles. As an introduction to the topic
of single right ventricle physiology one must first appreciate the specificity of
the right ventricle to pump to the pulmonary circulation and the adaptations of
pumping under high pressure are incomplete. An overview of the different sur-
gical stages of the Norwood procedure are provided. The burden of cardio-
vascular failure in patients with HLHS is described and the challenges of as-
sessing function in this group of patients is provided with comments on key
papers that have shaped our idea of cardiac function in this group of patients.
1.3.1 The normal heat
The normal heart is divided into a right and left side, each composed of an up-
per chamber known as an atrium and a lower chamber called a ventricle. De-
oxygenated blood returns from the body and enters the right atrium, it fills the
right ventricle which supports the low pressure pulmonary circulation.
Oxygenated blood from the lungs returns to the left atrium, this in turn fills the
left ventricle which supports the high pressure systemic circulation.  
Introduction
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1.3.2 Differences between the right ventricle and left ventricle
The healthy RV and healthy LV are morphologically different and an under-
standing of these is important prior to exploring the changes that occur when
the RV is used in place of the systemic LV. A healthy RV sits anteriorly in the
chest behind the mediastinum. It is thin walled and crescenteric in shape with a
sharp apex and curves over the ellipsoid shape of the LV. The RV pumps effi-
ciently to the low-pressure pulmonary circulation. It has low wall mass and a
large radius of curvature resulting in low wall tension. It is composed of three
parts, the inlet and outlet portions and the apical trabecular section. Morpho-
logical classification (Table 1) is dependent on the apical section which is the
most constant of these parts as the inlet and outlet portions can be malformed
or absent in various forms of CHD. The ventricle is identified based on the pat-
tern of the apical trabeculations. The RV has coarse trabeculations in contrast
to the fine trabeculations of the LV. It has been postulated that thick trabecula-
tions trap blood particularly in the apex, helping to smooth the intra-ventricular
blood flow, and conserving momentum of blood. 10 The flow of blood moves in
a gradual curvature between the basal and mid-ventricular portions before be-
ing ejected from the RV. This is in contrast to the LV where there is a more
acute turn at the apex. 11 12 This has no energetic advantages but acts to en-
sure blood is moved in and out of the ventricle in a “first-in first-out” model.
The filling of the RV is more dependent on valve plane motion sweeping over
blood whilst LV filling relies more on a suction-recoil effect which generates
Introduction
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more energetic momentum. As a consequence the LV, compared to the RV,
has a larger early diastolic kinetic energy (KE) peak corresponding with the E
wave inflow. 13 This point is explored further in Chapter 1.4.4.4 - Kinetic work.
The RV has two layers of fibres making up its myocardial wall. The subendo-
cardial layer is responsible for longitudinal shortening and the subepicardial
layer for circumferential shortening. The RV relies on longitudinal shortening
for ejection. In comparison the LV has three layers allowing torsion, longitudinal
and radial shortening to occur. The LV primarily contracts in a twisting motion
to eject blood. Individual fibres shorten by only 10-15% however the LV is able
to eject almost two-thirds of its end-diastolic volume. The muscle layers, fibre
orientation and motion of the LV result in a more energetically effective process
for pumping under high pressure. In healthy children and adults the RV after-
load from the pulmonary artery pressure is much less than the LV afterload
from the systemic blood pressure. This allows the RV to be energetically effi-
cient despite the RV possessing a thinner wall and less layers of fibres than the
LV. 14 The RV and LV are well designed for their respective jobs.
Introduction
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Attach to free wall




Infundibulum Well developed Absent
Coronaries One (RCA) Two (LAD + circumflex)
Conduction system radiations One Two
Table 1: Anatomic features of the right and left ventricle. Adapted from Nadas'
Pediatric Cardiology, 1992. 15 Where RCA is right coronary artery, LAD is left
anterior descending artery.
1.3.3 Incidence of congenital heart disease
Congenital heart disease (CHD) represents a spectrum of conditions charac-
terised by the abnormal development and maturation of the heart. It has a re-
ported incidence of 0.8%, affecting about 7 cases in every 1000 life births. 16
Introduction
- 27 -
The causes of CHD are often multi-factorial comprising a complex interplay be-
tween genes and the environment. 17
Congenital heart defects are typically divided into: (Figure 1)
1. lesions that cause abnormal mixing of blood between the right and left
sided circulations
2. obstructive lesions that prevent the egress of blood from the heart or
vessels
3. cyanotic lesions that prevent proper oxygenation of blood
Introduction
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Figure 1: Bubble chart showing the relative incidence of different forms of
congenital heart disease. The size of the bubble represents its incidence. The
aetiology of lesions can be divided into mixed, obstructive and cyanotic
causes. HLHS represents 2 - 3% of all cases of CHD.
1.3.4 Hypoplastic left heart syndrome
HLHS is an example of a single ventricle circulation. In HLHS the left sided
heart structures are small and under-developed and unable to support the sys-
temic circulation. (Figure 2). There is a spectrum of severity based on whether
the valves on the left side of the heart are small and narrow (stenosis) or un-
formed (atresia). HLHS accounts for 0.016-0.036% of live births 18 and consti-
tutes 2-3% of all cases of congenital heart disease. 13 
Transposition of the great arteries 
3%
Pulmonary atresia/Tricuspid atresia 
2%
Hypoplastic left heart syndrome 
3%
Ventricular septal defect 
37%
Atrial septal defect 
10%

















Figure 2: Circulation in HLHS soon after birth. Blue arrows represent
deoxygenated blood, red arrows represent oxygenated blood and purple
arrows represent blood of mixed origin. The above image demonstrates mitral
and aortic stenosis with a hypoplastic LV. The small LV and arch mean
systemic perfusion is dependent on mixing of blood across an atrial septal
defect and a patent ductus arteriosus. Despite the hypoplastic LV and aortic
arch the presence of the foramen ovale and ductus arteriosus permit adequate
mixing of blood and systemic perfusion. Once the duct and foramen ovale
close in the post-natal period this circulation becomes incompatible with life.
Where: SVC -superior vena cava, IVC - inferior vena cava, RA - right atrium, LA
- left atrium, RV - right ventricle, LV - left ventricle, RPA - right pulmonary















Sudden death in the neonatal period can result from coronary and systemic
under-perfusion or less commonly from congestion in the pulmonary venous
system with hypoxia if there is restrictive inter-atrial communication which pre-
vents blood form leaving the LA. 2 3 In those with HLHS, where the LV is
deemed too small to support a two-ventricle circulation, surgical palliation
forms an important role. It typically consists of three staged operations result-
ing in the right ventricle providing systemic cardiac output. 19 The RV becomes
a pressure loaded ventricle. 
1.3.5 The pressure loaded right ventricle
Subjecting the RV to raised pressures changes its function. The physiological
adaptations are important to understand as those with HLHS have a systemic
RV. In patients with a two ventricle (biventricular) healthy circulation but with
pulmonary hypertension, the RV must eject against a raised afterload. The ven-
tricle dilates and hypertrophies. This dilatation and increase in wall thickness
are in accordance with La Place’s law: 
where: σ = wall stress, P = pressure, r = wall radius, h = wall thickness
As the RV faces increased pressure and becomes more round, wall thickness
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increases to maintain wall tension. Maladaptive cardiac growth and contractile
dysfunction result from offsetting the increased wall stress. Alterations in my-
ocardial proteins occur with decreased amounts of α-myosin heavy chain pro-
tein (MHC) relative to the β-MHC type of protein. The β-MHC protein contains
less Adenosine Tri-Phosphate (ATP) than the α-isotope which in turn is associ-
ated with reduced systolic and altered energetic function. This, in combination
with a decrease in coronary perfusion due to the thicker wall layer, may con-
tribute to ischaemia and eventual heart failure. 20 The RV does not cope well
when faced with systemic pressures and a much greater drop in ejection frac-
tion (EF) is noted for every millimetre rise in mercury for the RV compared to
the LV. 21
Pressure-Volume (PV) loops illustrate the simultaneous change in ventricular
pressure with volume over the course of the cardiac cycle (See chapter 1.4.5.2
Pressure-volume analysis for more details). They provide some insight into
the changes that occur when the RV is pressure loaded. The first PV loop of
the RV was established in 1988 by a group at the Brompton Hospital (Figure 3).
Redington et al 22, 23 compared healthy LV and RV pressure loops showing ill-
defined isovolumetric periods in the RV with ejection continuing despite a
pressure decline. This trapezoid shape is efficient when coupled to the low
pressure circuit of the pulmonary vasculature.
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Figure 3: Typical pressure volume loops in the healthy LV and RV. Diagram
curtesy of Sheehan, Heart 2008. Compared to the healthy LV the RV displays
poorly defined isovolumetric contraction and relaxation intervals
In effect the RV works as a flow pump and experimental results from pig stud-
ies with induced pulmonary hypertension suggests it works at maximum effi-
ciency rather than maximum coupling. As afterload increases it switches from
a flow pump to a pressure pump with a corresponding fall in stroke volume and
ejection fraction. 24 Exposing the RV to a gradual pressure load alters the
shape of the PV loop to resemble a LV. Conversely the LV is also able to adapt.
When the LV is in the subpulmonary position, such as following Mustard repair
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(atrial baffle) for transposition of the great arteries (TGA), the LV PV loop comes
to resemble that of the RV. 25 
The RV is highly sensitive to increased afterload. 26 Similar findings have been
reported using echocardiographic techniques. 27 In young lambs the addition of
a temporary outflow tract obstruction increases RV afterload and leads to a
rise in end-systolic pressure and contractility 28 whilst over a longer period of
time (application of a pulmonary arterial band) a decrease in cardiac output for
the equivalent heart rate is observed. 29
Congenitally corrected transposition of the great arteries (ccTGA) is an interest-
ing example of a naturally occurring pressure loaded right ventricle within the
context of a two ventricular circulation and demonstrates the importance of the
ventricular-ventricular interaction. There is atrio-ventricular and ventriculo-arte-
rial discordance of the ventricles. In effect the ventricles have swapped
anatomical position. The RV receives oxygenated blood from the left atrium
and pumps to the systemic circulation whilst the LV receives systemic venous
blood and pumps to the pulmonary circulation. In the absence of any other le-
sion this condition may go undetected through childhood 30 as there are no
outward signs or symptoms. Comparing those born with ccTGA to those hav-
ing surgical creation of a systemic RV (atrial baffle groups in TGA) demon-
strates the systemic RV undergoes a set of adaptive mechanisms that are
more complete the closer to birth they occur. 27 However only 25% of those
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with ccTGA without any significant associated lesion develop congestive heart
failure by the fifth decade, rising to 67% in the presence of an associated le-
sion. 31 This is an example of the mechanical interdependence of the ventricles.
The ventricular-ventricular interaction between the healthy LV and RV aug-
ments RV pressure generation and cardiac efficiency. 32 In unison, the RV
enhances LV strain and radial motion via the motion of the septal wall. 33 Ac-
cordingly two ventricles albeit in a switched position (such as in ccTGA) func-
tion better than if there is an absence of one ventricle. 34 This in part explains
why those with a single ventricle circulation do worse than those with a two
ventricle circulation. 
However the presence or absence of a second ventricle in relation to cardiac
function is a simplification as this smaller ventricle is of a variable size. HLHS
represents a spectrum ranging from a non-existent LV (typically a combination
of mitral and/or aortic atresia) to a borderline sized LV (representing mitral and/
or aortic stenosis). The shape and size of the remnant LV on RV function has
been investigated. Furck et al35 performed a 12 year review of a single centre's
experience with the Norwood procedure. Those with mitral stenosis and aortic
atresia had the worst outcomes. The large LV remnant in this subtype was pro-
posed as a piggyback ventricle acting as a functional burden on the systemic
RV with subsequent deleterious effects such as reduced posterior RV wall mo-
tion. 36 Schlangen et al 37 studied 57 HLHS patients and found the contractility
of the systemic RV is unaffected by the size of the rudimentary LV but those
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with the largest LVs have impaired diastolic relaxation as determined by the
end diastolic pressure volume relationship. It is clear that the LV remnant plays
a role on RV function. In ccTGA the well functioning LV supports the systemic
RV, but in HLHS a small dysfunctional LV can be more detrimental than the
complete absence of an LV to the systemic RV function. The energetic basis of
this is examined in Chapter 4.1.
1.3.6 Stage I: - the Norwood procedure
A number of cardiac operations are performed in those with HLHS. An under-
standing of the impact of the different surgical procedures is important to help
understand and explore the mechanisms that impede systemic RV function
and to explain why patients experience a serious burden of comorbidity and
premature circulatory failure. 38 The first stage, the Norwood procedure, is per-
formed soon after birth with the aim of reconstructing the native aorta and
arch, maintaining pulmonary perfusion via a shunt and promoting mixing of
blood with an atrial septectomy. (Figure 4) Three available strategies exist. The
hybrid strategy currently performed in a number of centres is not considered in
this text as it is not a strategy currently employed at the Evelina Children's hos-
pital and data is not readily available. Two variations of the Norwood procedure
are discussed. The use of a Blalock-Taussig shunt was first suggested by Nor-
wood et al. 2 The shunt procedure uses a hollow tube made of polytetrafluo-
roethylene (PTFE) to connect the innominate or subclavian artery to one of the
branch pulmonary arteries allowing blood to shunt from the systemic circula-
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tion to the pulmonary circulation. This is now done by a side-to-side anas-
tomosis and is commonly known as a modified Blalock-Taussig (MBT) shunt.
Early mortality following the Norwood procedure performed via a MBT shunt
was initially 30 - 35%. This was primarily due to infants undergoing a rapid un-
predictable fall in pulmonary vascular resistance in the post-operative period.
This resulted in reduced systemic and coronary perfusion due to diastolic run-
off of blood into the low pressure pulmonary circulation. 38  
Figure 4: Stage I: Norwood circulation. Mixing of blood is maintained by
performing an atrial septectomy. The arch is reconstructed using the main
pulmonary artery and pulmonary circulation is maintained by inserting a shunt
typically between the innominate artery and the branch pulmonary artery (MBT
shunt) (seen on left) or via a right ventricle-to-pulmonary artery conduit (seen
on right). The green dashed lines represent the reconstructed aorta. The solid
green lines show the MBT shunt and Sano conduit.
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In response to the early high mortality rates Sano et al 39 developed an alterna-
tive method to the MBT shunt consisting of a right ventricle-to-pulmonary
artery (RVPA) conduit. A small incision known is a ventriculotomy is made on
the superior surface of the RV and a hollow tube is used to act as a conduit to
connect the RV to the pulmonary arteries. The initial data reported greater
haemodynamic stability with improved short-term survival rates as, although
blood could regurgitate into the ventricle through the valve-less conduit, sys-
temic perfusion was maintained as there was no shunting effect that can cause
a loss of diastolic blood pressure. As our understanding and experience has
improved so has our management of this group of patients. This is reflected by
some UK centres reporting a 30 day survival of 85-90%. 40 
1.3.7 Key studies underlying the choice of Norwood procedure
There is much interest over which type of Norwood procedure has the better
outcomes for patients and many studies have been limited by small datasets or
a lack of randomisation. The Single Ventricle Reconstruction Trial has attempt-
ed to answer this question. A large randomized North American study was de-
signed, 41 it found the RVPA conduit was superior to the MBT shunt for the pri-
mary endpoint of death or transplant at 12 months however the RVPA conduit
had significantly more interventions and complications. At inspection of the
most recent data (3 years) there were no differences in transplantation free sur-
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vival between the two groups. Echocardiographic measures of function found
both RV end-diastolic volume (EDV) and EF superior for the RVPA conduit
group up to Stage 2, but this had equalised between groups by 14 months of
age. 42  
The trial results were remarkable in that they involved 555 patients across 15
different centres being randomised to either a MBT shunt of RVPA conduit and
have represent the largest randomised study to date. However some of the en-
rolled centres operated only on a small number of patients and there was con-
cern about bias as the smaller centres favouring the RVPA conduits had better
results with this technique compared to more balanced results from larger cen-
tres. Furthermore there was a significant loss of patients to followup which
weakens some of the end-points. Despite the equalisation of function at
14months and survival at 3 years of age, a number of questions remain. Regur-
gitation through the RVPA conduit in diastole results in ventricular volume load-
ing. This would alter the shape of the ventricle as it has to pump an increased
blood volume, but does this differ to the MBT shunt where the volume load is
from a combined systemic and pulmonary venous return? The RVPA conduit
requires a ventriculotomy to be performed in the systemic RV, after the conduit
is removed a fibrous non-contractile scar is left which may have the longer
term effects on function that are not yet discernible. Whilst answering the im-
portant question of which procedure is best for early and midterm mortality
results, the SVR trial is limited by the use of how function is measured. Further-
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more the use of ejection fraction to measure function is both a strength in re-
gards to general utility but also a limitation as it is insensitive to early dysfunc-
tion. Could other measures be used to determine the impact of the two
different operations? This idea was the basis for exploring the effects in func-
tional terms of shape and motion. (See Chapter 5).
1.3.8 Stage II - the bidirectional superior cavo-pulmonary 
anastomosis
The second surgical stage is typically performed at 3 - 4 months of age as the
child begins to outgrow the shunt. A direct anastomosis between the superior
vena cava (SVC) and the pulmonary arteries is formed. This is known as a bi-
directional superior cavo-pulmonary anastomosis because blood is able to
flow from the SVC to either the right or left pulmonary arteries. (Figure 5) The
shunt is also taken down resulting in venous return from the head draining di-
rectly to the lungs whilst venous return from the lower body still returns to the
hert and mixes with oxygenated pulmonary venous flow. Stage 2 surgery
reduces the volume overload on the dilated RV leading to improved ejection
fraction. 43 It reduces the work of pulmonary blood flow and increases efficien-
cy by directing desaturated venous blood flow to the lungs in comparison to
the previous arterial-venous mixture. 38 
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Figure 5: Stage II: Superior cavo-pulmonary anastomosis. At 3 - 4 months of
age the shunt/conduit is taken down and a direct anastomosis between the
superior vena cava and branch pulmonary arteries is performed to maintain
adequate pulmonary flow. 
1.3.9 Stage III - total cavo-pulmonary connection
At approximately 3 - 4 years the venous return from the head is diminished as
the body grows and saturations dip due to arterial-venous mixing between pul-
monary venous return and inferior vena caval flow. Surgical completion of a
total cavo-pulmonary connection (TCPC), where the inferior vena cava blood
from the lower body is also routed directly to the pulmonary arteries, creates a










Fontan circulation, 8 and results in an improvement in saturations. (Figure 6)
The method of TCPC has now tended toward formation of a lateral tunnel
(blood is baffled within the atrium) or extracardiac conduit (blood flows through
a hollow tube around the outside of the atrium) with comparable outcomes 44, 45
though some studies 46 suggest those with a tunnel are susceptible to develop-
ing arrhythmias. In some centres a fenestration is created – in effect a small
right to left connection. The addition of a fenestration mitigates early post-
operative mortality but with the consequence of a decrease in arterial satura-
tions which worsen during exercise and the increased risk of a paradoxical
stroke. The benefits of closing the fenestration at a later date are not fully
demonstrated. Meadows et al 47 investigated the closure of the fenestration in
20 patients and found improvements in arterial saturations but with decreased
cardiac output and no improvement in exercise tolerance. However minute
ventilation-CO2 extraction improved during exercise reducing the work of
breathing as CO2 extraction was improved by a reduction in ventilation-perfu-
sion mismatching.  
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Figure 6: Stage III: Total cavo-pulmonary connection. Diversion of the inferior
vena cava either via a lateral tunnel or extra-cardiac conduit at 3 - 4 years of
age maintains pulmonary blood flow. A small fenestration is shown. This
circulation is also known as a Fontan circulation.
1.3.10 Circulatory failure in the Fontan circulation
In those with HLHS, circulatory failure contributes significantly towards mortali-
ty.48 The Fontan circulation exposes patients to high systemic venous
pressures and relative pulmonary hypotension due to the lack of a subpulmo-












a progressive deterioration in function over time. 49 The long-term morbidity for
those with a single ventricle circulation includes reduced exercise tolerance, 2, 6,
18, 47 increasing cyanosis, protein losing enteropathy, 50 plastic bronchitis, ar-
rhythmias and thromboembolic events. 38, 48
The incidence of exercise intolerance following HLHS-Fontan has been
measured at 55-63%. 5 During exercise, patients with a Fontan circulation
exhibit diminished peak oxygen consumption (VO2 max), decreased heart rate
response and lower stroke volumes leading to reduced cardiac output (CO). 51,
52 The causes of exercise intolerance in this group are multifactorial. The lack of
a subpulmonary ventricle, to drive blood through the pulmonary bed alongside
abnormalities in cardiac function and systemic vascular resistance have all
been suggested as contributing to diminished exercise capacity. 7, 53 
The underlying morphological differences underpinning the functional adapta-
tions of each ventricle are outlined in Chapter 1.3.2 and it appears that those
with a single RV (HLHS) are at a higher risk of heart failure than those with a
single LV.4 In a large study, Anderson et al 54 found that the systemic RV has
worse systolic function compared to the systemic LV with diastolic dysfunction
existing in 81% of patients as measured by echocardiography. However the
effects of inadequate preload could induce similar effects, making these differ-
ences difficult to tease out.  
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Systemic RV function is dependent on good returning blood volume (preload).
The preload on the systemic RV is postulated to be inadequate due to the ab-
sence of a subpulmonary ventricle which assists systemic ventricular filling. 7
Other causes of low preload are related to the flow of blood across the lungs
which may be damaged from previous operations and scars. A low pulmonary
vascular resistance (PVR) and low ventricular filling pressures are essential for
augmenting cardiac output especially during exercise. 55 Elevated PVR as a
cause of lowered preload has been proposed as a limitation to pulmonary
blood flow 56 and may be related to down-regulation of endogenous pulmonary
vasodilators, chronic pulmonary microemboli and loss of passive recruitment
of capillaries and loss of pulsatile blood flow. 57 The trans-pulmonary gradient
should increase in exercise 58 mediating a fall in PVR. The absence of a subpul-
monary ventricle means that those with a Fontan circulation are not able to in-
crease pulmonary pressures accordingly. The use of sildenafil, a pulmonary va-
sodilator, has mixed results depending on age. In children it has been shown to
improve ventilatory efficiency during exercise but without improvements in
peak VO2 max. 59, 60 Whilst in older groups of patients the administration of
sildenafil may result in a fall in PVR. 61 
The shape and architecture of the tricuspid valve also display more variation in
HLHS. 62 There is an increased incidence of tricuspid regurgitation (TR) occur-
ring in 25% of patients within 10 years of the Norwood procedure. 63 Severe TR
may require surgical repair due to the volume overload placed on the ventricle
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by re-circulation of regurgitant blood. Reducing TR and hence altering the vol-
ume, shape and amount of work the heart has to perform has been shown to
improve cardiac function and outcomes. 64, 65 
Many patients with HLHS report symptoms of decreased cardiac performance.
The rising number of patients now surviving beyond infancy underlines the im-
portance of being able to accurately assess cardiac function in this group.
However there appears to be a complex interplay between preload, systolic
and diastolic dysfunction. Being able to understand this in more detail may be
beneficial in understanding the underlying disease pathology.
1.3.11 The challenge of determining function in the single RV
Ejection fraction (EF) is typically used to assess and grade ventricular function.
EF measures the change in size of the ventricle between end-systole and end-
diastole and expresses this as a percentage relative to its maximal size at end-
diastole: 
where EF = ejection fraction, EDV = end-diastolic volume, ESV = end-systolic volume
In adults with acquired heart disease, EF is well studied and used extensively
to predict outcomes in those with systolic heart failure. In subjects with HLHS
!" = !"# − !"#!"# !×!100%!
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it has been shown to have a useful prognostic value. 66, 67 However within this
group, a number patients have a preserved EF not in keeping with significant
symptoms of reduced cardiac performance. 5, 68 This discrepancy is likely due
to a number of factors. As in the adult population, diastolic dysfunction may
play a role - also known as heart failure with preserved ejection fraction (HF-
pEF). 54 However difficulty in assessing the RV may be due to the complex in-
terplay of myocardial architecture and loading conditions. 69 For instance: 
• The RV has a very anterior thoracic position, which may limit echocardio-
graphic windows and prevent full assessment of the entire RV structure. 70 
• The systemic RV has a different geometry to a healthy RV and LV and within
the spectrum of HLHS there is a wide range depending on the LV morpholo-
gy. This leads to reduced inter-user reproducibility even on CMR assess-
ment. 71 
• Following surgical shunt/conduit palliation at Stage I, compensated ventricu-
lar volume overloading occurs. Thus despite the presence of significant ven-
tricular dilatation, preserved volumetric performance may be present and not
necessarily in keeping with clinical signs. 7, 72, 43
Other markers of cardiac function have been proposed for assessing the RV as
part of a biventricular system but the significance of these for the single ventri-
cle remains unclear. Early promising work into abnormal tissue doppler indices
73, 74 has recently been shown to resolve when corrected for higher heart rates
which are typical in children or the presence of tricuspid regurgitation which is
Introduction
- 47 -
common in those with HLHS. 62, 75 The prognostic value of findings such as the
presence of prolonged isovolumetric contraction and relaxation times are yet
to be fully understood.
1.4 Cardiac magnetic resonance and its applications
Technological developments in CMR offer the potential to develop new bio-
markers of function alongside the standard volumetric assessment detailed
above to overcome some of the existing limitation in assessing cardiac func-
tion in those with HLHS. (See chapter 1.3.11 The challenge of determining
function in the single RV) This section outlines the uses of CMR for the as-
sessment of those with HLHS at each of the different stages of surgery. It de-
scribes the benefits of the technique and the potential limitations. There then
follows an overview of different CMR sequences that are used for assessing
cardiac function and potentially how they might be developed and applied to
assessing those with HLHS. This will provide the necessary information to con-
textualise and appraise the methods and results included in later chapters.
1.4.1 CMR - advantages and disadvantages
The advantages of using CMR for assessment of CHD 76 are acquisitions are
not limited by anatomy. Images are resolvable in any 2D plane or in other cas-
es in 3D without the limitation imposed by echocardiographic acoustic win-
dows. This is beneficial in assessment of CHD where complex anatomy can re-
quire detailed anatomical reconstruction. Flow, volume, function and shunt
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assessments are possible providing detailed haemodynamic data. CMR does
not expose the patient to ionising radiation. At present cardiac magnetic reso-
nance imaging (CMR) is the gold standard for assessing right ventricular vol-
ume and function. 77–79 It provides detailed non-invasive anatomical and func-
tional data on the cardiovascular system. Most commonly this is used to
measure the change in volume of the heart as it contracts to give a measure of
the function. Importantly, the technology surrounding magnetic resonance
imaging (MRI) is rapidly developing and with it the potential to develop new
translational tools for studying the function of the heart. Detailed 3D imaging of
the heart allows the study of its shape in space and its motion throughout the
cardiac cycle. Advanced flow imaging permits assessment of the whole blood-
pool velocity paving the way for measuring ventricular energetics. 
However CMR is expensive and time consuming. It requires highly trained
operators and clinicians to interpret the data. Patients must be able to to lie
supine and still for a prolonged period of time which may necessitate a general
anaesthetic in those too young to comply. The data quality is not as highly
temporally or spatially resolved as echocardiography. Some implanted metallic
objects are not suitable for the magnetic field and MR conditional pacemakers
and other metallic implants can cause significant susceptibility artefact which
can make interpretation of images more difficult. CMR does not provide inva-
sive pressure measurements unlike catheterisation. Additionally the time for
acquisition is much longer than for CT and requires comprehensive post-pro-
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cessing for data interpretation.
1.4.2 CMR in the assessment of HLHS
In those with HLHS, CMR assessment of ventricular and valvular function and
vascular anatomy is used to plan surgery. 18, 80, 81 It has improved accuracy in
measuring RV volumes in HLHS compared to echocardiography. 82 It has be-
come the gold standard for accuracy and reproducibility in assessment of vol-
ume, mass, and wall motion. 83 Cardiac MRI has become the mainstay of eval-
uating function and anatomy in those with HLHS where available. It has been
shown to be viable for surgical planning prior to Stage II 80 and Stage III of
surgery. It is rarely performed in newborns as the relatively good echocardio-
graphic windows combined with the haemodynamic instability mean per-
forming a MRI under a general anaesthetic is unwarranted.  
Pre-Stage II and pre-Stage III scans have well defined protocols for assess-
ment and have recently been defined by the Society of Cardiovascular Magnet-
ic Resonance (SCMR). 84 Pre-Stage II scans should assess the inter-atrial com-
munication, the presence and degree of tricuspid regurgitation, RV function,
patency of the Damus-Kaye-Stensel anastomosis, arch patency, shunt paten-
cy, size of branch pulmonary arteries and pulmonary vein patency and also the
pulmonary to systemic blood flow ratio (Qp:Qs). The presence of any additional
collateral vessels should also be noted.
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Pre-stage III scans should include all of the above but instead of shunt patency
the superior vena cava (SVC) flow needs assessment. The presence of collater-
al vessels is also assessed using a combination of flow measurements and
MRI angiogram techniques.
At the Evelina London Children's Hospital, pre-stage II and III CMR scans are
performed in accordance with SCMR guidelines however at present those hav-
ing undergone completion of a Fontan (post Stage III) do not routinely undergo
CMR. Scans are performed on a clinical basis and usually come under the re-
mit of the following referral headings:
1. unstable requiring assessment in the peri-operative period
2. routine before transition to adult care typically at 16 years of age
3. increasing exercise intolerance of an uncertain cause
4. increasing cyanosis of an uncertain cause
5. other symptoms of heart failure such as protein losing enteropathy, en-
larged liver or embolism
Scans performed after completion of Fontan can be divided into those requir-
ing CMR for an anatomical assessment and those requiring XMR for a detailed
physiological assessment. The important elements for assessment include pa-
tency of the Fontan pathway, arch obstruction, ventricular parameters and sys-
temic to pulmonary collaterals. 
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The extensive use of CMR based assessment in clinical practice offers the op-
portunity to conduct studies on patients with HLHS undergoing routine clinical
imaging. The following section outlines some commonly used sequences and
how these could be developed into providing additional functional data based
on the concepts of  ventricular shape, motion and energetics.
 
1.4.3 Cine imaging
1.4.3.1 Balanced steady state free precession cine imaging
The motion, size and function of the heart can be captured using cine MR
imaging. Cine imaging is used extensively for assessing ventricular function.
Gradient echo based sequences have short repetition times most suitable for
fast cine imaging. Sequences can be spoiled or balanced. Following the ra-
diofrequency (rf) pulse residual transverse magnetisation can interfere with the
signal during the following repetition time. Spoiled sequences apply a gradient
to dephase this signal at the end of each repetition time. The short repetition
time and echo time give a T1 weighted image. This is appropriate for cine
phase contrast imaging. Balanced imaging utilises an additional gradient pulse
to rephase all transverse magnetisation. After a number of repetitions the
transverse magnetisation reaches a steady state hence the name balanced
steady state free precession (bSSFP) cine imaging. Balanced imaging has in-
creased signal, allowing a larger bandwidth to be used and improving imaging
efficiency.   
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Imaging of cardiac function performed using cine bSSFP imaging generates
white blood images of the heart. Images are acquired at multiple points after
the R wave of the QRS complex over many cardiac cycles. A retrospectively
ECG-gated sequence allows imaging of the entire cardiac cycle in a single
breath hold. Retrospectively gated sequences acquire data continuously
marking the R wave of the QRS complex with a synchronisation pulse. Data is
then allocated at the end of the acquisition of k space. In contrast to prospec-
tively ECG gated sequences, the retrospective acquisition allows capture of
the whole of the cardiac cycle. This is particularly valuable for assessment of
diastolic function or where beat-to-beat variation can alter the R-R wave inter-
val. Prospective ECG gating allows the shortest R-R wave interval to be select-
ed and in some instances under sampling techniques can only be performed if
the data is acquired at fixed intervals after the start of the R wave which does
not occur in retrospectively gated sequences where the desired number of
phases are stretched to fit into the given cardiac cycle (Figure 7).
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Figure 7: Prospective vs. retrospective ECG gating. Normal variability within the
R-R interval of the ECG means a trigger window needs to be employed in
prospectively ECG-gated sequences so as to await the next R wave. A small
portion of the beginning and end of the R-R interval is missed. Retrospectively
ECG-gated sequences acquire continuously and re-arrange the data into
phases after detecting the next R wave. This can lead to small differences in
the timing of acquired phases between different cycles.
CMR permits the heart to be imaged in any 2D plane determined by the opera-
tor. Long axis imaging provides functional data on the longitudinal function of
the heart whilst a stack of cine image slices orientated in the short axis plane
allows assessment of end diastolic volume (EDV), stroke volume (SV) and cal-
culation of ejection fraction (EF) and wall mass. Cine stack imaging can be
used to determine ventricle size throughout the cardiac cycle. Cine data can
may be used to look for jets of turbulence caused by stenosis, to look for re-
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gurgitation through incompetent valves or assess wall motion abnormalities. 84
Calculation of ventricular parameters involves segmentation of the ventricular
cavity. Manual tracing of the endocardial contour for each slice from apex to
base at end-systole and end-diastole allows calculation of the blood volume
via the modified disc summation method and also an accurate measure of
ejection fraction (See chapter 1.3.11 The challenge of determining func-
tion in the single RV). The position of the atrio-ventricular valve can be con-
firmed by linking the short-axis stack to the four-chamber view of the ventricle.
In addition an epicardial contour at each slice in end diastole only allows calcu-
lation of the myocardial wall mass. An axial stack of slices offers less variability
for the RV but not necessarily greater accuracy. 85 Consistency between inclu-
sion or exclusion of papillary muscles and trabeculations is important to ensure
low inter-operator variability. 84 
1.4.3.2 Motion Assessment: Strain and deformation
Cine imaging permits assessment of the motion of the ventricle in different
short or long axis planes. Motion can be quantified using strain to assess both
systolic and diastolic function. This section reviews the possibility of utilising
strain as a measure of function in those with HLHS.
Strain analysis is a measure of the change in length of the heart relative to the
original length. It is unitless and expressed as a percentage. 
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where ε = strain, L1 = length after deformation, L0 = original length
A shortening is represented by a negative value whilst a lengthening has a pos-
itive value. There are two forms of strain and whilst Langrangian strain, a
measure of strain relative to a fixed length, is usually quoted in clinical practice
it has been suggested that Natural strain, strain measured relative to a refer-
ence value which can change with deformation, may be more suitable for car-
diac practice. Strain rate can be derived from this and is a measure of the rate
of change in length and measured in s-1.  
Strain has been seen to be useful for detecting early cardiac dysfunction in
adults with cardiomyopathy. It is more sensitive than ejection fraction 86 as the
ventricular hypertrophy that is frequently seen as a response to dilatation
leaves ejection fraction preserved or even supranormal. 87 Strain could be ap-
plied as a useful potential early biomarker in those with HLHS -they also
demonstrate ventricular hypertrophy and dilatation as a consequence of vol-
ume loading shunt/conduit surgery leaving EF relatively insensitive to dysfunc-
tion. (See chapter 1.3.9 Stage III - total cavo-pulmonary connection)
However strain data is reliant on the quality of the acquired cine imaging and is




therefore prone error if there is wrapping artefact or poor breath-holds which
can distort data. Additionally as cine data is an average of multiple heart beats
so too is strain - it is a measure of the average motion of the heart so reliant on
a regular heart rhythm
1.4.3.3 Key studies in strain imaging in HLHS
The gold standard for MR strain analysis is tagging. 88, 89 There are a number of
studies and reviews assessing strain rates in the healthy heart. 90–92 Consistency
between different studies is greatest for longitudinal and circumferential strain
values. 93
Fogel et al 34 assessed the motion of the systemic RV in 7 patients with HLHS
and compared this to 11 patients with ccTGA using 2D MR tagging techniques
to compare the inter-ventricular effects on wall motion. Strain was altered de-
pending on the presence or absence of a LV. The presence of a LV augmented
strain values and decreased heterogeneity. In comparison to the healthy LV the
systemic RV in HLHS has abnormal clockwise twist apparent in the inferior wall
and altered radial shortening. It is unsure whether these changes are due to in-
complete remodelling, altered electrical activation pathways, ischaemia or an
idealistic energy state for the given situation. A further study by the same
group found strain in the single RV altered across operative stages. Those
having completed Stage II surgery had the lowest strain values. This was pos-
tulated due to any one of volume unloading, baffle placement or even the
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results of surgical scar formation. These studies were interesting in that they
were able to compare a range of single ventricle types albeit in a small number
of patients. However the age range between patients was not comparable due
to the small number enrolled in the study making broader inferences difficult.
The major limitation of this type of MR tagging technique is that they require
complex post-processing  which is not readily available.
Echocardiographic measures of strain are commonplace and speckle tracking
based methods have been pioneered for angle independency. Studies per-
formed in those with HLHS show significant mechanical dyssynchrony of the
systemic RV 94 in the presence of a normal ECG. Application of echo strain
imaging specifically to those having undergone a RVPA conduit as part of the
Stage I Norwood procedure localises abnormal regional strain to the right ven-
tricular outflow tract 95 corresponding to the position of the ventriculotomy
scar. 96 These measures have the advantage of bedside assessment but they
are limited by acoustic windows, RV geometry, 70 and the quality of the image.
There is also a large standard deviation on regional strain data of this type
which may reflect a degree of inaccuracy or inter-user variability.
Feature tracking (Diogenes MRI, Tomtec, Germany) analysis utilises MRI
steady-state free precession cine imaging of the heart to provide strain data.
Conventional short axis and long axis SSFP cine images are used. The endo-
cardial borders of the RV are manually defined in one time-frame and then
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automatically propagated using the analysis tool. The software propagates the
endocardial contour through all time frames tracking the endocardial-blood
border and adjacent features to provide strain data based on voxel motion
tracking. This data can be regional or global to give a measure of systolic or di-
astolic function. The primary benefit of feature tracking is that it rapidly extracts
measures of strain from conventional MR imaging techniques. 97 This allows
the analysis of large amounts of data retrospectively from the acquisition of
data from routine clinical scanning. It is not limited by acoustic windows.
Global assessment of circumferential strain using feature tracking correlates
highly with tagged imaging in children with heart failure, 98 although only a mid-
ventricular slice was used in this study. It also correlates in adult patients with
myocardial scar in comparison to echocardiographic measures of function . 97
Strain has been shown to be strongly linked to outcomes in those with LV dys-
function using echocardiographic speckle tracking which has the disadvantage
of being angle dependent. 99 Those with altered global circumferential strain
display the strongest likelihood of an adverse event. It is possible to track al-
tered myocardial motion during dobutamine stress imaging. 100 
The major advantage of feature tracking is that the technique can be applied
retrospectively to existing datasets. However feature tracking derived strain
values are susceptible to high inter-user variability particularly for longitudinal
and radial regional segmental assessments 98, 101, 102 with better reproducibility
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for global rather than segmental analysis. 101, 102 
Utilising MR based strain analysis could be suitable for assessing the RV pro-
vided the limitations surrounding its interpretation are understood. Feature
tracking is easy to use and can be applied to cine data which is readily collect-
ed. However the use of feature tracking does not have the same level of inter-
user reproducibility as 3D tagging. Additionally the current methods of deriving
and analysing regional strain are not validated and must therefore be viewed
cautiously.
1.4.3.4 Computational assessment: Shape and function
A stack of cine images can be used to determine the shape and size of the
ventricle at any point during the cardiac cycle. Computational tools have been
used to generate 3D atlases of cardiac geometry using cine imaging of the
ventricle to compare differences in ventricle shapes in 3D space. 103, 104 Rather
than being limited to volume, wall mass and ejection fraction these techniques
allowed a comprehensive three dimensional assessment of shape, orientation
and topology without pre-supposing any particular shape or aspect. They were
successful in showing differences in LV shape in babies born prematurely com-
pared to at term. 105 However these techniques are time consuming and re-
quire technological expertise and vast amounts of post-processing of data.
The results are also difficult to interpret without referencing traditional
measures of size. Applying this technique to those with HLHS where the right
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ventricle is exposed to a selection of surgical procedures would allow the cre-
ation of a map of 3D geometry and to determine the impact of the procedures
on the ventricular shape. This may permit subtle differences in shape to be de-
tected before they are apparent to the naked eye or through global measures
of size such as EDV alone. 43 
Computational modeling has an role in helping to understand and analyse
haemodynamics in those with HLHS. It has been used to assess systemic RV
filling. 9 A ventricle with effective energy conservation imparts just enough ki-
netic energy to the blood to achieve sufficient cavity expansion with minimal
energy loss. A toroidal ring forms beneath the TV during early inflow growing in
size and moving apically followed by atrial contraction and the creation of a
second ring. If atrial contraction happens early (fused EA waves) then the new
blood adds to the existing toroidal ring causing energy losses through viscous
dissipation. Lower cavity aspect ratios (dilated shaped hearts) displayed the
greatest viscous energy dissipation. These hearts impeded the normal move-
ment of toroidal flow of blood towards the apex of the heart instead causing it
to spread out and leading to energy loss. These models of inflow haemody-
namics are theoretical and based on a number of modelling parameters. Other
work has concentrated on modelling blood flow through the Fontan circuit 106–
109 demonstrating that shape can significantly alter haemodynamics and energy
losses. Whilst a potential powerful tool in simulating blood flow and the effects
on the heart, computational models are only as powerful as the data that is fed
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into the algorithm and errors can be multiplied if the given assumptions are not
well understood. Implementing these techniques and trying to correlate them
to function may be the first step towards us gaining a better understanding of
heart physiology and function and as models receive greater data inputs the
results will be more refined. The use of computational shape modelling is used
to assess the impact of the different Norwood operations on the shape of the
RV. (Chapter 2.12).
1.4.4 Phase contrast flow imaging
1.4.4.1 2D phase contrast imaging
Flow MRI is used extensively for assessing shunts, stenosis, regurgitation,
differential pulmonary arterial flow and significance of collateral vessels in
those with HLHS. The velocity and flow of blood can be determined by utilising
velocity encoded cine (VENC) spoiled gradient echo sequences. Placing the
body in a homogenous magnetic field causes an equal phase shift of all mag-
netic spins irrespective of whether static tissue or moving blood is assessed.
Applying a gradient across this field causes spins to precess at a frequency
according to their relative field exposure (Figure 8). In addition blood moving
though the field gains a different phase. The spins within static tissue can be
re-phased by applying an equal but opposite gradient echo resulting in the
spins of blood flowing into the slice ending with a different phase. This is pro-
portional to the velocity of the blood. Phase discrepancy can also occur
through motion along more than one direction and from magnetic field inhomo-
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geneities. A second acquisition with a different flow sensitivity minimises veloc-
ity changes only to the flow encoded direction. 110 Resultant images are dis-
played on a greyscale with white indicating flow towards and black indicating
flow away from the flow encoded direction. 
Figure 8: Blood and static tissue in a magnetic field. The application of a
bipolar gradient causes static tissue to become rephased whilst moving blood









1.4.4.2 4D phase contrast imaging
Developments in flow analysis now permit the acquisition of time resolved
three dimensional velocity mapping also known as four dimensional (4D) flow
MRI. 111 Visualisation of blood flow in a 3D volume over time permits both quali-
tative and quantitative analysis of motion patterns and retrospective analysis of
flow in any desired plane.112 The potential applications include flow volumes,
pulse wave velocities, 113 pressure gradients, 114 wall shear stress 115 and turbu-
lent kinetic energy, 116 alongside providing important new insights into flow
characteristics and pathological adaptations such as in those with a bicuspid
aortic valve. 117
4D flow MRI provides a detailed overview of the velocity of blood in three di-
rections helping to capture the intricacies of blood flow within the heart.
Echocardiography is reliant on flow being directed towards or away from the
insonation point. Velocities may be underestimated when using 2D echocardio-
graphy. Applying 3D techniques allows assessment of the peak velocity within
the voxel irrespective of the vector direction. Three-dimensional CMR acquisi-
tions provide a detailed overview of the velocity of blood in three directions
helping to capture the intricacies of flow within the whole heart. This is impor-
tant, as filling of the LV cavity does not occur solely from base to apex. Vor-
tices form below the mitral ring and move apically during healthy diastolic fill-
ing. 11 2D PC MRI or echocardiography may miss these subtleties, or require
larger study populations before differences become detectable. Additionally
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the mitral valve is elliptical and moves throughout the cardiac cycle. 118 It be-
comes distorted in cardiac disease such as DCM making accurate plane orien-
tation for 2D PC flow techniques more technically challenging. Three-dimensio-
nal flow echocardiography is currently a tool under development but this too is
limited by the patient’s habitus. 119 This detail is not adequately captured by
two-dimensional (2D) doppler echocardiography or 2D PC flow MRI which are
limited to a single imaging plane and measure velocities in only one direction. 
Initial 4D flow sequences performed a flow encoded and flow compensated
measurement per direction known as a six-point technique. This was extremely
time consuming. Current sequences make only four measurements, a refer-
ence scan and velocity scan in each direction, and are known as four-point
techniques. This has improved scanning time. 120 However 4D flow still remains
limited by the acquisition time. Multiple acquisitions for determining velocity di-
rection are required. Flow measurements must be respiratory gated to avoid
movement artefact and triggered according to the cardiac cycle. Conventional
sequences require 20minutes, not including navigator efficiency, and thus may
be 30 - 40 minutes in principle. 121 Furthermore 4D flow is highly sensitive to
eddy current effects, 122 Maxwell terms, gradient field distortions 123 and veloci-
ty aliasing. 124 Early work suggests higher Tesla scanners may provide greater
signal-to-noise ratios but are yet to be used clinically. 125 Following the acquisi-
tion post-processing techniques must be performed to remove these inaccura-
cies before the dataset is suitable for analysis.
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Advances in acceleration techniques 126 have brought down nominal scanning
times to the region of 5 - 7 minutes for high resolution whole heart acquisitions.
Prospective ECG gating allows advanced data encoding methods and acceler-
ation techniques offer increases in acquisition time by a factor of 8 over fully
sampled acquisitions. However due to the need to ECG-trigger from a R wave
the cardiac cycle is incompletely sampled (Figure 7). The effects of this need to
be evaluated. Furthermore the accuracy of accelerated reconstructions partic-
ularly in relation to temporal and spatial blurring requires evaluation before rou-
tine introduction into clinical practice. 
Despite long acquistion times 4D flow MR technqiues are beginning to be em-
ployed as a diagnostic tool particularly for CHD where complex anatomy and
flow patterns can be difficult to interpret when limited to two dimensions (Fig-
ure 9). Amongst other uses they have been used to describe flow patterns in
those with bicuspid aortic valves, 117 describe pulmonary arterio-venous
malformations, 127 to assess haemodynamics in single ventricle circulations 128,
129 and to quantify blood flow in patients with complex shunts. 130
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Figure 9: Pathlines in a criss cross heart. The colour of the pathlines are
velocity encoded with the fastest velocities displayed in red and the slowest
velocities in blue. In this congenital heart condition the inflow of blood into
each ventricle can be seen to cross at the atrial level. 4D flow imaging helps us
to understand complex anatomy in 3D.
Clinical interpretation of 4D flow data is usually in the form of either traditional
quantitative measurements of flow through segmented blood vessels or quali-
tative descriptions of streamline or pathline data. Streamline data represents
the instantaneous velocity vector of a particle and changes with each phase of
the cardiac cycle. Pathline data averages the path that a particle takes through
the cardiac cycle to form pathlines. Proprietary software such as GTFlow (GT-
Introduction
- 67 -
Flow, Gyrotools, Zurich) or EnSight (CEI, Research Triangle Park, NC) are used
to both visually assess the data and extract flow measurements. Despite the
potential of 4D flow CMR particularly in CHD, the current limitations to mass
clinical introduction remain acquisition time, resolution and accuracy, along-
side a suitable workflow for timely post-processing. 
Proprietary software is used to analyse the images. The vessel of interest is
identified and a region of interest drawn around it. The contour is propagated
across all time points. Adjustments are made to the contour to account for
vessel motion during the cardiac cycle. Values for forward flow, backward flow,
peak velocity and cardiac output amongst others can then be determined. 
1.4.4.3 Errors in flow imaging
An understanding of sources of error in PC flow acquisition is important as an
appreciation and suitable allowance for these effects must be made in the in-
terests of accuracy. Phase contrast (PC) images are susceptible to phase
correction errors. 131 Phase correction errors represent the apparent presence
of flow in static tissue. The error accumulates into areas of true flow leading to
a 1 - 2% error. This cumulative error can result in stroke volumes much greater
than expected. Phase offset errors, eddy currents and concomitant field gradi-
ents are caused by the steep magnetic field gradients alongside the paramag-
netic affect of tissue. Post-processing can correct for this by creating a region
of interest (ROI) within static tissue where there is no apparent flow and
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deducting this from flow within vessels or else by defining static tissue across
the whole image and calculating a correction slope which can be subtracted
from the whole image to improve accuracy. Measuring the flow of blood
through a 2D slice requires a plane orthogonal to the vessel to be determined.
Selection of an off-angle slice leads to underestimation of the true velocity of
blood. 132 A true representation of a wave requires sampling at a rate of twice
the frequency (Nyquist limit). Correct selection of the VENC by the MRI opera-
tor determines the sampling rate. Values lower than the real velocity result in
aliasing within the image and values above the velocity lead to decreased sen-
sitivity to low velocities. Selection of the correct temporal and spatial resolution
by the operator is important to minimise operator error and record accurate
flow measurements.
1.4.4.4 Kinetic work
There has been recent interest in the use of four-dimensional (4D) phase con-
trast (PC) flow magnetic resonance imaging (MRI) to non-invasively measure
intra-cardiac kinetic energy (KE). 10, 118 Kinetic energy (KE) is the amount of en-
ergy required move blood due to its inertia. 133 Although a small proportion of
the overall energy that the heart consumes per beat; alongside stroke work it is
part of the work performed to eject blood and therefore a marker of the useful
work of the heart. 134 
The total energy expenditure of the heart per beat is composed of the internal
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and external work. Internal work represents a large proportion of the work of
the heart with the energy used to rearrange cytoskeletal structures; stretch
elastic and viscous elements in the myosin cross bridges and maintain cell
membrane potentials. Much of the internal energy consumption is released as
heat energy contributing to the heart’s inefficiency. 135 External work is referred
to as the useful work of the heart and is composed of stroke work and kinetic
work. Stroke work constitutes the greater part and is the energy used to over-
come the systemic blood pressure. The remainder of the external work is im-
parted as kinetic energy onto the blood volume. Importantly kinetic work can
now be derived non-invasively offering the opportunity to study it in detail with-
out the risks of an invasive catheter intervention. (See chapter 1.4.5.2
Pressure-volume analysis) Whilst metrics such as ejection fraction give a
measure of the change in shape of the ventricle it provides no idea of its ener-
getic cost. Measuring kinetic energy would give a measure of part of the useful
work performed by the heart in pumping blood. This has led to a growing inter-
est into its applicability.
Investigating KE parameters in those with HLHS would offer an opportunity to
study the energetic changes that occur in the systemic RV. The dilated hyper-
trophic RV often has normal values not in keeping with patients perceived
symptoms. Assessing how the useful work of the heart is altered might provide
insights into its efficiency. The heart beats over 100000 times per day and
small inefficiencies would accumulate up over time. Therefore small inefficien-
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cies could become significant over months or years. There is however currently
no literature on measuring KE in those with single ventricle circulations and the
majority of work has focused on determining the intra-cardiac KE of blood to
ascertain normal indices in health. 
Prec et al 136 were one of the first to try and determine the role of KE as a 
proportion of the total work performed by the heart. Limited by the 
angiographic techniques of the time they found that the KE of the right heart 
represented 2.4 - 12.5% of total external work and the KE of the left heart 
represented 0.25 - 2.0% of total external work. The differences were thought to
be due to the higher systemic vascular pressures compared to pulmonary 
artery pressures that the respective ventricles had to work against. This work 
formed the first study into KE. It was limited by the methods available at the 
time with values derived by making assumptions on fixed vessel sizes and 
mean pressure values.
The methods of calculating the kinetic energy from 4D flow differ slightly be-
tween research groups but follow the same principles. Firstly a 4D flow se-
quence is used to measure velocities in a whole-heart volume. Balanced SSFP
images are acquired and used to segment the blood pool. Kinetic energy is
then calculated using the formula:
Kinetic energy = ½ mass x velocity2
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Carlsson et al 118 took the sum of the kinetic energy of each particle within the
ventricular cavity at an instantaneous time point. The KE value was then plot-
ted for each time point through the cardiac cycle. Both the right and left ventri-
cles were found to have three peaks of KE during the cardiac cycle coinciding
with systole, early diastole and atrial contraction. The RV had a higher systolic
peak (7.5 ± 0.8mJ) than the LV systolic peak (4.9 ± 0.4mJ) due to better con-
servation of energy and the different outflow tract geometries. In both ventri-
cles the early diastolic peaks were larger than the late diastolic peaks. The LV
early diastolic peak was higher than the RV early diastolic peak. This was pos-
tulated to be due to a suction effect from elastic recoil of LV muscle and the
different movement of the tricuspid valve plane which acted like a hinge sliding
over static blood rather than imparting energy onto it. Mean values over the
cardiac cycle for both ventricles were very similar (RV 2.3 ± 0.3mJ; LV 2.1 ±
0.2mJ). During exercise the proportion of kinetic energy imparted to blood is
thought to rise. Computational modelling predicted a 57-times increase in KE
at peak exercise (rising from 0.3% to 2.9% of total work) in contrast to poten-
tial energy, which increased only 7-times. 118 This was more pronounced in the
RV where KE increased from 2.8% to 24% of the total work of the heart. Con-
ditions with outflow tract obstruction displayed higher KE proportions relative
to external work as the smaller cross-sectional area for flow meant that where
cardiac output was preserved the blood velocity and consequently the KE had
to increase. 133 This study used only a small number of healthy volunteers with
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a narrow age range to determine normal intra-cardiac parameters. The method
of determining KE was computationally intensive. They were not able to exer-
cise their patients and relied on a computational model to describe these
effects.
Fredriksson et al 10 assessed the pathway of different flow components of
blood. Particles were seeded at end systole and pathline analysis used to de-
termine different components of flow. Flow was divided into: 
1. particles entering and leaving the heart in one cycle; 
2. particles entering but not leaving; 
3. particles starting in the heart and leaving and; 
4. particles that remain in the heart for more than two cycles.  
The peak velocity achieved at each timepoint for each flow component was
summated, before being divided by the flow component volume to form an en-
ergy density. Direct flow in the RV followed a curving route that did not extend
into the apex. Furthermore it comprised the largest volume of blood in the ven-
tricle at end diastole and possessed the highest pre-systolic energy (0.4 ± 0.3
mJ/particle) of all the flow components. Assessment of the inflow patterns
demonstrated that they follow the motion of the atrio-ventricular valve plane.
The right atrio-ventricular valve plane is hinged and accordingly the tricuspid
valve inflow sweeps around the infundibulum. The movement of the left atrio-
ventricular valve is in the long axis direction of the ventricle. Mitral valve inflow
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is towards the apex and changes direction in the mid-portion of left ventricle.
This correlated with computational models of ventricular inflow. 12 This study
used a differing method of determining KE but the magnitude of the values
were comparable to other studies indicating the validity of the differing tech-
niques. However the determined parameters of KE were only in health with no
description of disease.
Most recently Arvidsson 134 assessed atrial kinetic energy using a similar intra-
cavity time summation method. Three peaks were found during the cardiac cy-
cle coinciding with ventricular systole, early diastole and atrial contraction. The
left atrial peak KE was greater than the right atrial peak KE in early diastole and
correlated directly with the ventricle wall mass indicating that LV wall recoil is
essential for LV filling in early diastole whereas the RV fills by conserved helical
flow and AV plane motion. Reassuringly KE values from each of the three stud-
ies studies have all been within the same magnitude despite differing tech-
niques for deriving the values. Atrial values of KE are extremely small and
whilst physiologically interesting the clinical impact is yet to be understood.
Early work considering the effect of heart failure on intra-ventricular kinetic en-
ergy has begun. 137 The presence of disease is seen to change kinergetics.
Eriksson 137 used the same method as Fredriksson 10 to calculate KE for differ-
ent blood flow components. Patients with LV dysfunction had a smaller propor-
tion of direct flow compared to the healthy adults but with a similar energy
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density. The retained flow (>2 cycles) contained a much higher energy density.
This indicated that ventricular dysfunction changes the energetics within the
heart with less efficient flow mechanisms occurring as demonstrated by a
reduced direct flow component (loss of energetic momentum) and higher end
diastolic volumes with higher energy density of the large residual component.
Interestingly they were able to show that KE indices are altered in the small
number of dysfunctional ventricles that they studied. This was not correlated
with any clinical outcomes. However it does show the potential for this to be
utilised in those with HLHS as a potential marker of dysfunction. See Chapter
4.
1.4.5 XMR - Combined catheter and MRI imaging
1.4.5.1 XMR - Applications, advantages and disadvantages
Combined cardiac catheter and MRI guided imaging (XMR) involves the simul-
taneous placement of a vascular catheter whilst undergoing a MR scan to pro-
vide detailed insights into circulatory physiology. It provides simultaneous
catheter derived pressure and MRI derived volume data which is more accu-
rate and reproducible than values derived solely by either catheter techniques
or MRI techniques. 138 This is in contrast to utilising only one modality which in-
troduces assumptions which can skew the data. For instance: 
- using only a catheter technique requires extrapolating the area from a ven-
triculogram into a volume 
- CMR alone provides volumetric data but no indication of pressure data
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- echocardiography is simple to perform as a bedside investigation but it does
not provide pressure data and also requires area to be converted into a volume
which is not as robust for the RV as it is for a normal shaped LV due to its
differing shape. 
Despite the advantages of XMR, catheter derived measures of resistance and
shunt quantification are still in common use in many centres. The uptake of
XMR is limited by the high level of expertise, equipment, time and post-proces-
sing required. XMR has the disadvantages of all of the risks expected of a
catheter based procedure including, but not limited to, bleeding, infection,
valve and vessel damage and thromboembolism. 139–143 Furthermore conduc-
tance catheters are not suitable for the MR environment necessitating the need
for MR safe equipment. 144 Fluid filled catheters are therefore used and are
more susceptible to dampening of pressure traces. However where available it
offers the potential for accurate, reproducible data that can be used to guide
clinical management.
The current clinical practice for patients at the Evelina hospital with HLHS and
exhibiting signs of heart failure is for them to undergo XMR for assessment of
their PVR, and additionally ventricular pressures and presence of collateral
vessels. This procedure has been well described 145 and is frequently per-
formed in coǌunction with a pharmacological stress study to assess the re-
sponse of PVR to higher heart rates (see Chapter 1.4.5.4. ). At present only
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vessel flow and ventricular volumes are recorded but the use of XMR allows for
a much richer dataset to be analysed. The combination of pressure, volume
and flow data allows for an in depth study of ventricular haemodynamics. In
particular both systolic and diastolic function as well as preload and afterload
can be derived. In Chapter 1.3.11 the difficulties in accurately assessing RV
function were described. XMR provides valuable pressure data in addition to
flow and volume data allowing functional indices to be characterised under the
particular loading condition at that time. Studying the energetics of the sys-
temic RV using XMR techniques to express the performance of the systemic
RV in terms of work and energy could provide useful insight in to the function
of the ventricle. 146, 147 The literature covering energetics in those with HLHS is
sparse. Studies generally involve small sample sizes or data is collected during
separate procedures which may not be physiologically accurate. The main
studies and their outcomes are discussed below and despite the small amount
published it opens the opportunities for some interesting work to be done in
the area.
Tanoue et al 148 used an estimation method to assess the mechanical efficiency
of a 3 staged or 2 staged surgical palliation in those with HLHS. They showed
Stage II interim surgery is beneficial for high risk patients as it removes the vol-
ume loading on the single ventricle allowing contractility and mechanical cou-
pling to improve in comparison to those proceeding directly from Stage I to
Stage III. These results are in keeping with the results noted by clinicians where
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better outcomes occur with a staged technique. Senzaki et al 149 used
pressure-area analysis to show Fontan patients have lower cardiac index due
to higher afterload and abnormal contractile response to inotropic agents. It
should be noted that many of Senzaki's studies were later withdrawn by the
publisher due to improper ethical consent. Schmitt et al, 150 applied XMR to as-
sess load independent markers of function. The technique was first verified in
animal studies 151 and then pressure-volume loops were created in a heteroge-
nous group of subjects with single ventricle circulations. 150 Aorto-pulmonary
flow was found to augment pulmonary blood flow with increasing pharmaco-
logical stress. Importantly they demonstrated the feasibility of using XMR to
derive some measures of energy and also load-independent measures of func-
tion using pressure-volume loops. 
1.4.5.2 Pressure-volume analysis
Pressure volume-analysis provides an interesting assessment of ventricular
work in particular the use of load independent assessment of function. Many
markers of ventricular function are load dependent. They vary according to the
patient's current physiology and can change depending on whether they have
drunk well or are dehydrated. Load independent markers reflect the intrinsic
property of the heart and do not vary in this fashion. This is important as load-
ing conditions vary tremendously between operative stages in patients with
HLHS. Patients frequently demonstrate preserved compensatory ejection frac-
tion values. This is one of the reasons for ejection fraction being relatively in-
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sensitive towards detecting early cardiac dysfunction. (See chapter 1.3.11
The challenge of determining function in the single RV) If the pressure-
volume analysis could be applied to those with HLHS then additional meaning-
ful data could be used to understand the ventricle's properties. XMR is avail-
able and already utilised safely in other forms of congenital heart disease. at
the Evelina hospital. The challenge is to generate pressure-volume loops for
analysis. This following section provides a brief overview of pressure-volume
loop physiology as a background for developing this into a study of ventricular
function in those with HLHS. 
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Figure 10: Typical pressure volume loops seen in the healthy LV. A counter-
clockwise rotation of the curve occurs through the cardiac cycle. Starting at
the lower right point which coincides with end-diastole, the heart first
contracts with no change in volume, the isovolumetric contraction time. As the
aortic valve opens blood is ejected and the volume falls. At end-systole the
aortic valve closes and pressure falls with no change in volume, the
isovolumetric relaxation time. The opening of the atrio-ventricular valve causes
filling of the heart and return to the starting point.
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The PV loop shows the simultaneous ventricular pressure against ventrciular
volume over the cardiac cycle as the heart ejects and fills during systole and
diastole respectively. The stroke work performed by the heart can be derived
from the area represented by the ventricular pressure-volume (PV) loop (Figure
10). 135, 152 A cardiac catheter is placed within the ventricle whilst the change in
ventricular volume is measured. 
Varying preload whilst maintaining a fixed arterial resistance and stable con-






Figure 11: ESPVR and Ventriculo-arterial coupling ratio. (a) Varying preload
allows the construction of multiple PV loops. The ESPVR follows a broadly
linear trend whilst the EDPVR is non-linear. (b) The internal and external work
of the heart can be measured by the area encompassing the PV loop and the
ESPVR and EDPVR. (c) Inotropic agents increase myocardial contractility
resulting in a increase in the slope of the ESPVR (Ees). (d) Afterload is the
gradient of a line drawn between the end diastolic volume and the end systolic
pressure (Ea). The relationship between contracility and afterload is known as
the ventriculo-arterial coupling ratio (Ees:Ea) and is a measure of hydraulic
coupling between ventricle and vessel.
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The end-systolic pressure points of each loop have a broadly linear relationship
within physiological ranges known as the end-systolic pressure volume rela-
tionship (ESPVR). 153 In expressing the heart as a time varying elastance model
the slope of the ESPVR is a measure of the contractility (Ees) or elastance of
the ventricle under that given condition. This is the pressure required to elicit a
change in volume or its resistance to expand. A similar line can be drawn be-
tween the end-diastolic points of each loop and is referred to as the end dias-
tolic pressure volume relationship (EDPVR). The slope of the EDPVR represents
the relaxation properties of the heart. The area encompassed by the EDPVR,
ESPVR and isovolumetric contraction lines represent the total work the heart
performs (Figure 11b). 152 Increasing contractility increases the slope of the ES-
PVR (Figure 11c). ESPVR and EDPVR are load independent parameters as they
do not vary based on preload or afterload. They provide an important measure
of the intrinsic properties of the heart. 
The relationship of end-diastolic volume (EDV) to the end systolic pressure
gives the afterload that the heart pumps against. It is a measure of the elas-
tance of the artery (Ea). (Figure 11d) Afterload is a better marker of end systolic
ventricular stress compared to systemic vascular resistance which is more re-
flective of peripheral vasomotor tone. 154 The ratio of Ees:Ea is known as the
ventriculo-arterial coupling ratio. 155 It is a measure of the ability of the arterial
system to match the hydraulic load imparted onto it by the ventricle contract-
ing and ejecting blood. The greatest mechanical efficiency occurs when after-
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load is less than Ees.
Maximal stroke work occurs when Ees equals Ea, 155, 156 corresponding to a ra-
tio of SV to effective EDV of 50%. In other words ejection fraction is also 50%.
However EF is not usually less than 50% in healthy individuals and in vivo en-
ergetic efficiency occurs at higher ratios 155 with a typical ratio of Ees:Ea usually
1.5:1.0. 147, 157 The heart is able to maintain work and efficiency at 90% of opti-
mal values between a large range corresponding to ejection fractions between
40-80%. As a healthy person ages the arterial vessels become more stiff and
this is represented by a fall in Ees:Ea. 158, 159
Deriving PV loops from a XMR approach requires a number of considerations
to the methodology to ensure useful physiological data is being collected. Tra-
ditionally, deriving ESPVR involved occluding the systemic veins to alter the
preload on the heart. The subsequent pressure and volume change over multi-
ple beats were averaged and used to plot the ESPVR. (See chapter 1.4.5.2
Pressure-volume analysis) However CMR based ventricular volumetric cine
assessments are acquired over a number of minutes making the effects of a
temporary occlusion obsolete before the end of the acquisition. Therefore de-
riving ESPVR by this method would be inaccurate. The single-beat estimation
method appeared to be a promising alternative. It was initially described in the
LV, 160 and has since been validated for the RV 161 and more recently in single
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ventricle physiology.150, 151 Making the assumption that for the physiological
range the ESPVR is broadly linear, Brimioulle et al 161 described a method by
which the maximal pressure generated by the heart is estimated at each state
based on the intersection of two lines representing maximal rise in pressure in
systole (dP/dtmax) and the maximal fall in pressure in diastole (-dP/dTmin). This
pressure value is plotted against the volume of the ventricle at end diastole. A
line linking this point to the end systolic pressure point of the PV loop provides
a reliable estimate of the ESPVR. Most recently applying combined cardiac
catheter and MRI techniques to assess pressure volume loops and ESPVR has
been validated for the single ventricle physiology. 151, 162 However the single-
beat estimation method technique is not applicable for estimating EDPVR
which follows a non-linear relationship. In place of EDPVR, Tau (τ), the early
relaxation constant, has been shown to be a reliable substitute as it is relatively
load independent.149, 150 It is calculated from the reciprocal of the natural loga-
rithm of the early maximal fall in ventricular pressure during diastole.
Studying the energetics of the systemic RV using XMR techniques to express
the performance of the systemic RV in terms of work and energy could provide
useful insight in to the function of the ventricle. 146, 147 It appears feasible albeit
with a modified approach to deriving parameters of contractility and relaxation.
Patients would require an anaesthetic, (the effects of this are considered in
chapters 3.2.6) and patients would still be exposed to the same risk of any
catheter based techniques. Applying PV loop based analyses in those with
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HLHS would require consideration and minimisation of these risks. 162 However
load independent measures of function and an energetic assessment would be
useful in providing a deeper insight into single ventricle performance; particu-
larly if the data was collected on a more homogenous group of young sympto-
matic patients then this might provide additional insights into the mechanisms
of circulatory failure.
1.4.5.3 Stress imaging
Assessment of ventricular work only under resting conditions provides a limited
understanding of the pathological processes underpinning symptoms of exer-
cise intolerance that are experienced by subjects at higher heart rates. Howev-
er as XMR is performed under a general anaesthetic this precludes the use of a
treadmill or exercise bike to stress the circulation. Instead pharmacological sti-
mulation using dobumtaine has previously been proposed and used to simu-
late the effects of exercise. 163 Dobutamine (DL-3-4dihydroxy-N-(3-(4-hydrox-
yphenyl)-1-methyl-n-propyl)-phenylethylamine) is an analogue of isoproterenol.
It acts on the adrenergic receptors of the heart and also on peripheral recep-
tors. At low levels it has mainly inotropic effects on the myocardium with in-
creasing chronotropic effects at higher levels. At high levels it also reduces
peripheral afterload. Dobutamine stress has been shown to be safe and reliable
at low levels (7.5mcg/kg/min). 149, 164, 165 at levels of 20mcg/kg/min 166 and even
high dose at 40mcg/kg/min. 167 Dobutamine has a logarithmic relationship to
the dose response curve. Once the early dose response is achieved a doubling
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of the dose will lead to a doubling of the haemodynamic effect. 
Oosterhoff et al 163 examined the accuracy and reliability of pharmacological
stress in lieu of exercise on cardiac physiology. In healthy adults low dose
dobutamine resulted in a stable end-diastolic volume (EDV) with stroke volume
(SV) and ejection fraction (EF) increasing via a fall in end systolic volume (ESV)
and a rise in heart rate. It compared favourably to exercise (Figure 12).
Figure 12: Effect of dobutamine compared to exercise on healthy controls.
Taken from Oosterhoff, JCMR 2005. End diastolic volume remains stable and a
fall in end systolic volume drives a rise in stroke volume and ejection fraction.
This in combination with a rise in heart rate in both groups contributes towards
an overall increase in cardiac output.
Four existing studies compare how patients with a Fontan circulation respond
to dobutamine. These have employed a range of modalities for assessing the
contractile and energetic response of the ventricle. Senzaki 149 and Schlangen
37 used catheter data, Robbers-Visser 165 used CMR alone and Schmitt 150 used
XMR (Table 2). All studies show a fall in EDV with a variable fall in ESV resulting
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in a mixed response to SV. However there is a consistent increase in heart rate
driving cardiac output. The cardiac output at higher heart rates is limited yet
markers of contractility are normal. The fall in EDV at higher heart rates is sug-
gestive of a restriction to preload but this is only inferred from the available
data. This differs markedly to healthy individuals. Similar responses have been
reported in ccTGA where a baffle repair restricts flow through the atria. 168 In in-
terpreting the available data, the differing methodologies and the heterogenous
morphology and ages of the single ventricle populations in each of the studies
mean direct comparison of results must be viewed carefully.
Table 2: Summary of evidence from stress MRI studies involving children. 
The use of dobutamine in HLHS in lieu of exercise also appears to offer consis-
tent results. Supine CPET demonstrates a fall in EDV and a rise in HR are simi-
SUMMARY OF EFFECTS OF DOBUTAMINE 




Group HLHS HLHS Mixed HLHS
Age Children Children Mixed Children
Dobutamine 7.5 5 10 10








Relaxation (Tau) Normal and falls Normal and falls Normal and falls
Stiffness (non sig)




larly responsible for augmentation of cardiac output. 61 This point is important
to establish as during XMR, muscle relaxants are used and the lack of muscle
contraction is counter to normal Fontan physiology. 169 
Applying pharmacological stress under XMR conditions offers a useful surro-
gate to exercise, albeit with limitations. End diastolic volume falls and cardiac
output is maintained via a rise in heart rate but the cause for why cardiac out-
put is limited is less certain. Investigating cardiac function in terms of ventricu-
lar mechanics and work and applying it to a homogenous group of young sym-
ptomatic patients with HLHS may provide further details on why they
experience symptoms of reduced exercise capacity.
1.5 Conclusions
Assessing the systemic RV is challenging. Developments in CMR technology
offer the opportunity to characterise the function of the systemic RV in terms of
energy, shape and motion. Many of the techniques described in this chapter
have been employed only in adults thus far, and translating the application of
these techniques to children with systemic RV physiology will require a number
of adaptations and assumptions to be made. These have been detailed within
each section above. However two important features stand out from the back-
ground assessment and literature review:
The first is CMR studies require patients to be supine or anaesthetised which is
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counter to normal Fontan physiology. The available literature suggests the de-
rived data should still be reflective of the underlying cardiovascular physiology
but it is clear any results will need to be interpreted carefully in this respect. 
The second is rare conditions such as HLHS mean single centre studies fre-
quently suffer from small sample sizes. Collaborative projects between differ-
ent institutions can be beneficial in this respect. In the Evelina London Chil-
dren's Hospital, there are approximately 250 patients with HLHS under the
care of the medical team with an additional 20 patients born each year. Whilst
this represents a relatively large cohort of patients a joint project was initiated
with a second centre to study this condition in greater depth. Building links and
collaborations in this way is an important step towards improving our under-
standing of rare conditions.
There is a great richness of information to be gathered through multi-modality
imaging, computational modelling and collaboration. These areas represent a
highly technical field which comes at a cost in terms of expertise, training,
equipment and good-will. Ultimately, in exploring new methods of characteris-
ing the systemic RV in HLHS this thesis hopes to provide further insight into
the functional limitations faced by this group of patients.
To explore the interaction between cardiac function and shape, motion and en-
ergy in HLHS a stepwise approach is used:
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1. Firstly a study to understand ventricular work and function in HLHS during a
range of conditions using MRI catheterisation (XMR) techniques combined
with pressure-volume analysis. (Chapter 1.4.5) We hypothesised that In
those with HLHS, load-independent measures would provide us with in-
sight into ventricular dysfunction.
2. Continuing with the theme of energetics; translation of a non-invasive MRI
sequence into a tool to assess cardiac function based on indices of kinetic
energy (KE). (Chapter 1.4.4) Subjects with a systemic RV undergo early cir-
culatory failure and those with the largest, stiffest LV remnants have poorer
outcomes. We hypothesised that an analysis of the intra-cardiac systemic
RV kinetic energy would reveal that subjects with the largest LV remnants
would have the most diminished diastolic KE values. Furthermore we hoped
that that markers of function based around ventricular energetics should be
better than markers based around ventricular volumetrics.
3. Finally employing computational post-processing tools to build upon our
understanding of the shape and motion of the ventricle in relation to cardiac
function. (Chapter 1.4.3) We hypothesised that strain would be reduced in





In all studies involving adults the local research ethics committee approved the
design and volunteers and patients gave written consent (10/H0802/65). In
studies involving children the local research and ethics committee approved
that any child undergoing a clinically indicated MRI scan (anaesthetized or
unanaesthetized) could undergo an additional 15minutes of scanning for re-
search purposes (09/HO802/78). Those undergoing clinical XMR were permit-
ted to have their data used for research purposes (Ethical approval 09/
H0804/62). The attending medical professional was used to identify children
who were felt suitable for inclusion into the studies. The family was provided
with verbal and written information about the study and was allowed to consid-
er whether they wished to participate and to seek further information if neces-
sary. A signed consent form was completed for all studies. Assent was taken
from younger children where they wished and was sought in all children who
were deemed competent.
CMR scans of patients who underwent RVPA conduit were provided by Boston
Children’s Hospital, USA (ethical approval IRB-P00012488). CMR scans of pa-
tients who underwent MBT shunt were provided by Evelina London Children’s




The XMR data was acquired as a separate study involving prospective data
collected from ten consecutive studies in patients with HLHS undergoing clini-
cal XMR. Patients were referred by their clinician for assessment of exercise
intolerance. Modified NYHA criteria were used by the referring clinician to qual-
ify their level of exercise intolerance. All had undergone completion of a total
cavopulmonary anastomosis at our institution and were scanned under general
anaesthesia using low-dose inhaled sevofluorane with remifentanyl whilst
maintaining normocarbia as per institutional preference. All subjects underwent
cardiac MRI on a 1.5 Tesla scanner (Achieva; Philips Healthcare, Best The
Netherlands) using a two-channel coil. Importantly all patients were too short in
stature to undergo a cardiopulmonary exercise test. XMR assessments last ap-
proximately three hours and the young age of the patients meant that a general
anaesthetic was required. The use of supine anaesthesia is further discussed in
chapter 3.2.6. However the major disadvantages were: (1) lying supine is
counter to normal Fontan physiology where systemic venous return partially re-
lies on the action of the muscles to pump blood through the peripheral circula-
tion; (2) anaesthesia involves the administration of medication which can po-
tentially change the vascular resistance and; (3) positive pressure ventilation is
counter to the normal mechanics of inspiration. To counter this only a light
anaesthetic was utilised, patients were ventilated on minimal pressures and in
a fractionated oxygen content close to room air. Response to this is consid-
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ered on page 136.
A second study collecting 4D flow data was performed prospectively on 41
consecutive adults and children with single ventricle physiology (31 systemic
right ventricle, 10 systemic left ventricle), 43 healthy volunteers (35 adults and 8
children) who acted as the negative control and 14 patients with left ventricle
(LV) dysfunction (11 dilated cardiomyopathy, 3 ischaemic cardiomyopathy)
who acted as the positive control. The aim being to compare health with single
LV and single RV if enough volunteers were recruited. 
Patients with a single ventricle circulation were recruited only at pre-Fontan
and post-Fontan stages of their surgical palliation. Patients with a systemic-
pulmonary shunt (the earliest palliative stage in the first few weeks of life) were
excluded from the study due to their volume loaded physiology. All healthy vol-
unteers were without cardiovascular disease, in sinus rhythm, with normal ECG
and normal blood pressure. All patients under the age of 10 years were
scanned under general anaesthesia using low-dose inhaled sevofluorane with
remifentanyl whilst maintaining normocarbia as per institutional preference.
Single LV datasets were collected to act as a control group for the Fontan
group. Only a limited number of single ventricle subjects (n =5) had undergone
cardio-pulmonary exercise testing (CPET) as most were of young age and
short stature. As such an estimated assessment corresponding to the New
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York Heart Association (NYHA) functional classification of heart failure symp-
toms was performed. 
The collaboration between Boston and Evelina involved the most recent scans
from both institutions from 2004-2014 of any patient with HLHS who under-
went a Norwood procedure as the primary palliation were included and analy-
sis occurred in a core laboratory (Kings’ College London). Datasets consisted
of balanced steady state free precession (bSSFP) cine imaging in 4 chamber
and short axis orientations acquired on a Phillips Achieva MRI scanner accord-
ing to recent guidelines.84 At Evelina London Children’s Hospital all children
with HLHS undergo routine pre-operative CMR to help with surgical planning
for Stage II and Stage III. Subjects only undergo cardiac catheterisation if addi-
tional information is needed for planning or optimising clinical status prior to
surgery. At Boston Children’s Hospital CMR is performed on those considered
lowest risk (ie no echocardiographic evidence of ventricular dysfunction, se-
vere AV valve regurgitation, atrial restriction or arch obstruction), with most still
also undergoing additional cardiac catheterisation. Exclusion criteria for the
study were subjects with other diagnoses such as unbalanced atrioventricular
canal defect, or subjects that received an initial procedure other than a Nor-
wood. There were differences in MRI selection criteria between the two institu-




2.3 Cardiac catheter - Stress MRI protocol
The research protocol is outlined in Figure 13. The preference would have been
to use a pressure wire as it provides higher fidelity data than fluid filled
catheters which are are susceptible to dampening. However due to the mag-
netic field of the MRI scanner they were not safe to use. Fluid filled Magnetic
Resonance (MR) compatible catheters were used instead. Care was taken to
minimise excess tubing to reduce damping. A catheter was placed in the sys-
temic RV under X-ray guidance. A second MR compatible catheter was placed
in one of the branch pulmonary arteries. 
               
Figure 13: Workflow for composing pressure volume loops using cine MRI and






A mean pulmonary artery and mean pulmonary capillary wedge pressure were
recorded and the difference used to calculate the trans-pulmonary gradient.
Pressures were recorded on a haemodynamic tracer system (TechnoMed
Medical Solutions, UK). Patients received a standard heparin bolus for anti-co-
agulation, which was monitored using activated clotting time to reduce the risk
of thrombus. Once the catheters were in-place, the patient was transferred to
the MR scanner to undergo simultaneous pressure and volume measurements.
145
Invasive ventricular pressures, pulmonary and pulmonary capillary wedge
pressures were recorded at rest and then repeated with infusion of dobutamine
first at 10mcg/kg/min and then at 20mcg/kg/min to assess the incremental re-
sponse to different levels of stress. Simultaneous cine short axis stacks of the
ventricle with aorta, left pulmonary artery (LPA) and right pulmonary artery
(RPA) 2D PC flow were performed during each condition. See chapter 1.4.4.1
2D phase contrast imaging The protocol was terminated if the patient be-
came haemodynamically unstable (a supra-physiological rise in blood pressure
or heart rate). All patients tolerated the stress imaging.
2.4 Cine MR imaging
A retrospectively ECG-gated balanced-SSFP (bSSFP) cine short axis stack
planned parallel to the atrio-ventricular valve plane of the systemic ventricle
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was performed to assess volumes, wall mass and function. See chapter
1.4.3.1 Balanced steady state free precession cine imaging Images
were acquired during end expiratory breath holds covering apex to base. Typi-
cal imaging parameters: TR = 3.0 - 3.6 ms; TE = 1.5 - 1.8 ms; parallel imaging
(SENSE) factor 2; flip angle 60°; field of view 200 to 400 mm, slice thickness 6
to 8 mm depending on patient size, in-plane resolution 1.3 to 2.0 mm; acquired
temporal resolution 30 to 40 phases, breath-hold duration 5-7 seconds per
slice, 10-14 slices to cover the heart. The initial imaging demonstrated that in-
consistencies in breath holds affected the accuracy of the ventricular segmen-
tation. A 15mm respiratory gating window was required on awake patients to
ensure breath holds were consistent between slices to reduce spatial misalign-
ment. This occasionally meant the breath hold had to be repeated. The cross-
sectional area of the outflow tract was measured on these images in two
planes on the bSSFP images.
2.5 Two dimensional phase contrast flow MRI
A free-breathing retrospectively ECG triggered two-dimensional (2D) phase 
contrast (PC) flow was acquired orthogonal to the ascending aorta at the level 
of the right pulmonary artery (RPA) and additionally orthogonal to the superior 
and inferior vena cavae (SVC and IVC) with NSA 3, spatial resolution 1.5 x 1.5 x
6mm, acquired temporal resolution 30 phases. This was used to determine 
aorto-pulmonary collateral (APC) flow. The peak velocity of flow in the aorta 
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was used to target the velocity encoding (VENC) range of the 4D flow PC scan.
2.6 Four-dimensional phase contrast flow MRI
Preliminary work on this subject required validating a 4D flow sequence for 
clinical use. This work was led by a colleague and I was involved in recruiting 
subjects, performing the acquisition, analysing the data and preparing the 
manuscript. An edited version of this paper is reproduced to demonstrate the 
technical developments undertaken to validate 8-fold acceleration of 4D flow 
MRI technology prior to its use later in this chapter to derive kinetic energy.
Towards Highly accelerated Cartesian time-resolved 3D flow cardio-
vascular magnetic resonance in the clinical setting
Giese et al, Journal of Cardiovascular Magnetic Resonance 2014, 16:42
The fidelity of k-t PCA (principal component analysis) was first investigated on
fully sampled datasets with under-sampling applied retrospectively. A range of
different acceleration factors were used to compare the data quality. Subse-
quently, k-t PCA with 8-fold nominal undersampling was applied on 10 healthy
volunteers and 5 patients with different congenital heart diseases (CHD). Scan
parameters are listed in Table 3. Quantitative flow validation was performed in
vessels of interest and compared to 2D through-plane flow acquisitions. Parti-
cle trace analysis was used to qualitatively visualise flow patterns in patients. 
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Table 3: 4D flow validation study: scan parameters
Accelerated 4D flow data was successfully acquired in all subjects with 8-fold
nominal scan acceleration thereby outperforming previously validated under-
sampling techniques for Cartesian 4D flow imaging. Nominal scan times ex-
cluding navigator efficiency were in the order of 6 min and 7 min in patients
and volunteers. Figure 14a shows flow curves retrospectively undersampled
with a k-t acceleration factor of R = 4, 8 and 10 along with the reference flow
curve (R=1). Datasets were reconstructed using k-t SENSE (top row) and k-t
PCA (bottom row). The accumulated flow error for both reconstructions as a
function of the acceleration factor is shown in Figure 14b. Flow error increased





















2.5x2.5x2.5% 24% 320x320x140% 200% 5.6% 29y% no%
1% HLHS%(I)%% AAo%(200),%LPA%(150),%RPA%(200)% 2.5x2.5x1.75% 32%(17)% 140x70x200% 400% 3.6% 11m% yes%
2% ToF%% AAo%(200),%MPA%(150)% 1.78x1.61x2.5% 24%(33)% 200x280x100% 200% 5.2% 21y% no%
3% HLHS%(II)%% AAo%(250),%DAo%(150),%LPA%(70),%RPA%(70),%
%SVC%(70)%
1.26x1.61x1.79% 24%(21)% 141x180x79% 200% 5.2% 2y% yes%
4% HLHS%(III)%% AAo%(200),%LPA%(80),%RPA%(80),%SVC%(80),%IVC%(80)% 2x1.4x2% 24%(37)% 208x320x130% 150% 7.1% 11y% yes%
5% DILV%% AAo%(200),%LPA%(80),%RPA%(80),%SVC%(80),%%
IVC%(80),%Fen%(150)%





SENSE above this threshold.
Figure 14: Retrospective undersampling with different kt acceleration factors
A correlation and Bland-Altman analysis of all stroke volumes derived from 2D
flow acquisitions and undersampled 4D flow data reconstructed using k-t PCA
is shown in Figure 15. Linear regression resulted in a correlation coefficient of
R2 = 0.93 and the Bland-Altman analysis revealed a mean deviation of 2.5 ml
and a standard deviation of 8.4 ml corresponding to 5.6 ± 14.9% with respect
to the stroke volumes derived from the 2D flow datasets. Mean differences in
stroke volume in selected vessels of interest were 2.5 ± 8.4 ml and 1.7 ± 4.7 ml
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in volunteers and patients, respectively. 
Figure 15: Liner regression and Bland Altman plots of 2D vs. 4D flow measurements
Qualitative flow pattern analysis in the time-resolved 3D dataset revealed valu-
able insights into hemodynamics including circular and helical patterns as well
as flow distributions and origin in the Fontan circulation.
In conclusion, highly accelerated 4D flow using k-t PCA with a factor of 8 was
demonstrated to be clinically feasible. Nominal scan times of 6 minutes were
well tolerated and allowed for quantitative flow assessment in all great vessels. 
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Following this validation a free-breathing prospectively ECG triggered 4D flow 
whole heart MRI sequence was acquired using a targeted VENC based on 2D 
PC aortic peak velocity. The mean field of view was 300x70x150mm, with a 
spatial resolution specific to the size of the patient: small children (<20kg) 
2.0mm isotropic voxels, large children and adults (20-90Kg) 2.5mm isotropic 
voxels, large adults (>90Kg) 3mm isotropic voxels. The number of phases was 
adjusted to between 24-32 phases to acquire a temporal resolution of <35ms. 
These factors also helped ensure that the scan acquisition was within 
15minutes as stipulated in the research ethics. Other imaging parameters 
included: TR= 3.8ms; TE=2.4ms; Flip angle 5; acceleration kt+= 8; bandwidth 
500Hz. Respiratory gating for motion correction was applied giving a nominal 
scan time of 5-7minutes. 126, 170 Data was reconstructed using in-house 
implemented kt-PCA method 171, 172 and subsequently corrected for 
background errors. The analysis of flow data was performed using proprietary 
software (GTFlow, GyroTools LLC, Zurich, Switzerland). Balanced cine SSFP 
images were used to help segment the motion of the mitral valve annulus 
throughout the cardiac cycle on the 4D PC imaging. This allowed us to 
measure peak through-plane inflow velocities into the left ventricle (the mitral E
wave) and compare them to changes in diastolic KE.
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2.7 Flow and volume analysis
Analysis of MRI volumetric and flow data was performed using a Viewforum
workstation (Viewforum EWS, release 2.0, Philips Healthcare, Best, Nether-
lands). RV volumes and wall mass were measured using a Viewforum worksta-
tion (Viewforum, release 2.0, Philips Healthcare, Netherlands). End-diastolic
(EDV) and end-systolic (ESV) volumes were manually contoured from a cine
short-axis stack corresponding to the ventricle cavity. Trabeculations were ex-
cluded from the blood volume. The difference between EDV and ESV was the
stroke volume (SV). Ejection fraction (EF) was calculated from: (EDV-ESV)/EDV
x 100. Tricuspid regurgitation was recorded from the original MRI report. (Mild
<15%, moderate 15-25%, moderate-severe 25-45% and severe >45%). 
Cine short and long axis imaging was used to categorise the LV remnant. The
function of the systemic RV is affected more by the shape and size of the LV
remnant rather than the presence or absence of forward flow across the mitral/
aortic valve. LV morphology was therefore described in terms of (1) shape: slit-
like or globular and; (2) size: based on the median volume of the LV. Slit-like
LVs tended to represent those with mitral atresia/aortic atresia (MA/AA) whilst
those with globular LVs tended to represent those with mitral stenosis/aortic
atresia (MS/AA) and mitral stenosis/aortic stenosis (MS/AS).
APC flow was calculated as follows:
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where: Q = flow, Ao = ascending aorta, SVC = superior vena cava, IVC = 
inferior vena cava
2.8 Pressure-Volume loops
Pressure-volume loops were constructed for each condition. The end-systolic 
pressure-volume relationship (ESPVR) was derived at each state from a 
validated maximal pressure (Pmax) estimation method using the average of 
multiple pressures. 161 The slope of the ESPVR represents the elastance of the 
ventricle (Ees). The slope of the relationship of end diastolic volume (EDV) to 
end systolic pressure (ESP) defines the elastance of the artery (Ea). Ventriculo-
arterial coupling is represented by the ratio of Ees to Ea.  The area within the 
pressure volume loop was used to establish ventricular stroke work and 
multiplied by heart rate to calculate power. Tau (τ), the early relaxation 
constant, was calculated from the reciprocal of the natural logarithm of the 
early maximal fall in ventricular pressure during diastole. 
The LV is a prolate ellipsoid and RV geometry differs markedly from this. When
calculating RV preload different assumptions must be made. Therefore preload
values were taken from multiple averaged measurements and calculated using




σ = mean end diastolic wall stress
P = RV pressure (dynes/cm2)
r = endocardial radius of curvature (cm)
h = wall thickness (cm)
 
The branch pulmonary artery flows and trans-pulmonary gradient were used to
calculate pulmonary vascular resistance. 138
2.9 Calculation of Kinetic Energy
Initially the endocardial border of the left ventricle was manually segmented in 
the first time frame from the short axis cine stack bSSFP images using 
CardioViz3D software. 174 This allowed the generation of endocardial surfaces 
and a separately labelled mask image. LV motion, as seen in the cine data, was
tracked by an image registration based method 175, 176 using the “Image 
Registration Toolkit” (IRTK, IXICO Limited) to create displacement fields. The 
displacement fields were used to morph the systemic ventricular myocardial 
mask creating a 4D ventricular mask. 








equivalent to the voxel size of the 4D flow images for each time frame and the 
phase contrast 4D data used to measure the velocity. 
KE was calculated by taking the instantaneous velocity magnitude of a particle 
and applying the following formula:
Kinetic energy = ½ mass x velocity2
The mass of blood was derived from multiplying the mean density of blood 
(1060g/mm3) by the voxel volume represented by each particle. 
To allow comparison between hearts of different sizes the KE values were 
indexed and expressed as a kinetic energy density also described as an 
indexed kinetic energy based on the instantaneous volume blood present in the
ventricle at that phase of the cardiac cycle. The resultant parameter was 
expressed in the form of energy per millilitre of blood (mJ/ml). KE values were 
expressed as a fraction of the R-R interval. KE was measured throughout the 
cardiac cycle. KE in different parts of the cardiac cycle is demonstrated in 
Figure 16 for a healthy LV.
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Figure 16: Illustrative example of 2, 3 and 4 chamber views of a healthy heart demon-
strating the KE density during different portions of the cardiac cycle.
2.10 Calculation of Kinetic and Particle Energy
A new systolic metric of function was developed around the work used to per-
form useful ejection of blood compared to the total kinetic work performed in
systole. The blood particles were divided into ejected and residual compo-
Figure 1. Illustrative example of 2, 3 and 4 chamber views of a healthy heart 








nents. Ejected blood was defined as blood that started in the ventricle at end-
diastole and was ejected through the aortic valve during the systolic phase and
represents the useful work imparted onto blood. Residual blood was defined
as blood that started in the ventricle at end-diastole and remained in the ventri-
cle at end-systole (see Figure 17) this represented the less energetically effi-
cient processes. The peak of the total kinetic energy achieved by each compo-
nent of blood was chosen to reflect the maximum systolic energy exerted by
the heart on the blood (see Figure 18). We expected to see that most KE would
be imparted to ejected blood and any energy imparted to the residual blood
would be small in healthy hearts.
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Figure 17: Three chamber views showing examples of ejected and residual
particles from each of the three groups. Particles are seeded throughout the
ventricle cavity in end diastole and based on streamline velocity vectors
tracked through systole. Red particles represent retained particles and green





































Two energetic metrics were derived. In the first method, the peak
instantaneous kinetic energy achieved by each component of blood was
chosen to reflect the maximum systolic energy exerted by the heart on each
blood component (see Figure 18). This is comparable to other published
methods. In the second method, a novel approach was used. An advantage of
4D flow MRI is the ability to study the motion of individual particles of blood.
The individual peak energy value achieved by each particle was summated for
each blood component to provide a measure of particle energy (PE). Assessing
the motion of blood on a particle-by-particle basis represents a Lagrangian
approach to assessing fluid dynamics. Our aim was to see if either metric
offered useful insights into ventricular function.
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Figure 18: Typical kinetic energy curves for the ejected and residual blood
components in a healthy volunteer. To allow for different heart rates the time is
indexed as a fraction of total length of systole.
To compare hearts of different sizes the KE and PE values were indexed.
Indexing to body surface area was considered but since the heart grows
allometrically and also can vary in size dependent on physiology and pathology
it was felt to be more accurate to index it based on the blood volume and
express it as an energy density based on the volume of the ejected and
residual blood components. Ejected energy was divided by stroke volume (SV)
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and residual energy was divided by end-systolic volume (ESV). The resultant
parameters were respectively known as iKEej or iPEej, and iKEres or PEres. They
were expressed in the form of energy per millilitre of blood (mcgJ/ml). 137  
As a smaller outflow tract could cause acceleration of blood and act as a
confounder in any analysis we compared the relationship between the size of
the outflow tract and peak energy values. In addition, the time and location at
which each particle reached peak velocity was assessed. For the ejected blood
streamline data showed this invariably occurred in the aorta. 
2.11 Energy ejection fraction
The kinetic energy ejection fraction (KE EF) index was calculated 
corresponding to the following formula:
Where: 
KEejected = peak total KE value of the ejected blood component during a single cardiac
cycle, 
KEresidual = peak total KE of the residual blood component during a single cardiac cycle.
The particle energy ejection fraction (PE EF) was calculated corresponding to






PEejected = total individual peak PE value of the ejected blood component during a single
cardiac cycle, 
PEresidual = total individual peak PE of the residual blood component during a single
cardiac cycle.
These relationships determined the proportion of useful energetic work done in
ejecting blood compared to the overall energetic work during systole. KE EF
reflecting the instantaneous kinetic energy, PE EF representing a particle-
based approach to particle energetics. These values were compared to VV EF
for each patient group to determine their impact.
2.12 Creation of a Cardiac Atlas
The RV myocardium of all short-axis cine stacks was manually contoured at
end-diastole, using ITK-SNAP (2.4.0). 177 The septal wall was included as part
of the RV whereas the LV free wall was excluded from the segmentation as
only the RV shape was of interest. Trabeculations were also excluded from the
segmentation. 84 The position of the LV was marked on the most basal slice, as
illustrated in Figure 32, to correctly align each segmentation and allow
comparison of cases.




A 3D geometrical model was then built from each RV segmentation using
previously described methods. 104 The 3D geometrical model is described by a
detailed set of 3456 variables that govern the geometry and orientation of the
model in 3D space. They include traditional 2D geometric indices of thickness,
length, and diameter which were automatically extracted from these
computational models.
Finally, a computational atlas was built from the collection of 93 RVs which
described the change of shape from an average anatomy. To more easily
permit comparison between the MBT and RVPA groups, the cardiac atlases
which contained the largest variability in shape were detected using a principal
component analysis (PCA). As a result the description of each shape was
reduced from 3456 variables to 10 variables. The variables which represent
the largest variability in shape have previously been described in the literature
as anatomical modes.
2.13 Strain analysis
Longitudinal and short-axis cine images were used to compare systolic and
diastolic strain in the two HLHS populations using CMR feature tracking
software (Diogenes MRI, Tomtec, Germany). The endocardial borders of the
RV were manually defined in 1 time frame then automatically propagated
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through all time frames, tracking the endocardial-blood border and adjacent
features to provide strain data. The 4-chamber view was used to measure RV
longitudinal function. The short-axis images were used to assess RV
circumferential and radial function at basal, mid-ventricle, and apical levels.
Short axis stacks were linked to the position in the 4 chamber view to choose
the appropriate slice. Global strain was recorded as the mean of the segmental
strain values for systolic strain, systolic strain rate, and diastolic strain rates.
Strain measures the change in length of the myocardium relative to its original
length. Positive strain values indicate a lengthening of the ventricle (as seen in
radial motion) and negative values indicate a shortening of the ventricle (as
seen in longitudinal and circumferential motion). Values of a greater magnitude,
irrespective of the vector, reflect improved motion. Regional strain particularly
in the area of the ventriculotomy would be useful to determine if the scar
caused dyskinesia. However in view of the high variability of regional strain
only global strain value were recorded.
2.14 Statistical analysis
Statistical analysis was performed using SPSS version 23 or Stata 13.1 (for
KEEF).  
Analysis of categorical variables comprised of Chi-squared tests (eg tricuspid
regurgitation and LV morphology). Continuous variables were expressed as
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mean ± SD. Unpaired t-tests were used for inter-group comparisons in co-
horts containing only two subgroups. Paired t-tests were used for comparison
in age and sex matched subjects. For cohorts with three or more subgroups,
one-way analysis of variance (ANOVA) with Bonferroni-adjusted, post hoc t-
tests were used for the majority of variables, provided the assumptions for
ANOVA were met (normal distribution, equality of variance). However, this did
not apply for ejection fractions (VV EF, KE EF, PE EF) which were bounded by
0% and 100%, do not exhibit equal variance, and, in the case of KE EF and PE
EF, were highly left skewed. Ejection fractions were thus analyzed using a gen-
eralized linear model (GLM), assuming a binomial distribution for the depen-
dent variable and utilizing a logit link function and robust standard errors. 178
Quantile-quantile (Q-Q) plots and the Shapiro-Wilk method was used to assess
for normality. Throughout a p value < 0.05 was considered significant.
Multiple linear regression analysis was performed using early diastolic KE as
the dependent variable and iEDV, iESV, iSV, indexed wall mass and indexed LV
remnant volume as the independent variables.  
Inter-user variability of the single ventricular volume segmentations and aortic
flow measurements was quantified using an intra-class correlation coefficient
2-way model with absolute agreement. Measurements were sampled for 10
subjects from the systemic RV group by two authors (JW, KP).
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Values of kinetic energy were indexed to the volume of blood within the 
ventricle at each recorded time-point and expressed as a proportion of the R-R
ECG interval to allow comparison between subjects of differing sizes, heart 
rates and function. The Haycock method of calculating body surface area 
(BSA) was used as an index to compare differently sized children. This method 
is used in chapters 3 and 4. However several studies have shown there exists a
non-linear relationship between cardiovascular dimensions and BSA within the 
paediatric population. The heart grows at a different rate to the body. 
Allometric cardiac growth occurs with age so linear indexing to body surface 
area is permissible only between fully-grown adults of different sizes. 179 180 This
allometric growth of the heart means comparisons between individuals of 
different ages is best performed by indexing volumes to BSA raised to the 
power of 1.3 (ml/BSA1.3) and indexing measures of length to the square root of 
BSA (mm/√m2). 181, 182 Indexing in this way has been shown to have a bearing 
on prognosis. 183 This technique was adapted for the later paper in Chapter 5 
along with conventional indexing of values to allow for a comparison.
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3. Characterising ventricular function: XMR
The XMR study provided data for two publications. The first focusing on the re-
sponse of PVR during pharmacological stress and the second assessing ven-
tricular energetics during stress. An edited version of the first manuscript is re-
produced below outlining the effects of nitric oxide on pulmonary vascular
resistance. It forms the preliminary work to pressure-volume loop assessment
of the systemic right ventricle using XMR. My involvement was patient selec-
tion, data collection, data analysis and editing the final manuscript. 
3.1 Magnetic Resonance Imaging catheter stress hemodynamics 
post Fontan in hypoplastic left heart syndrome. 
Pushparajah et al, Eur Heart J Cardiovasc Imaging. 2016 Jun;17(6):644-51.
Given our knowledge of the exercise limitations in those with HLHS we sought
to quantify their response to pharmacological stress compared to a healthy co-
hort of adults and additionally assess the impact of a pulmonary vasodilator on
cardiac output. The major findings in this study were that healthy adults are
able to sustain a 61% rise in cardiac output with administration of dobutamine
at 10mcg/kg/min followed by a 19% rise in cardiac index with administration of
dobutamine at 20mcg/kg/min. In comparison, in subjects with HLHS the equiv-
alent response to incremental dobutamine are a 40% rise followed by a plateau
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in cardiac index. The addition of inhaled nitric oxide, a selective pulmonary va-
sodilator, did not cause any change in the measured pulmonary vascular resis-
tance (baseline mean pulmonary vascular resistance was 1.51 ± 0.59 WU.m2)
or improvements in cardiac output. These results suggest that the blunted in-
crease in cardiac index that occurs during dobutamine stress is not due to a
limitation in pulmonary vascular resistance. Investigation of the function of the
ventricle might help distinguish whether abnormal ventricular function, after-
load or preload are responsible for these effects.
3.2 Pressure-volume loop derived cardiac indices during 
Dobutamine stress; a step towards understanding limitations in 
cardiac output in children with hypoplastic left heart syndrome 
International Journal of Cardiology. 2017 Mar; 230:439-446 
3.2.1 Background
In this section a group of children with HLHS exhibiting symptoms of dimin-
ished exercise capacity were studied. The focus was on assessing ventricular
energetics and function whilst applying incremental dobutamine stress to study
the changes in physiology through a range of heart rates and to help unravel
the cause of the blunted cardiac output shown in the preliminary study. Evi-
dence suggests impaired systolic and diastolic function may contribute to-
wards reduced cardiac output 54, 184 but the load dependency of many of the
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measures of function in this group of patients give inconsistent results. 69–71 Us-
ing load independent measures of function as described in Chapter 1.4.5.2
would allow a detailed understanding of the limitations of cardiac function. We
hoped that stepwise increments of dobutamine might unmask ventricular dys-
function only seen at the highest heart rates (Chapter 1.4.5.3) and explain why
these patients have to a limited ability to increase cardiac index (CI). 51, 52 
3.2.2 Results
Ten consecutive studies were performed with all patients having undergone
staged palliation for HLHS. All were prospectively recruited and all tolerated
the full dobutamine protocol. Table 4 shows the demographics. Mean age
8.6years (range 3.5 - 11.6yrs), mean weight 25.8Kg (range 16 - 46Kg), mean
time since Fontan completion 5.5 years (range 0.5 - 9 years). No significant tri-
cuspid regurgitation in any patient. All subjects recruited into the study were re-
ferred for assessment of reduced exercise capacity. All patients were NYHA 2
as described by their clinician.
Characterising ventricular function: XMR
- 121 -
Table 4: XMR study: patient demographics. TR is tricuspid regurgitation
MRI derived indices of Cardiac function
Tables 5 and 6 show haemodynamic response and MRI derived parameters.
Ejection fraction (54.0 ± 6.7%) was in the normal range but baseline CI was low
(2.7 ± 0.6 L/min/m2) compared to published values for healthy children which is
usually in the range of 3.3-5.1L/min/m2. 179, 180 During administration of 10mcg/
kg/min dobutamine there was an expected rise in CI (p =0.01). This was driven
solely by a rise in HR (p = 0.0001). SV remained the same as although ESV fell














HLHS indicates hypoplastic left heart syndrome 













1. HLHS 9.2 26.5 5.7 98 Mild 
2.  HLHS 11.6 45.9 8.9 95 None 
3.  HLHS 9.2 20 6.7 92 None 
4.  HLHS 5.9 21.5 3.5 95 None 
5.  HLHS 5.8 16 3.5 93 Mild 
6.  HLHS 9.1 14.1 6.5 98 Mild 
7.  HLHS 5.5 16 0.5 93 Mild 
8.  HLHS 7.6 30 4.2 92 None 
9.  HLHS 10.1 34.4 8 93 Mild 
10. HLHS 12.2 34.6 6.5 96 None 
Mean ± SD 8.6 ± 2.3 25.8 ± 10.2 5.5 ±2.6 95 ±2  
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(p = 0.001) there was a similar fall in EDV (p = 0.0001). At maximum stress with
20mcg/kg/min dobutamine there was no further increase in CI, HR rose (p =
0.002), however SV fell (p = 0.045) as the fall in EDV was greater than the fall in
ESV.
Table 5: XMR study: haemodynamic response. Where bpm indicates beats per
minute, iCO indexed cardiac output, EF ejection fraction, BP blood pressure,
Dob dobutamine
Table 2. Haemodynamic response 
ID Heart rate (bpm) iCO (l/min/m2) EF % Mean BP (mmHg) 
 Rest Dob10 Dob20 Rest Dob10 Dob20 Rest Dob10 Dob20 Rest Dob10 Dob20 
1 53 113 127 2.2 5.0 4.7 49 66 63 46 66 60 
2 69 107 142 2.3 3.9 4.3 49 65 67 71 122 120 
3 59 95 140 2.1 4.1 4.1 57 81 73 59 110 153 
4 76 115 138 2.4 3.9 4.3 46 55 60 59 104 99 
5 60 128 141 3.0 4.9 5.3 56 58 66 46 60 73 
6 68 95 105 3.3 4.1 4.4 61 70 71 44 56 57 
7 65 120 132 3.9 4.4 4.6 67 69 76 41 43 48 
8 62 113 141 2.9 4.4 3.4 49 65 55 51 91 81 
9 68 141 149 2.5 4.1 4.4 49 68 64 55 71 66 
10 69 122 132 2.3 3.1 3.0 57 62 66 42 80 81 





























0.0001 0.0001 0.001  0.012  
Post-hoc compared to rest  * denotes p < 0.01 † denotes p < 0.05    
 
bpm indicates beats per minute, iCO indexed cardiac output, EF ejection fraction, BP 
blood pressure, Dob dobutamine 
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Table 6: XMR study: MRI derived volumetric indices. Where iRVEDV indicates
indexed right ventricular end diastolic volume, iRVESV indexed right ventricular
systolic volume, iSV indexed stroke volume, APC aorto-pulmonary collateral
flow, CO cardiac output
Contractility and Coupling
In expressing the heart as a time varying elastance model (a pressure-volume
loop) the slope of the ESPVR is a measure of the elastance of the ventricle un-
der that given condition. This is the pressure required to elicit a change in vol-
ume of the ventricle and measures ventricular contractility (Ees). The elastance
Table 3. MRI derived volumetric indices 
ID iRVEDV (ml/m2) iRVESV (ml/m2) iSV (ml/m2) APC as % of CO 
 Rest Dob10 Dob20 Rest Dob10 Dob20 Rest Dob10 Dob20 Rest 
1 80 65 58 38 20 21 41 45 37 14.5 
2 65 53 42 31 17 13 33 35 30 10.8 
3 63 53 40 26 10 10 36 43 29 27.8 
4 69 60 50 36 26 19 33 34 31 22.4 
5 80 63 49 30 24 18 49 39 37 12.5 
6 81 61 54 31 17 18 51 43 42 0.0 
7 72 56 44 12 19 9 61 39 35 7.2 
8 97 60 44 49 21 20 48 39 24 21.4 
9 74 45 46 37 13 17 37 29 29 6.6 
10 58 40 35 25 15 12 33 25 23 6.1 

























0.0001 0.0001 0.019  
Post-hoc compared to rest  * denotes p < 0.01 † denotes p < 0.05  
 
iRVEDV indicates indexed right ventricular end diastolic volume, iRVESV indexed 
right ventricular systolic volume, iSV indexed stroke volume, APC aorto-pulmonary 
collateral flow, CO cardiac output 
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of the aorta is the relationship of the LV end systolic pressure to the stoke vol-
ume. It measures the load on the arterial system (see Chapter 2.8 for further
details). Figure 19 shows the MRI-catheterization derived indices of contractili-
ty and coupling. Contractility (as measured by end-systolic elastance, Ees) in-
creased 67% during the low dose dobutamine stress (10mcg/kg/min) (p =
0.045) with no further increase with dobutamine 20mcg/kg/min. This was ac-
companied by a stepwise increase in afterload (as measured by arterial elas-
tance, Ea), which reached significance at dobutamine 20mcg/kg/min (p =
0.012). The ventriculo-arterial coupling ratio (Ees:Ea) was calculated. This is a
ratio of elastances of the aorta and ventricle. The heart has the greatest me-
chanical efficiency when elastances are matched. 155, 156 However physiological-
ly the heart works with a typical ratio of 1.5:1.0. 147, 157 (See also Chapter 1.4.5
for further details). The ventriculo-arterial coupling ratio (Ees:Ea) was 1.45 ± 0.2
at rest. It remained adequately coupled during administration of incremental
doses of dobutamine due to increases in both contractility and afterload. The
wide standard distribution may explain why although increases in contractility
and afterload were seen between some conditions of dobutamine these were
non-significant.
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Figure 19: Effect of dobutamine on ventriculo-arterial coupling. Mean effects of
dobutamine stress on contractility (top left), afterload (top right) and ventriculo-
arterial coupling ratio (lower)
Ventricular work
Figure 20 (top panel) shows PV loops for each condition of dobutamine. During
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stroke work did not alter from resting conditions however large corresponding
increases in HR meant cardiac power increased significantly (114%) with
dobutamine 10mcg/kg/min (p = 0.001) but plateaued with dobutamine 20mcg/
kg/min as the late fall in SV offset any further incremental rise in power (lower
panel).
Myocardial Relaxation
Parameters of diastolic function were normal at rest (Table 7) with an end dias-
tolic pressure (EDP) and early relaxation constant (Tau) that compared to the
literature. EDP remained low throughout the study, which is not in keeping
with the rise that usually occurs during stress in healthy subjects. When index-
ing EDP to the RVEDV (mmHg/ml) to give an indexed filling pressure, there was
no significant change with application of stress (p =0.99). There was an overall
stepwise improvement in myocardial relaxation as demonstrated by the fall in
Tau, which reached significance at dobutamine at 20mcg/kg/min (p = 0.038). 
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Figure 20: Pressure-volume loops and energetic effects of dobutamine. Top
panel shows pressure volume loops for all ten subjects at rest, with
dobutamine at 10mcg/kg/min and with dobutamine at 20mcg/kg/min (right
panel). Volumes are indexed to body surface area to allow comparison of
loops. Lower panel shows the response of power (left) and stroke work (right)
to dobutamine.
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Table 7: Cardiac diastolic function. Where EDP indicates end diastolic
pressure, Tau is the early relaxation constant, PVR is pulmonary vascular
resistance
Preload and PVR
There was a stepwise fall in preload of 30% between rest and dobutamine
10mcg/kg/min and of 50% from rest to dobutamine 20mcg/kg/min. This
reached significance with dobutamine at 20mcg/kg/min (p = 0.008). The rela-
tionship of preload to SV is shown in Figure 21. The change in preload was not
related to PVR, which was in the normal range (1.7 ± 1.2WU.m2) and remained
unchanged throughout (Table 7). APC flow contributed 12.9% of cardiac output
Table 4. Cardiac diastolic function 
ID EDP (mmHg) Tau Preload x103 dynes/cm2 PVR (WU.m2) 
 Rest Dob10 Dob20 Rest Dob10 Dob20 Rest Dob10 Dob20 Rest Dob10 Dob20 
 1 8.0 4.8 7.0 28.9 22.8 17.7 80 33 28 0.9 1.7 1.7 
2 7.5 9.5 6.0 12.5 6.4 4.3 68 61 27 0.9 0.42 2.0 
3 12.5 11.5 10.5 45.7 22.0 18.5 77 53 28 0.8 1.5 1.6 
4 4.5 4.5 4.0 28.7 27.0 8.8 37 27 25 2.1 2.5 2.1 
5 12.0 9.0 10.7 28.6 12.4 4.6 81 41 36 1.0 0.5 0.5 
6 3.5 4.0 6.0 18.0 13.0 6.3 19 18 16 0.9 0.8 0.8 
7 10.7 9.5 11.0 62.5 18.8 27.0 89 70 46 0.95 0.9 1.1 
8 5.0 2.0 2.0 18.4 18.8 14.2 36 46 36 1.5 1.8 1.7 
9 10.0 10.0 7.0 28.8 23.4 19.8 42 31 22 1.9 1.8 1.5 


































0.72 0.005 0.037 0.97 
Post-hoc compared to rest  * denotes p < 0.01 † denotes p < 0.05  
 
EDP indicates end diastolic pressure, Tau is the early relaxation constant, PVR 
pulmonary vascular resistance 
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at rest (Table 6).
 
Figure 21: Relationship of mean preload to mean indexed stroke volume.
Standard deviation bars are shown.
Reproducibility of ventricular volumes and aortic flow
Intra-class coefficient (95th confidence interval) was 0.97 (0.86 - 0.99) for aortic
SV, 0.97 (0.80 - 0.99) for EDV, 0.95 (0.82 - 0.980) for ESV, 0.95 (0.82 - 0.98) for
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3.2.3 Discussion
In this study XMR was used to gain further insights into the causes of reduced
functional status in patients with HLHS post-Fontan. The hypothesis was load
independent measures of function would allow for a detailed analysis of
whether abnormalities in systolic or diastolic indices of the systemic right ven-
tricle might become apparent with application of stepwise increments of
dobutamine stress and explain the abnormal CI and blunted response to stress
previously demonstrated in the literature. 185 However, in this study using
pressure-volume loop derived indices of function, there were no abnormalities
in systolic or diastolic ventricular function. In fact, this symptomatic group of
patients had normal functional indices and the major factor limiting SV and CI
was a fall in preload with a corresponding plateau in indexed EDP.
Relevance to previous studies
Previous studies have shown 185 that CI is low at rest with a blunted response
to dobutamine stress compared to normal left ventricles. The rise in CI with
dobutamine 10mcg/kg/min is driven by an increase in HR, and there is no fur-
ther rise in CI at peak stress. 165 This is because SV does not rise with dobuta-
mine 10mcg/kg/min and in fact falls with dobutamine 20mcg/kg/min. This in-
ability to increase SV is driven by an incremental fall in EDV, and is unrelated to
PVR. The use of XMR allowed us to gain additional insights into the physiology
of the blunted CI response in these HLHS post-Fontan patients during dobuta-
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mine stress. In healthy adults dobutamine increases SV whilst EDV remains
stable. These are similar to the volumetric changes seen during exercise. 163
Studies assessing ventricular function in response to dobutamine 150, 165, 149 and
exercise 61 have shown similar findings in patients post-Fontan: a low base line
CI and with moderate stress a HR driven rise in CI with no change in SV. These
studies involved older patients with mixed systemic ventricular morphology.
None had looked at high dose dobutamine, although recently Van De Bruaene
et al 61 showed a similar finding of no additional rise in CI between moderate
and peak exercise. The possible causes for the observed fall in SV with peak
stress may be (1) inadequate preload; (2) abnormal systolic or diastolic my-
ocardial properties; (3) altered afterload or uncoupling of the heart; or (4) or
combination of all of these.
Preload and PVR
In Fontan circulation the absence of a subpulmonary ventricle might be expect-
ed to reduce the preload of the ventricle. 55 This could lead to an inability to re-
spond to the higher systemic venous return needed during stress. 186, 187 In this
study the observed resting preload values for the systemic RV were of a similar
magnitude to the healthy LV (32 x 103 ± 4 x 103 dynes/cm2). 188 However dur-
ing dobutamine stress changes in preload mirrored SV with an unexpected fall
at peak stress. We were able to unmask a limitation in the filling of the ventricle
that was not evident at resting conditions.
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Elevated PVR has been proposed as a factor for low preload. However base-
line PVR was normal in this group of young patients and remained low
throughout the procedure. In older Fontan patients PVR was found to be ele-
vated at rest and values subsequently fell to normal during administration of
dobutamine. 150 The difference in PVR values between this study and ours, is
reflected in the difference in ages between the two study groups. Completion
of the Fontan results in an absence of pulsatile blood flow this has the effect of
reducing endothelin and increasing the risk of pulmonary emboli. Older sub-
jects have had a longer cumulative exposure increasing their likelihood of
raised pulmonary tone. This may explain the increased benefits seen with ad-
ministration of sildenafil in older Fontan patients 61 compared to children during
exercise. 188 Interventions to improve the trans-pulmonary gradient are current-
ly focusing on minimising power loss within the Fontan circuit 189 and new tech-
niques to improve the duration of forward flow through the systemic veins may
offer therapeutic benefits.
Systolic function
Previous studies using load-dependent markers of function have suggested
systolic function as measured by EF is reduced in those with single systemic
RV circulations compared to those with single systemic LV circulations. 184 Our
data for EF falls into a similar range as that published in the literature. Interest-
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ingly, through the construction of pressure-volume loops, we were able to look
at load independent measures of systolic ventricular function and found con-
tractility increased 67% in response to dobutamine 10mcg/kg/min whilst pow-
er output increased by 114%. The systemic RV demonstrated good load inde-
pendent systolic function albeit at a high energetic cost. The disparity in
energetic cost is related to the raising of CI through HR rather than a SV re-
sponse. Most of the external work performed by the heart is consumed in over-
coming systemic afterload. Increased CI mediated by HR causes a dispropor-
tionate increase in this work. The increase in HR seen between moderate and
peak dobutamine stress was without an increase in CI and so further reduced
energy efficiency.
Diastolic function
Findings from echocardiographic-based studies suggest diastolic abnormali-
ties exist in 67-72% of patients undergoing Fontan 54, 184 However our patient
cohort had normal EDP and Tau at rest. These findings are in accordance with
studies assessing function using a catheterisation technique. 149, 150 Abnormal
diastolic myocardial properties are difficult to distinguish from abnormal pre-
load when using load dependent echocardiographic indices 7 and this may ex-
plain the differences in findings. We assessed if diastolic dysfunction was un-
masked during stress. Interestingly throughout dobutamine administration EDP
remained abnormally low. However Tau, a measure of active early diastolic
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relaxation, fell indicating improving, rather than abnormal, ventricular relax-
ation. Those with HLHS often have a dilated ventricle as a consequence of the
previous volume loading effects of a shunt dependent circulation. To account
for this, we indexed EDP to the RVEDV to provide a measure of filling pressure
per millilitre of blood -there were no significant changes. This lends further sup-
port to restricted preload rather than diastolic dysfunction as a cause for
reduced cardiac output in this group of patients.
Afterload and Coupling
The pressure-volume loops for the systemic RV displayed a similar pattern to
that described in the literature for those with pressure loaded RVs. 25 During
administration of dobutamine, a gradual increase in the afterload was ob-
served. However the systemic RV matched the increased hydraulic load by in-
creasing Ees. Under resting conditions, the systemic RV has a ventriculo-arter-
ial coupling ratio that compares favourably to the healthy LV 190 and this
remained well matched throughout the application of pharmacological stress
indicating good energetic efficiency. 147, 157 The systemic RV displayed good
contractile reserve and effective coupling during stress may explain the limited
benefit found from administering afterload reducing agents to this group of pa-
tients during exercise. 191
A useful comparison would be to contrast Fontan patients with single right
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ventricles to Fontan patients with single left ventricles. Both patient groups lack
a subpulmonary ventricle so the focus would be on the role that ventricular
morphology has on cardiac energetics. Single LV Fontan patients usually have
a good sized native aorta and do not need this reconstructed during the first
Norwood procedure, unlike those with HLHS. They often require only a shunt
and atrial septectomy rather than arch reconstruction with prosthetic material.
This would also allow a study of the effects of this arch reconstruction on ven-
triculo-arterial coupling.
Aorto-Pulmonary Collaterals
Schmitt and colleagues 150 demonstrated the contribution of mean APC flow on
cardiac output doubles during stress. We quantified APC contribution only dur-
ing resting conditions due to the length of the study. Our baseline values were
of similar magnitude and we would expect them to increase in the same way.
APC flow has the benefit of contributing to preload but leads to diversion of
blood from systemic perfusion. Despite this contribution it was unable to offset
a fall in preload and EDP under peak stress conditions.
3.2.4 Limitations
In those with a Fontan circulation peripheral muscle contractions and respira-
tory effort play a prominent role in driving blood through the systemic veins. 169
Care must be taken interpreting data from anaesthetised patients performing
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breath-holds. However the results of this study correspond to those observed
by subjects undergoing CPET, namely a limited CI and fall in SV. 5, 51, 192, 193 In a
recent study assessing the effects of supine cycling on CI in adults with single
ventricle circulations,61 SV was also found to decline with the highest levels of
exertion corresponding to the highest level of Dobutamine administered in this
study. Pharmacological stress mimics many of the physiological changes the
heart is subjected to during exertion and is particularly useful in those too
young or small to ride an exercise bike. 
The patients in this study were anaesthetised using sevofluorane and remifen-
tanil. We tried to manage the patients with the lowest doses of these drugs to
maintain effective anaesthesia. The effects of sevofluorane on loading condi-
tions and contractility has been extensively studied in animals. 194 It demon-
strates a dose dependent effect including decreases in systolic arterial
pressure, heart rate, cardiac index, left ventricular minute work index, maxi-
mum rate of rise of left ventricular pressure (LV dP/dt), and systemic vascular
resistance. There were no effects on stroke volume and left ventricular end-di-
astolic pressure. High-dose remifentanil has been shown to reduce indexed
stroke volume, heart rate, and mean arterial blood pressure. 195 However, the
synergistic effects of these two anaesthetic agents appear to alter the loading
conditions and contractility on the heart in different ways to their individual ac-
tions. A study performed in 2005 by Chanavaz 196 used echocardiography in a
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group of children undergoing anaesthesia to assess ventricular function at
baseline with sevofluorane and then reassess the following the addition of
remifentanil. The addition of remifentanil was found to reduce heart rate, blood
pressure and cardiac index. However, it led to increased systemic vascular re-
sistance with a fall in contractility which is not in keeping with the actions of ei-
ther drug alone. The effects of these anaesthetic drugs are dose dependent. As
we maintained effective anaesthesia with the lowest dose as possible these
haemodynamic effects would have been minimised. Indeed, in an earlier study
carried out by our group 185 we compared cardiac function in subjects with
HLHS-Fontan to a control group of awake healthy adult subjects. There were
no significant differences in indexed end diastolic volume, indexed end systolic
function and indexed stroke volume. This indicates that through the use of low
dose anaesthetic agents and careful management of physiological parameters
we may have been able to alleviate some of the published haemodynamic
effects of higher dose general anaesthesia during our study protocol.
The systemic RV is not a true prolate ellipsoid. Therefore the formula that are
applied to calculate LV wall stress are not applicable to the RV as they over-es-
timate the values. Although other formulas specific to the RV exist, in HLHS the
septal wall is thought of belonging to the systemic RV so a modified formula
such as that used by Janz 197 or Quaife 198 for idiopathic hypertension is also
not applicable. Stress represents a mean value across the entire RV wall, with
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the potential to underestimate stress on the endocardial layer and in regional
areas where the myocardium may be thicker (commonly the septal wall in
those with a residual LV). Stress may be over-estimated when compared to fi-
nite element methods 173 but as a comparative estimation between states it
broadly serves its purpose.
The single beat estimation method was originally conceived for the LV and has
been validated in the RV. Early work on the systemic RV has been performed
150, 151 and our results are in keeping with these findings. Altering preload would
have offered a load independent measure of diastolic function, the end-dias-
tolic-pressure-volume- relationship. However acquiring MRI volumetric data
within a suitable timeframe isnot yet feasible. Tau was used instead although it
primarily assesses early diastolic relaxation.
3.2.5 Conclusions
Children with HLHS-Fontan and symptoms of mild exercise intolerance display
a blunted response in CI and a fall in SV at peak stress due to a failure to ade-
quately preload the heart. The heart rate driven response makes this is an en-
ergetically costly process. PVR remains low. Surprisingly the systolic and dias-
tolic function tends to be normal which is not as expected. Once load 
ing conditions are removed the ventricle can be seen to be functioning well un-
der that set of conditions.The ventricle is well coupled to the hydraulic load. In
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young patients introducing measures that focus on improving the preload of
the heart may offer the most benefits.
3.2.6 Summary
Background: Patients with a systemic right ventricle frequently experience
reduced exercise capacity. This is related to a limited ability to increase car-
diac index. Elucidating the cause of this would help with optimising treatment
strategies. 
Methods and Results: Prospective data from ten consecutive studies on pa-
tients with HLHS undergoing clinical cardiac magnetic resonance with
catheterisation (XMR) were analysed. Mean age 8.6 years (range 3.5 - 11.6yrs),
mean time since Fontan completion 5.5years. All New York Heart Association
(NYHA) class II or greater. Fluid filled MR compatible catheters were placed in
the systemic RV and branch pulmonary arteries to record pressures at rest
(condition 1), with dobutamine infusion at 10mcg/kg/min (condition 2) and at
20mcg/kg/min (condition 3). Cine short axis stacks of the ventricle were per-
formed at each condition and used to construct pressure-volume loops. 
Compared to rest, cardiac index increased with condition 2 (p < 0.01) with no
further rise at peak stress despite a further, albeit, blunted rise in heart rate (p =
0.002). An overall fall in stroke volume occurred (p = 0.014) despite good con-
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tractility (74% increase, p =0.045) and a well-coupled ventriculo-arterial ratio.
End diastolic pressure and early active relaxation, markers of diastolic function,
remained normal. Preload fell at peak stress (p <0.008) whilst pulmonary vas-
cular resistance (PVR) was low throughout. 
Conclusions: In symptomatic patients with HLHS a fall in stroke volume oc-
curs at peak stress due to a decrease in preload. There is a failure to ade-
quately fill the ventricle implying a ceiling of maximal flow through the Fontan
circuit despite a low PVR. Conventional markers of systolic and diastolic func-
tion are normal. In children therapies to improve preload may be the most
beneficial.
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4. Characterising ventricular function: Kinetic Energy
In the previous chapter the energetics of the ventricle were studied using inva-
sive methods. The pressure-volume loops for the single systemic RV resem-
bled that of a healthy LV during resting conditions. Stroke work was assessed
and found to increase disproportionately at higher heart rates. Stroke work
forms part of the useful work the heart performs in ejecting blood. The other
part is kinetic work, the energy given to the blood as momentum. Kinetic work
is now quantifiable using non-invasive methods based on 4D flow CMR. This
chapter established the kinetic work in those with HLHS and explores how it
might be used as a new marker of systolic function. 
4.1 Intra-ventricular kinetic energy in HLHS
4.1.1 Background
Using 4D flow MRI to study the KE profile in the systemic RV could provide
some insight to the extent of its adaptation as a systemic ventricle. HLHS is
characterised by a LV that is too small to support the systemic circulation. 1, 199
There is a spectrum of severity with the size and shape of the LV dependent on
the anatomy of the mitral and aortic valves. Furthermore the size and shape of
the LV remnant has an impact upon clinical outcomes. Subjects with the
largest LV remnant have the stiffest RV function37 and the worst post-operative
outcomes. 35 Existing KE studies have demonstrated distinct energetic differ-
ences are present between the healthy LV and RV during the cardiac cycle. 118
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KE declines with ageing 200 and is detrimentally affected in those with LV dys-
function. 137, 201 KE values are also affected by cardiac conditioning. In athletes
an increased LV myocardial mass correlated with improved diastolic KE whilst
RV diastolic KE improved with a larger end-diastolic volume. 202 KE appears to
be a sensitive marker of cardiac physiology.
The aims of this study were to assess the intra-cardiac KE profile in the sys-
temic RV specifically comparing it to other healthy left and right ventricles to
understand the degree of adaptation. Additionally the impact that the nonfunc-
tional LV remnant has on the kinetic energy profile of the systemic RV was
examined. Those with the largest remnants should cause the greatest adverse
effect on diastolic KE.
4.1.2 Results
Eight healthy children (mean age 7.3 years, range 1.5–15 years) were recruited.
The reasons for the MRI referrals in children were as follows: exclusion of vas-
cular ring (n =3), assess for tortuosity of head and neck vessels (n =2), assess
for arrhythmogenic right ventricular cardiomyopathy (ARVC) (n =2), exclusion of
partial anomalous venous drainage (n =1). All children included in the study
were confirmed to have structurally and functionally normal hearts by a cardiol-
ogist experienced in reporting CMR. Thirty children with HLHS (mean age 6.3
years, range 0.8 years – 16years) were recruited. One was excluded as they
moved significantly during the 4D flow acquisition leading to severe artefact.
Demographic data is shown in Table 8 All children with HLHS were taking as-
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pirin and captopril as per institutional protocol. Patients with HLHS had lower
heart rates than healthy children 79 ± 16bpm vs. 104 ±23bpm (P = 0.001) which
may be a reflection of the use of general anaesthesia.
Table 8: HLHS KE study: demographic data
The healthy cohort had normal cardiac function (LV EF, RV EF). With no 
significant differences between the LV and RV for EDV, ESV or SV. As 
expected LV wall mass was significantly greater than RV wall mass (p <0.05). 
Those with HLHS had significantly more dilated hearts compared to the healthy














Parameter  Healthy HLHS P value 
Gender Male:Female 4:4 21:9  
Mean age ± SD (years) 7.3 (± 6.3) 6.3 (±4.5) 0.54 
Mean BSA (range) 
HF 
Fontan 




Mean BP systolic ± SD (mmHg) 115 (±6) 99 (±21) 0.16 
Mean BP diastolic ± SD (mmHg) 71 (±14) 53 (±12) 0.021 
Heart rate bpm 104 (±23) 79 (±16) 0.001 
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population (iRVEDV p = 0.015) with an increased stroke volume (iSV p = 0.014) 
leading to preserved cardiac function. Indexed systemic RV wall mass was 
significantly increased compared to the healthy LV and RV (p = 0.0001). The 
degree of tricuspid regurgitation was at most mild. There were no difference in 
ventricular volume or function between those having undergone HemiFontan or
Fontan surgery although there was a trend towards less ventricular dilatation 
following Fontan but this did not achieve significance. The MS/AS group 
tended to have a globular LV remnant whilst those with MA/AA had either a 
slit-like or no LV remnant. The morphologically globular shaped LV group were 
composed of 18 patients and the morphologically slit-like LV group composed 
of 11 patients. The median LV volume was 2.4mls. There were no differences in
RV size or function between those with globular or slit-like LV remnants or 
between those with the largest or smallest LV remnants. (See Table 9)
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Table 9: HLHS KE study: MRI derived ventricular parameters. iEDV indicates
indexed end diastolic volume, iSV is indexed stroke volume, EF is ejection
fraction, LV is left ventricle, RV is right ventricle
The KE profile of the healthy LV and RV are shown in Figure 22. They were 
composed of two peaks corresponding with systole and diastole. The diastolic 
peak was a fused monotonic peak. Systolic KE peak in the RV was greater 
than the LV but this did not reach significance. There was a larger diastolic KE 
peak in the LV compared to RV (p =0.05). 
 




EF   
(%) 
Indexed Wall mass  
(g/m2) 
Healthy LV 8 69.2 (±9.6) 28.1 (±2.3) 59.0 (±3.3) 47.0 (±5.8) 
Healthy RV 8 68.4 (±9.2) 39.1 (±6.6) 57.6 (±10.6) 23.2 (±3.0) Ŧ 
All HLHS 29 93.7 (±24.5) Ŧ 53.8 (±11.6) Ŧ 58.7 (±8.4) 76.5 (±23.7) ** 
ANOVA p value  0.02 0.001 0.92 0.0001 
HemiFontan 14 100.4 (±29.8) 57.9 (±10.9) 60.2 (±10.0) 77.3 (±23.2) 
Fontan 15 88.1 (±19.1) 50.1 (±12.1) 57.4 (±7.2)  78.9 (±24.6)  
p value  0.19 0.08 0.39 0.86 
Globular LV group 18 91.4 (±27.8) 52.1 (±10.7) 58.8 (9.6) 72.9 (±21.3) 
Slit-like LV group 11 98.3 (±20.7) 56.9 (±13.9  58.6 (±7.3  88.4 (±25) 
p value  0.48 0.30 0.94 0.10 
LV > 2.4mls group 15 94.4 (±25.2) 54.4 (± 11.4) 59.9 (± 10.3) 75.2 (±22.6) 
LV  < 2.4mls group 14 93.7 (±20.3) 53.4 (±13.0) 57.5 (± 6.5) 81.7 (± 25.0) 
p value  0.94 0.82 0.46 0.48 
 
P value compared healthy LV 
** p <0.001 
* p <0.01  
Ŧ p <0.05 
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Figure 22: Mean intra-ventricular kinetic energy values for 8 heathy children
over the cardiac cycle in the LV and RV
In comparison the systemic RV also displayed two peaks of KE (see Figure 23).
The systolic KE peak was of a similar magnitude to the healthy LV and RV. 
However, the monotonic diastolic KE peak was significantly lower than the 
healthy systemic LV (p = 0.023) (see Table 10) and more in keeping with a 
healthy RV.
Figure 23: Mean intra-ventricular kinetic energy values during the cardiac cycle
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Table 10: HLHS KE study: comparison of intra-cardiac kinetic energy (KE)
based on ventricular morphology
Figure 24 shows the KE curves for those with HLHS. There were no differences
in any of the intra-cardiac KE parameters between the HemiFontan and Fontan
circulations. Those with globular LVs had significantly lower diastolic KE than 
those with slit-like LVs 21.3 ± 7.8mcJ/ml vs 45.0 ± 31.1mcJ/ml; p =0.024. 
Similarly those with a larger LV remnant (n = 15) had lower diastolic KE than 
those with a smaller LV remnant (n =14) 20.5 ± 6.0mcJ/ml vs. 41.0 ± 29.0mcJ/
ml; p = 0.016. (See Table 11 and Figure 25)
 
 Systolic KE  
(mcJ/ml) 
End- systolic KE  
(mcJ/ml) 
Early diastolic KE  
(mcJ/ml) 
Healthy child LV (n=8) 14.2 (±6.6) 3.2 (±2.0) 53.8 (±9.2) 
Healthy child RV (n=8) 25.5 (±11.9) 5.0 (±2.9) 28.9 (±12.1) Ŧ 
Single RV (n=29) 17.2 (±12.7) 2.7 (±1.8) 31.3 (±23.4) Ŧ 
ANOVA p value 0.131 0.027 0.019 
 
P value compared to healthy child LV  
** p <0.001 
* p <0.01  
Ŧ p <0.05 
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Figure 24: Intra-cardiac KE values over the cardiac cycle for those with HLHS.
The top panel shows subjects divided according to surgical stage, the bottom
panel shows subjects divided according to the morphology of the LV remnant.
On the right are Box and Whisker plots of the mean early diastolic KE values






















 Comparison of intracardiac KE in HLHS for subjects with a globular or slit-like LV remnant 
p = 0.25
p = 0.005
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Table 11: Intra-cardiac KE values in those with HLHS based on surgical stage
and the size and morphology of the LV remnant
Figure 25: Boxplot demonstrating the diastolic kinetic energy for those with the
largest and smallest LV remnants
 
 Systolic KE  
(mcJ/ml) 
End- systolic KE 
(mcJ/ml) 
Early diastolic KE 
(mcJ/ml) 
Fontan (n =15) 18.4 (±16.1) 2.5 (±0.9) 26.5 (±15.8) 
HemiFontan (n =14) 15.9 (±8.0) 3.0 (±2.4) 36.5 (±29.2) 
p value 0.6 0.39 0.25 
Slit-like LV (n=12) 17.1 (±7.6) 3.5 (±2.6) 45.0 (±31.1) 
Globular LV (n=17) 17.3 (±15.6) 2.2 (±0.7) 21.3 (±7.8) 
p value 0.97 0.044 0.005 
LV  < 2.4mls group (n =15) 17.5 (±9.0) 3.5 (±2.2) 41.0 (±29.0) 
LV  > 2.4mls group (n =14) 16.9 (±16.3) 2.0 (± 0.05) 20.5 (± 6.0) 
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There were no strong correlations between the early diastolic KE in those with
HLHS and parameters of iEDV, iESV, iSV, wall mass or size of LV remnant (see
Table 12)
Table 12: Multiple linear regression analysis of early diastolic kinetic energy in
the systemic RV
4.1.3 Discussion
The focus of this study was to assess KE in the systemic RV of those with 
HLHS and contrast this with healthy ventricles. The derived values of kinetic 
energy were of similar magnitude to previously published data despite using a 
different methodology. Carhäll et al 203chose a single timepoint (isovolumetric 
contraction) and then tracked particles forward and backward through the 
cardiac cycle to calculate KE. In contrast we calculated instantaneous KE from 
the velocity data based on cine segmentations of the ventricle. This was similar
Table 5. Multiple linear regression analysis of early diastolic kinetic energy in 
the systemic RV 
 
 R2 P 
iEDV 0.041 0.29 
iESV 0.123 0.063 
iSV 0.006 0.684 
iMass 0.077 0.162 
iLVmass 0.121 0.064 
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to Carlsson et al 118 differing only in the level of manual segmentation. Both 
techniques produce values of KE that are very similar and appear equally valid.
The major findings of the study were: (1) interestingly the KE profile closely 
resembled the healthy RV rather than showing any significant adaptations; (2) 
the shape and size of the morphological LV remnant was observed to have an 
important impact on diastolic KE values as hypothesised.
The initial part of the study required determination of normal KE values in 
children. Briefly, children frequently exhibit a single fused diastolic monotonic 
peak compared to the two diastolic peaks seen in adulthood due to the higher 
heart rates common in children. In children the diastolic kinetic energy peak in 
the LV was observed to be greater than that of the RV. Furthermore the RV had
a greater systolic peak due to outflow tract geometry.  However, unlike in 
adults, this did not quite reach significance. It is likely that with a larger cohort 
of children any differences in RV systolic KE would have reached significance. 
Reassuringly these findings were in keeping with the existing literature. 10, 118, 134, 
137, 204  
The characteristic diastolic KE profile of the LV is due to the greater recoil of
the LV myocardial mass. A suction like-effect is created drawing blood into the
ventricle. This effect is less prominent in the healthy RV due to a lower myocar-
dial mass. Carlsson et al 118 postulate that the differing motions of the tricuspid
valve and mitral valve are responsible for generating more diastolic KE in the
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LV. They hypothesise that the hinge-like motion of the tricuspid valve tends to
sweep over and around the blood without imparting much additional KE whilst
the mitral valve draws in blood from the atria. We are skeptical of this theory.
Although there are differences in shape between the mitral valve annulus and
tricuspid annulus with the mitral valve displaying a reduced antero-posterior di-
rection making it more saddle shaped, both have the same area and circumfer-
ence so blood flow and velocities will be equivalent. {Makaryus et al., 2017,
#80358} Valve opening is a consequence of pressure gradients from active
ventricular diastolic relaxation with no discernible active process from the
leaflets themselves.
In those with HLHS the diastolic KE profile continued to closely resemble that 
of a healthy RV. This was unexpected. In Chapter 3.2 the pressure-volume 
loops for the systemic RV were altered to resemble a healthy LV pressure-
volume loops. Despite the single RV being in the systemic position there were 
no alterations in diastolic KE. The intrinsic architecture of the RV is responsible 
limiting the production of diastolic KE. However the systemic RV undergoes 
changes in volume and mass which do not appear to alter the diastolic KE. As 
a consequence of the first and then second stages of surgical palliation the RV 
undergoes extreme changes first in volume loading and then volume reduction.
43 Overall it remains dilated and hypertrophied. In well trained athletes, right 
ventricular dilatation and left ventricular hypertrophy are associated with 
increased diastolic KE values. 202 In contrast this association was not seen in 
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those with HLHS -neither myocardial mass or ventricular volume altered the 
KE. The observed findings are in keeping with Gewillig's hypothesis 7 that the 
systemic RV, following Stage 2 of the palliation, is an overgrown and under-
filled ventricle. Whilst remaining well-coupled to the systemic circulation 200 it is 
unable to generate the same levels of diastolic KE as seen in the healthy LV. 
The observed changes in mass and volume are a compensatory response to 
reduce wall tension and persist with no added kinetic energy advantages. 
Interventions and measures to reduce the extent of early volume loading, such 
as earlier timing of Stage II surgery might therefore be postulated to improve 
energetic function.
In assessing other factors which alter the kinetic energy of the RV we looked at
the size and shape of the LV remnant. In those with HLHS the presence of a 
larger LV remnant has a bearing on the stiffness of the systemic ventricle and 
also on outcome following surgery. Those with the largest LVs have been 
demonstrated to have the stiffest ventricles and the poorest outcomes. 35, 37 In 
this study we observed that the presence of a morphologically globular LV 
remnant leads to a reduced diastolic KE. Additionally those with the largest LV 
remnant similarly had the lowest diastolic KE values. These findings were in 
keeping with other literature but importantly we were able to demonstrate this 
non-invasively and also show that parameters of KE which reflect the useful 
work and energy of the heart are altered offering this metric as a potential new 
marker of diastolic dysfunction. The presence of a non-functioning piggy-back 
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ventricle adversely affected the development of diastolic KE by decreasing 
ventricular compliance and the greater the size the more the impact on 
energetic momentum. A larger dysfunctional LV has a greater negative 
ventricular-ventricular interaction on the RV. This in turn may well lead to 
altered conservation of momentum and higher viscous energy losses. 9 
Interestingly these results were not detected by using measures of ejection 
fraction. Lower diastolic KE values have also been demonstrated to occur with 
ageing and in those with LV dysfunction.  This raises the question as to 
whether the group with the largest LV remnants may be predisposed to 
developing symptoms of heart failure at an earlier stage. 
The accuracy of the 4D flow data, particularly velocity is important in 
measuring KE. Previous work performed by our group 126, 170, 205 shows the 
validity of using accelerated 4D flow sequences to acquire highly temporally 
undersampled data. Mean bias was only -0.06m/s with no systematic bias 
seen on Bland-Altman plots. The 4D flow data used in this study was 
meticulously collected. The velocity encoding (VENC) value was determined 
using a 2D phase contrast sequence prior to the 4D flow scan to ensure peak 
velocities were not underestimated.  Three-dimensional CMR acquisitions 
provide a detailed overview of the velocity of blood in three directions helping 
to capture the intricacies of flow within the whole heart. This is important, as 
filling of the LV cavity does not occur solely from base to apex. Vortices form 
below the mitral ring and move apically during healthy diastolic filling. 11  2D PC
MRI or echocardiography may miss these subtleties, or require larger study 
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populations before differences become detectable. Additionally the mitral valve
is elliptical and moves throughout the cardiac cycle. 118 It becomes distorted in 
cardiac disease such as DCM making accurate plane orientation for 2D PC 
flow techniques more technically challenging. Three-dimensional flow 
echocardiography is currently a tool under development but this too is limited 
by the patient’s habitus. 119 This detail is not adequately captured by two-
dimensional (2D) doppler echocardiography or 2D PC flow MRI which are 
limited to a single imaging plane and measure velocities in only one direction. 
4.1.4 Limitations
The number of CMR scans from those with HLHS was limited. Whilst interest-
ing conclusions were able to be drawn, a larger case series might continue to
provide more detail particularly as the children age.
The 4D flow MRI sequences used prospective ECG triggering which acquired
90% of the cardiac missing some of late diastole. This meant that atrial peaks
were not evident in all subjects. However given the majority of changes seem
to occur in systole and early diastole we were still able to draw interesting con-
clusions from the data. Only CMR data was acquired. The addition of invasive
catheter data to assess the compliance of the ventricles particularly in those
with HLHS would have been useful albeit with the risks of an invasive
procedure.
Almost all scans were acquired with the subject under general anaesthesia.
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This represents a reversal of normal Fontan physiology. 206, 207 The effects and
influence of general anaesthesia agents have been discussed in detail in the
limitations section of Chapter 4.2.7. Ethical considerations and institutional
practice did not allow awake scans to be performed. As increasing patients
survive into adulthood and tolerate awake scans the acquisition more faithful
physiologically representative should become available.
4.1.5 Conclusions
The systemic RV demonstrates incomplete adaptation as a pressure loaded
ventricle. Its kinetic energy profile remains inherently limited by its architecture
as it continues to resemble a RV rather than a LV. Diastolic KE values are most
adversely affected by the presence of a non-functioning larger LV remnant.
This is in keeping with the literature demonstrating that this group have the
worst post-operative outcomes.
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4.1.6 Summary
Background: In HLHS the RV performs as a systemic ventricle, however the
adaptation is incomplete. Patients experience early circulatory failure and
those with the largest LV remnants have poorer outcomes. Intra-cardiac KE
differs between the healthy LV and RV and is sensitive to changes in systolic
and diastolic function. We compared intra-cardiac KE in healthy children to
those with HLHS to study the energetic limits imposed on the systemic RV and
how residual LV size affects the KE profile. 
Methods and Results: 4D flow MRI was acquired in 8 healthy children (1-16
years) and 30 children with HLHS (1-16 years) undergoing clinical MRI (15
HemiFontan, 15 Fontan). Intraventricular KE was measured throughout the car-
diac cycle and indexed to ventricular volume. LV remnant was grouped into
shape (slit-like or globular) and size (median volume =2.4mls).
Two intra-cardiac KE peaks were present reflecting systole, and the fused in-
flow of early diastole. The healthy LV displayed a larger diastolic peak com-
pared to the healthy RV (p <0.05). Compared to the healthy RV those with
HLHS had a similar diastolic peak in the presence of preserved function, but
despite increased mass (p <0.001) and volume (p <0.05). No differences
emerged between stages of surgery. Globular shaped LV remnants had the
lowest RV diastolic KE compared to slit-like LV remnants (p =0.005). This was
also related to the size of the LV remnant with lower KE seen in those with larg-
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er median LV size (LV >2.4mls; p =0.016). 
Conclusions: In HLHS, the RV displays incomplete physiological adaptations
to its role as a systemic ventricle with diastolic KE limited by the inherent RV
morphology. This is further influenced by larger, globular LV remnants acting
as stiff piggy-back ventricles with adverse effects on diastolic momentum. 
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4.2 Exploring kinetic energy as a new marker of function in the 
single ventricle circulation
4.2.1 Background
In Chapter 3.2 ventricular contractility and stroke work were studied in patients
with HLHS through a range of heart rates. The work of the heart rose dramati-
cally at higher heart rates. The contractility was preserved and well matched to
the arterial system. Continuing with the theme of energetics we examined a
different component of the useful work that the heart performs - the kinetic
work imparted to blood as momentum. We examined the kinetic work in a
range of patients with HLHS in Chapter 4.1 using a non-invasive MRI tech-
nique. The previous section demonstrated that KE is altered in those with
HLHS compared to healthy hearts. Here 4D flow MRI derived KE is used to de-
rive and investigate its use as a potential new marker of function. Two ap-
proaches are examined. The first approach assessed peak instantaneous KE
and was named the kinetic energy ejection fraction (KE EF). This is the maxi-
mum energy exerted onto the whole blood volume. The second approach used
a novel particle-based assessment and was named the particle energy ejection
fraction (PE EF). This is the maximum energy exerted onto individual particles.
It utilises the ability of 4D flow to study fluid dynamics using a Lagrangian
method. We compared each technique in those with single ventricle circula-
tions to those with established LV dysfunction and used healthy control sub-
Characterising ventricular function: Kinetic Energy
- 160 -
jects across the age spectrum to determine normal ranges and act as compar-
isons. We hypothesized that as metrics based on kinetic energy are related to
the useful work of the heart they could act as an improved marker of function
for assessing cardiac performance compared to VV EF.
4.2.2 Results
Accuracy of 4D flow measurements
Four dimensional flow was compared to 2D flow. The peak velocity measure-
ments showed a mean bias of -0.06 m/s with the 95% limits of agreement
ranging from -0.305 m/s to +0.186 m/s. There was no statistical difference in
2D and 4D peak velocity measurements between the different patient groups
(healthy LV vs. single ventricle vs. LV dysfunction, p = 0.163) (see Figure 26). A
mean of 4.8% of particles were discarded due to leakage across the myocar-
dial border. This did not significantly differ between groups (ANOVA p =0.09). 
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Reproducibility of ventricular volumes and aortic flow
Intra-class coefficient (95th confidence interval) was 0.97 (0.86 - 0.99) for aortic
SV, 0.97 (0.80 - 0.99) for end diastolic volume (EDV), 0.95 (0.82 - 0.980) for
ESV, 0.95 (0.82 - 0.98) for SV and 0.89 (0.58 - 0.97) for VV EF.
Demographics
The demographic data for each patient group is shown in Table 13. As expect-
ed from the disease aetiology those from the single ventricle circulation group
were younger than those from the LV dysfunction group.
Table 13: Kinetic energy function study: patient demographics. F = female, M =
male, BSA = body surface area, HR = heart rate, BP = blood pressure, LV = left
ventricle
Distribution of systolic kinetic energy
The percentage of particles at peak velocity during each systolic time point
were plotted against the fraction of systole (see Figure 27) to permit
Table 1. Patient demographics 
  Healthy controls Single ventricle hearts 
LV dysfunction ANOVA 
P value 
Gender  22F:21M 12F:29M 5F:9M  
Median age  [range] (years) 31 (1.5 – 62) 5 (0.6 – 28) * 50 (28 – 79) * <0.001 
BSA [range] (m2) 1.7 (0.5 – 2.2) 0.9 (0.5 – 2.2) * 1.9 (1.3 – 2.5) <0.001 
Median HR  [range] (bpm) 71 (48 – 138) 77 (43 -110) 64 (45 – 80) 0.055 
Median BP 
systolic   (± SD) (mmHg) 118 (± 10) 97 (± 21) * 122 (± 22) <0.001 
Median BP 
diastolic  (± SD) (mmHg) 74 (± 10) 54 (±12) * 79 (± 10) <0.001 
      
p value compared to healthy LV *p < 0.01 †p < 0.05   
 
F = female, M = male, BSA = body surface area, HR = heart rate, BP = blood 
pressure, LV = left ventricle  
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comparison between subjects with different heart rates. Visually those with
single ventricle circulations appeared negatively skewed. The Q-Q plots are
shown in Figure 28. Surprisingly despite the visual skewedness, particularly in
those with single ventricle circulations, when tested all groups demonstrated a
normal distribution (Healthy LV p = 0.127; SV p = 0.132; LV dysfunction p =
0.262). In all groups, a maximum of 10% of ejected particles were at peak
velocity (and therefore peak KE) at any time with the remainder of particles still
gaining or already losing velocity. 






































































































Characterising ventricular function: Kinetic Energy
- 163 -
Figure 28: Quantile-Quantile plots of expected vs observed values for
percentage of particles at peak velocity during systole.
Streamline data showed maximal velocities occurred in the outflow. The effect
of the size of the outflow tract on the peak systolic KE showed a weakly posi-
tive correlation (R2 = 0.204, p <0.001) indicating that smaller outflows were not
associated with a greater velocity and, or KE (see Figure 29).
Figure 29: Peak ejected kinetic energy against outflow tract size. Smaller
outflows are not associated with increased velocity or KE.
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Comparison between healthy children and adults
Table 14 shows the volumetric and KE indices for healthy children and adults.
Cardiac volumes display an exponential allometric change in size with patient
age. There were no differences between healthy adults and children for VV EF
(p = 0.52), KE EF (p = 0.7) or PE EF (p = 0.3) allowing them to be combined into
one group of healthy controls. This point and the differences in age range be-
tween our study population, healthy controls and positive controls with heart
failure are discussed further in the limitations section. 
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Table 14: Kinetic energy function study: MRI derived volume indices for healthy
adults and children. iEDV = indexed end diastolic volume, iESV = indexed end
systolic volume, iSV = indexed stroke volume, VV EF = ventricular volumetric
ejection fraction, iKEej = kinetic energy density for ejected blood, iKEres =
kinetic energy density for residual blood, KE EF = kinetic energy ejection
fraction, iPEej = particle energy density for ejected blood, iPEres = particle
energy density for residual blood, PE EF = particle energy ejection fraction
Comparison between the single ventricle group and control groups
Volumetric and kinetic energy data for the three different study groups is
shown in Table 15, and Figure 30. For VV EF, patients with single ventricle
circulation exhibited values that were very similar to healthy controls (GLM
adjusted mean 60.1% vs. 60.1%, p = 0.99), which were both very dissimilar to
patients with LV dysfunction (GLM adjusted mean 39.6%; p < 0.001 for both
 
 
Table 2: Kinetic energy function study: MRI derived volume indices for healthy adults and 
children.  
iEDV = indexed end diastolic volume, iESV = indexed end systolic volume, iSV = indexed stroke 
volume, VV EF = ventricular volumetric ejection fraction, iKEej = kinetic energy density for 
ejected blood, iKEres = kinetic energy density for residual blood, KE EF = kinetic energy ejection 
fraction, iPEej = particle energy density for ejected blood, iPEres = particle energy density for 
residual blood, PE EF = particle energy ejection fraction 
	
Table 2. MRI derived volume indices for healthy adults and children. 
 
  Adult LV n = 35 
Child LV 
n = 8 
p value 
iEDV (± SD) ml/m2 84 (± 11.8) 69 (± 9.6) 0.002 
iESV (± SD) ml/m2 33 (± 7.5) 28 (± 2.3) 0.05 
iSV (± SD) ml/m2 50 (± 6.9) 41 (± 7.1) 0.002 
     
VV EF (± SD) % 60.3 (± 5.5) 59.0 (± 3.3) 0.5 
iKEej (± SD) mcgJ/ml 110.9 (± 39.5) 108.7 (± 37.4) 0.8 
iKEres (± SD) mcgJ/ml 3.6 (± 1.4) 3.8 (± 2.6) 0.7 
KE EF (± SD) % 97.9 (± 0.8) 97.9 (± 0.9) 0.7 
     
iPEej (± SD) mJ/ml 0.247 (± 0.078) 0.216 (± 0.080) 0.31 
iPEres (± SD) mJ/ml 0.010 (± 0.003) 0.008 (± 0.005) 0.11 
PE EF (± SD) % 97.3 (± 0.8) 97.6 (± 0.5) 0.3 
 
iEDV = indexed end diastolic volume, iESV = indexed end systolic volume, iSV = 
indexed stroke volume, VV EF = ventricular volumetric ejection f action, iKEej = 
kinetic energy density for ejected blood, iKEres = kinetic energy density for residual 
blood, KE EF = kinetic energy ejection fraction, , iPEej = particle energy density for 
ejected blood, iPEres = particle energy density for residual blood, PE EF = particle 
energy ejection fraction, LV = left ventricle 
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comparisons). This was in stark contrast to the values for kinetic energy
ejection fraction and particle energy ejection fraction, where single ventricle
patients now yielded results similar to the diseased left ventricle group and
both of which were lower than healthy controls.  
Table 15: Kinetic energy function study: MRI derived volumetric and kinetic
energy indices for healthy control, single ventricle and left ventricle dysfunction
groups. GLM = generalised linear model
 
 
Table 3: Kinetic energy function study: MRI derived volumetric a d kinetic e ergy indices for 
healthy control, single ventricle and left ventricle dysfunction groups.  
GLM = generalised linear model 
	
Table 3. MRI deriv d volumetric and kinetic energy indices for healthy control, single 
ventricle and left ventricle dysfunction groups. 
 
  Healthy controls 
n = 43 
Single ventricle 
n = 41 
LV dysfunction  
n =18 
ANOVA or GLM 
P values 
iEDV (± SD) ml/m2 81 (±13) 93 (± 23) † 105 (± 25) * <0.0001 
iESV (± SD) ml/m2 33 (± 7) 38 (± 16) 64 (± 24) * <0.0001 
iSV (± SD) ml/m2 49 (± 8) 55 (± 11) † 41 (± 10) † <0.0001 
VV EF (± SD) % 60.1 (± 5.2) 60.1 (± 8.5) 40.4 (± 10.7) * <0.0001 
GLM adjusted VV EF % 60.1 60.1 39.6 * <0.001 
      
iKEej (± SD) mcgJ/ml 111.0 (± 38.7) 73.7 (± 27.5) * 101.0 (± 36.9) <0.0001 
iKEres (± SD) mcgJ/ml 3.6 (± 1.7) 3.8 (± 2.5) 2.8 (± 1.1) 0.2 
KE EF (± SD) % 97.9 (± 0.8) 96.4 (± 2.6) † 95.1 (± 4.3) * <0.0001 
GLM adjusted KE EF % 97.9 96.4 * 95.1 † <0.001 
      
iPEej (±  SD) mcJ/ml 241.6 (± 78.3) 166.9 (± 81.4) * 214.7 (± 66.0) <0.0001 
iPEres (±  SD) mcJ/ml 9.9 (± 3.6) 36.2 (± 68.5) † 17.9 (± 2.7) 0.029 
PE EF (± SD) % 97.3 (± 0.8) 90.9 (± 7.9) * 90.1 (± 6.9) * <0.0001 
GLM adjusted PE EF % 97.3 90.9 * 90.3 * <0.001 
      
Particles discarded % 4.2 (± 3.5) 4.4 (± 4.1) 6.7 (± 4.6) 0.086 
     
p value compared to healthy LV *p < 0.01 †p < 0.05   
 
iEDV = indexed end diastolic volume, iESV = indexed end systolic volume, iSV = 
indexed stroke volume, VV EF = ventricular volumetric ejection fraction, GLM = 
generalised linear model, iKEej = kinetic energy density for ejected blood, iKEres = 
kinetic energy density for residual blood, KE EF = kineti  ener y ejection fraction, 
iPEej = particle energy density for ejected blood, iPEres = particle energy density for 
residual blood, PE EF = particle energy ejection fraction, LV = left ventricle 
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Figure 30: Box and whisker plots showing relationship between patient group
and ejection fraction (kinetic and volumetric) for all patients. P values are
shown for inter-group comparisons, and are calculated post hoc from the
Generalized Linear Model using the Bonferroni adjustment.
The role of single ventricle morphology
Table 16 shows the morphology of those from the single ventricle circulation 
group including the degree of atrio-ventricular valve regurgitation (AVVR). 
Subjects with moderate or severe AVVR (regurgitation fraction > 25%; n = 5) 
had a significantly worse PE EF than those with none or only mild regurgitation 




Figure 7: Box and whisker plots showing relationship between patient group and ejection 
fraction (kinetic, particle and volumetric) for all patients. P values are shown for inter-group 



























P = 0.001 P = 0.23
P < 0.001
P < 0.001 P = 0.99
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comparing KE EF or VV EF. There were no differences between the group with 
a systemic RV and the group with a systemic LV. Both had similar sized hearts 
with equivalent VV EF (p = 0.22), PE EF (p = 0.49) and KE EF (p = 0.5).
Estimates of functional status were made in 40 of the 41 subjects (Table 20). 
One child was not included as they were too young (6 months old) for a reliable
estimate to be made. There was no clear relationship between NHYA status 
and VV EF and KE EF; however, this was not the case for PE EF, which 
demonstrated a fall as NHYA status worsened. Figure 8 shows VV EF and PE 
EF across the three NYHA sub-groups within the single ventricle patients. 
There was no significant correlation between VV EF and PE EF in the single 
ventricle patients (r = 0.23, p = 0.15) (Figure 31).
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Table 16: Kinetic energy function study: single ventricle morphology and
functional status.. Where HF = Hemifontan, F = Fontan, ccTGA = congenitally
corrected transposition of the great arteries, DORV = double outlet right
ventricle, IVS = intact ventricular septum, DILV = double inlet left ventricle, APC
= aorto-pulmonary collateral vessels, VSD = ventricular septal defect, NHYA =
New York Heart Association functional class
 
Normal atrial situs 39/41 
Apex to left 33/41 
Systemic Right Ventricle 14HF:17F 
Mitral atresia/Aortic atresia 
Mitral stenosis/Aortic stenosis 








Mild (15 – 25%) 







Mean APC % cardiac output (± SD) 13 (±15)% 
VSD 2/31 
Systemic Left Ventricle 3HF:7F 
Tricuspid atresia 
Pulmonary atresia/IVS 
DILV + Pulmonary stenosis 





Atrio-ventricular valve regurgitation 
None (< 15%) 
Mild (15 – 25%) 
Moderate (25 - 40%) 






Mean APC % cardiac output (± SD) 13 (±14)% 
VSD 7/10 
NYHA Status 40/41 
NYHA I 24 
NYHA II 11 
NYHA III 5 
NYHA IV 0 
Blood density  
Haemoglobin (mean ± SD) 13.8 ± 2.1 g/dL 
Haematocrit (mean ± SD) 0.418 ± 0.06 
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Figure 31: Scatter plot single comparing kinetic energy and ventricular
volumetric ejection fractions for single ventricle patients 
4.2.3 Discussion
Patients with single ventricle circulations have poor long-term outcomes 48
making accurate assessment of ventricular function a crucial tool in picking up
early signs of deterioration. However, our standard way of grading ventricular
function, VV EF, is often preserved despite reduced maximal oxygen
consumption (VO2 max) on exercise testing. 5, 54, 68 Recently there has been
interest in measuring ventricular kinetic energy with a focus on patterns of
intra-cardiac kinetic energy in health and disease to see if this could provide an
additional tool in the assessment of ventricular function. 203, 208 In this paper we
proposed two new measures of ventricular systolic function based
conceptually on kinetic energy, the KE EF and PE EF, and assessed their
usefulness in patients with single ventricle circulation. 
Figure 3. Scatter plot single comparing kinetic energy and ventricular volumetric 
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The results of this study showed that markers of function based on KE
displayed a small but significant difference in values between health and
disease. The KE EF and PE EF in healthy individuals had a very small variance
(±0.8% for each respectively). In contrast, in patients with single ventricle
physiology, both the KE EF and PE EF values were significantly decreased
(96.4 ± 2.6% and 90.9 ± 7.9% respectively), with a broader range suggesting a
spectrum of impaired function. The magnitude of the difference was small,
only 1.5% lower in KE EF and 6.4% in PE EF but the small variance involved in
both figures is in marked contrast to VE EF which had a broad range in health
and furthermore showed no differences in values between the two groups. The
positive control group represented by subjects with LV dysfunction, where we
would expect abnormalities in kinetic energy, 137 showed a reduction in both
KE EF and PE EF similar to the single ventricle group indicating that metrics
based around systolic kinetic energy indices may offer a new tool for functional
assessment across a spectrum of cardiac diseases.
Existing studies 137 on KE in patients with compensated DCM demonstrate
preserved stroke volume compared to healthy controls. However the
proportion of blood that enters the heart in diastole and is then ejected in the
following systolic contraction - direct flow - is significantly reduced.
Comparably we note that our LV dysfunction population also had identical
stroke volumes to our healthy control group. Although we did not measure
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direct flow we were able to demonstrate a significantly reduced peak early
diastolic KE value. 
Comparing differences in ventricular and kinergetic assessment
The broad range of VV EF in health makes detection of abnormalities in cardiac
function more challenging with larger numbers needed to separate healthy
hearts from those with reduced function. This is in part due to our method of
assessing ventricular volumes. Standard CMR protocols recommend planning
stacks of slices in the short axis plane parallel to the atrio-ventricular valve
plane for assessment of VV EF. 209 Whilst CMR is the gold standard for
volumetric assessment this process can be prone to errors that may increase
the variability in measurements. 77, 78 Stacks of transverse slices offer less
variability 85, 210 but not necessarily a more accurate volume. An inconsistent
breath-holding position between slices leads to loss of contiguity further
contributing to increased margins of error. Indeed, the large range and
variability in VV EF 211 may be responsible for its poor gradation of risk in those
with only mildly reduced ejection fraction. 212 The physiological adaptations
undergone by those with a single ventricle circulation further contributes to the
difficulty in accurate assessment of function using VV EF. Single ventricles are
dilated, hypertrophic and hypocontractile. 7 They undergo dramatic changes in
loading conditions during early operative procedures that leave VV EF
sensitized to preload and relatively insensitive to detecting mild cardiac
dysfunction. 72 We found that as a group although patients with single ventricle
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physiology had an increased end diastolic volume (EDV), they also had an
increased SV which led to a VV EF that was similar to the control group. The
preservation of VV EF was at odds with patient reported symptomology. Whilst
16 out of 40 assessed patients with single ventricle physiology described
symptoms of exercise intolerance (NYHA class II or greater) we found no
relationship between VV EF and NYHA class. In contrast, KE EF and PE EF
values were significantly depressed in single ventricle patients, indicating the
presence of an underlying abnormality in the dynamics of energy transfer from
myocardium to blood. Furthermore, PE EF fell in tandem with subjectively
reported symptoms of heart failure. Those describing significant limitations in
function had the lowest PE EF values. PE EF allowed stratification of function
that appeared to match with reported symptomology in a way that is not
permitted by VV EF or KE EF. These results are from a small sample size but
warrant further work in assessing particle based measures of kinetic energy as
a potential new functional biomarker.
The role of single ventricle morphology and valvular regurgitation on energetics
The reduction in KE EF and PE EF seen in those with single ventricle physiolo-
gy is a multifactorial process. We assessed the impact of left and right single
ventricular morphology and found no apparent differences. We additionally as-
sessed if the severity of AVVR played a part and found a significant fall in PE
EF. The severity of AVVR is correlated to the degree of volume loading on the
ventricle. More AVVR results in an increase in the end diastolic and end sys-
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tolic volume of the ventricle. Those with only modestly dilated hearts frequently
demonstrate compensatory changes leading to preserved function. This does
not reflect the increased work performed by the heart in ejecting the recirculat-
ing regurgitant blood volume and the additional KE imparted to the larger
residual volume of blood. Altered energy efficiency has been demonstrated in
computational models 9 and the changes in PE EF may reflect this altered ener-
gy efficiency.
Relevance to previous studies
Previous studies performed using 4D flow MRI have assessed the intracardiac
KE in healthy hearts 10, 118, 204, established normal values through a range of
ages 200 and also investigated the impact of heart failure on normal kinergetics.
137, 213, 214 In one study KE was used to assess function in Tetralogy of Fallot, a
form of congenital heart disease, with mixed results. Importantly these studies
have all assessed the peak kinetic energy of the total blood volume. This study
used a previously validated method to derive KE 200 Two different measures of
energetic ejection fraction were then assessed. The KE EF used a similar
principle of measuring peak total KE as compared to the existing body of
published work. However, a second method based on a particle-by-particle
analysis was also evaluated. The use of PE EF represented a novel approach
to assessing kinetic energy in the heart. It utilised the advantages of particle
analysis afforded by 4D flow MRI, with advances in computational processing
to permit detailed kinematic analysis of blood flow. The importance of a
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Lagrangian approach to assessing particle energetics and fluid dynamics
becomes clear when considering that at any instance a maximum of 10% of
particles are ever at peak velocity. Assessing whole blood volumes in this way
may underestimate the total work of the heart. The area of energetics is an
emerging topic and further work is currently being performed to compare
energetics in healthy hearts to those with heart failure 201, 213–215 and there is
much potential to expand this into congenital heart disease to help us better
understand these conditions.
4.2.4 Limitations
The large majority of the patients with single ventricle physiology in our study
were children, but it was difficult to match a healthy volunteer cohort with simi-
lar ages with only eight of our normal volunteers being children. However when
analysed as separate groups, the energetic parameters in our adult and chil-
dren healthy volunteers were similar, including their KE EFs with a narrow
range in both children and adults. For our positive controls we were unable to
include any children in the heart failure group as none underwent cardiac MRI
during the study period. However as there were no differences between the
adults and children in the healthy control group then we would expect our pos-
itive controls to be a reasonable comparative group. 
4D flow MRI was acquired using a free-breathing technique only during expira-
tion, which loses the normal respiratory variation in flow. There was no signifi-
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cant difference between the peak velocities of different groups measured by
signal averaged free breathing 2D or 4D flow indicating no systematic bias
caused by patient size or morphology. The highly accelerated 4D flow se-
quence allowed us to acquire at an isotropic spatial resolution of 2.0-3.0mm
and a true temporal resolution of <35milliseconds falling within previously de-
fined recommendations for accurate flow acquisitions. This resolution was
comparable to other published 4D flow literature
Although MRI 4D flow is now becoming increasingly available on scanners with
the latest generation software, the technical expertise to perform detailed post-
processing to calculate kinetic energy is less generally available. As familiarity
grows with this concept we hope that our work to improve post-acquisition
and processing analysis 216 may prove invaluable for increasing accuracy and
reliability of such sequences and lead to increased clinical integration. In addi-
tion, in the future it may be possible to acquire the 4D flow data using novel
echocardiographic techniques that would make data acquisition much simpler
and possible at the bedside or in the clinic. 119
The density of blood taken was assumed to be 1060gm/mm3 for all cases. This
can alter in those with cyanotic heart disease. The haematocrit for the single
ventricle group was measured prior to anaesthesia and was within the normal
range for all but three patients. The literature suggests a large change in
haematocrit from 0.30 to 0.60 is required to cause a small 1.9% increase in the
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blood density from 1040gm/mm3 to 1060gm/mm3 permitting the use of a mean
blood density value. 217
4.2.5 Conclusions
Kinetic energy parameters offer new insight into the function of the heart. They
are consistent in health and show deviation in cardiac disease particularly in
conditions such as single ventricle physiology where standard ejection fraction
values are often normal. Particle based analysis seems sensitive towards
detecting dysfunction and may be a new biomarker of disease if the
computational cost of the analysis can be improved in future.
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4.2.6 Summary
Background: VV EF is often normal in patients with single ventricle circulations
despite them experiencing symptoms related to circulatory failure. We sought
to determine if  KE could be a better marker of ventricular performance.
Method and Results: KE was prospectively quantified using 4D flow MRI in 41
patients with a single ventricle circulation (0.5 - 28 years) and compared to 43
healthy volunteers (1.5 – 62 years) and 14 patients with LV dysfunction (28 – 79
years). Intraventricular end-diastolic blood was tracked through systole and di-
vided into ejected and residual blood components. Two ejection fraction (EF)
metrics were devised based on the KE of the ejected component over the total
of both the ejected and residual components using: (1) instantaneous peak KE
to assess KE EF or; (2) summating individual peak  PE to assess PE EF. 
KE EF and PE EF had a smaller range than VV EF in healthy subjects (97.9 ±
0.8% vs. 97.3 ± 0.8% vs. 60.1 ± 5.2%). LV dysfunction caused a fall in KE EF
(p =0.01) and PE EF (p =0.0001). VV EF in healthy LVs and single ventricle
hearts was equivalent however KE EF and PE EF were lower (p <0.001) with a
wider range indicating a spectrum of severity. Those reporting the greatest
symptomatic impairment (NYHA II) had lower PE EF than asymptomatic sub-
jects (p =0.0067). 
Conclusions: KE metrics are markers of healthy cardiac function. PE EF may
be useful in grading dysfunction.
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5. Characterising ventricular function: Shape and Strain
5.1 Right ventricular morphology and function following stage I 
palliation with a modified Blalock-Taussig shunt versus a right 
ventricle-to-pulmonary artery conduit 
European Journal of Cardio-Thoracic Surgery (2016) 1–8
5.1.1 Background
In Chapter 1.3.7 the two different type of Norwood operation were described.
Briefly, the modified Blalock-Taussig (MBT) shunt involves a connection
between the innominate or subclavian artery and one of the branch pulmonary
arteries allowing blood to shunt from the systemic circulation into the
pulmonary circulation. The MBT shunt has been associated with
haemodynamic instability 218 and sudden death 219 in the postoperative period.
The right ventricle-to-pulmonary artery (RVPA) conduit was developed to offset
this risk. 39 Following a ventriculotomy, a tube is inserted between the RV and
the main pulmonary artery to act as a conduit. This results in volume loading
from conduit regurgitation and a scar on the systemic ventricle predispose the
patient to an increased risk of arrhythmias or aneurysmal dilatation of the
outflow tract. 220, 221 At present, the direct impact of the ventriculotomy scar on
the growth and motion of the systemic RV remains incompletely understood.
222, 223  
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In this study we performed a dual centre retrospective analysis of cine imaging
to investigate the differences in shape and motion of the ventricle after each
procedure. Datasets from Boston Children's hospital were used as Evelina
hospital preferentially performs the mBT shunt based Norwood procedure.
Computational anatomical analysis of CMR images was used to create detailed
3D cardiac atlases and to detect small differences in ventricular geometry. 103,
105 Using traditional two-dimensional (2D) measurements such as length and
diameter to assess a complex 3D shape does not capture subtle variations in
topology. Strain analysis captured the motion of the ventricle and these were
used to examine the impact of the RVPA conduit on the function of the
systemic RV in patients with HLHS. The ventriculotomy scar would be
expected to cause adverse remodelling and motion of the ventricle and alter
the shape and motion in those with RVPA conduits.
5.1.2 Results
There were a total of 93 CMR datasets from the two congenital centres. 34
underwent RVPA conduit and 59 underwent MBT shunt. The MBT shunt
population comprised 30 Stage I scans and 29 Stage II scans. The RVPA
conduit population comprised 20 Stage I scans and 14 Stage II scans.
Demographic data is shown in Table 17. A more limited ventriculotomy scar
was introduced in those undergoing RVPA conduit after 2009. 5 Stage I scans
and 3 Stage II scans had the more limited incision.
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Table 17: Shape and strain study: demographic data showing means and
standard deviations
There were no significant differences in birth weight or age at Norwood
procedure between groups. Stage I scans for the RVPA conduit group tended
to be performed later than the MBT shunt group and, as expected, these
patients were larger in size. Table 18 shows the MRI derived data. 
 MBT shunt RVPA conduit P value 
Number 59 34  
Birth weight 3.2 ± 0.4 kg 3.0 ± 0.5 kg 0.22 
Re-coarctation 4/59 7/34 0.06 
Occlusion of collateral vessels 8/59 33/34 0.0001 
Stage 1 scans 30 20  
Age at Stage I 7.1 ± 6.7 days 5.3 ± 2.8 days 0.28 
Age at MRI scan 103 ± 24 days 141 ± 57 days 0.0007 
BSA 0.40 ± 0.04 m2 0.44 ± 0.06 m2 0.0087 
Stage 2 scans 29 14  
Age at Norwood  7.1 ± 6.7 days 7.3 ± 3.8 days 0.98 
Age at Stage II 172 ± 38 days 177 ± 65 days 0.72 
Age at MRI scan 30.6 ± 8.2 months 27 ± 11 months 0.16 
BSA 0.67 ± 0.23 m2 0.70 ± 0.11 m2 0.53 
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Table 18: Shape and strain study: MRI derived data for systemic RV global
function following either a MBT shunt or RVPA conduit. Values are indexed to
BSA.
 MBT shunt RVPA conduit P value 
Total n = 59 n = 34  
iEDV ml/ BSA1.3 80 ± 20 106 ± 33 0.0001 
iESV ml/ BSA1.3 34 ± 13 47 ± 24 0.001 
iSV ml/ BSA1.3 46 ± 11 59 ± 15 0.0001 
EF % 57.9 ± 8.3 56.5 ± 8.5 0.43 
    
Stage 1 n = 30 n = 20  
iEDV ml/ BSA1.3 83 ± 23 110 ± 32 0.001 
iESV ml/ BSA1.3 38 ± 15 48 ± 24 0.087 
iSV ml/ BSA1.3 44 ± 10 62 ± 13 0.0001 
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Stage 2 n = 29 n = 14  
iEDV ml/ BSA1.3 77 ±17 98 ± 33 0.014 
iESV ml/ BSA1.3 30 ± 9 47 ± 19 0.001 
iSV ml/ BSA1.3 47 ± 13 51 ± 17 0.38 



















   Slit-like 











Characterising ventricular function: Shape and Strain
- 183 -
Compared with the MBT shunt group, patients with RVPA conduit had more
dilated hearts at all stages of surgery (Stage I, p = 0.001; Stage II, p = 0.014).
Indexed end-diastolic volume decreased following volume off-loading Stage II
surgery in both groups. There were no differences in tricuspid regurgitation.
There were no differences in the range of LV morphology between the two
groups.
Geometric analysis
All 93 computational shapes were successfully created reaching a sub-voxel
accuracy (average fitting error 1.43 mm). Average cardiac shapes for the MBT
shunt and RVPA conduit groups at each stage are illustrated in Figure 32. 
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Figure 32: Ventricular shape difference between RVPA and MBT shunt groups
in the entire HLHS population. The top row shows average ventricular shape
for MBT shunts at each surgical stage and then an overall ventricular shape for
both stages. The second row shows the equivalent average ventricular shape
for RVPA shunts. The third row shows an overlay of the two averaged shapes
for MBT and RVPA shunt groups. The solid colour represents the endocardial
surface whilst the mesh represents the epicardial surface. The position of the
LV remnant is marked with a red dot. Boxplots for each of the first ten Modes
are shown in the fourth row, with their corresponding p-values in the fifth row,
showing a significant difference in shape in Mode 6 occurring only at Stage II
(p-values before Bonferroni correction).
The statistical atlas was built, and 10 cardiac atlases representing 79.0% of the
variance in shape within the population were selected for analysis. A
comparison between all RVPA and MBT groups revealed a significant
difference in the mean of Mode 6 (p <0.001) (Figure 32). A statistical difference
in Mode 6 was not apparent between a comparison of RVPA vs. MBT groups
after Stage I surgery but then became statistically significant following Stage II
surgery (p < 0.001). This corresponded to the removal of the conduit. Figure 33
shows a visualisation of the extreme shape variations (i.e. ±3 standard
deviations) for Mode 6.  
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Mean -3 standard deviations 
MBT shunt tendancy	
Mean +3 standard deviations 
RVPA conduit tendancy	
	
Figure 33: Changes in ventricular shape described by the anatomical Mode 6.
Dark blue mesh represents the average ventricle of the 93 cases, and the
brown and purple meshes illustrate the ± 2 standard deviations of the range in
shape variation described by Mode 6. MBT shunt shows a positive (brown)
tendency, and RVPA shunt a negative (purple) tendency. The shell represents
the endocardial surface and the mesh is the epicardial surface, and the
position of the LV remnant is marked with a small red sphere. 
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The traditional geometrical measures in Table 19 revealed that the RVPA
conduit group had a more spherical-shaped heart (1.35 ± 0.25 vs. 1.49 ± 0.25;
p = 0.007), increased indexed RV cavity diameter (59 ± 13mm/√m2 vs. 53 ±
9mm/√m2 ;p = 0.006), and a larger indexed EDV (106 ± 33ml/BSA1.3 vs. 80 ±
20ml/BSA1.3; p <0.0001, Table 18). However the models in Figure 33
additionally demonstrated subtle differences in size at the base of the ventricle
and orientation of the apex. These topological differences were not captured
by parameters in Table 19.
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Table 19: Two-dimensional traditional geometrical measurements of the
systemic right ventricle. Values are derived from personalised computational
meshes, following either a modified Blalock-Taussig shunt or right ventricle to
pulmonary artery conduit. Values show mean and standard deviations and are
indexed to BSA.
  MBT shunt RVPA conduit P value 
Total     
Myocardial mass gm/BSA1.3 104.4 ± 31.0 91.6 ± 50.5 0.12 
Length mm/ m2 77.8 ± 10.1 78.3 ± 14.2 0.82 
Maximum ventricular cavity diameter mm/m2 53.0 ± 8.9 59.2 ± 13.3 0.006 
Maximum ventricular epicardial diameter mm/m2 71.4 ± 7.2 74.5 ± 15.3 0.17 
Sphericity ratio  1.49 ± 0.25 1.35 ± 0.25 0.007 
Maximum wall thickness mm/m2 8.9 ± 2.4 7.9 ± 2.8 0.044 
Standard deviation of septal wall thickness mm/m2 2.45 ± 0.76 2.76 ± 1.06 0.10 
     
Stage I     
Myocardial mass gm /m2 115.9 ± 32.1 99.3 ± 56.0 0.17 
Length mm/m2 81.0 ± 10.5 78.1 ± 11.3 0.31 
Maximum ventricular cavity diameter mm/m2 55.4 ± 7.6 56.6 ± 10.9 0.63 
Maximum ventricular epicardial diameter mm/m2 74.8 ± 6.5 70.3 ± 7.4 0.020 
Sphericity ratio  1.47 ± 0.15 1.41 ± 0.28 0.29 
Maximum wall thickness mm/m2 9.4 ± 2.4 7.8 ± 2.9 0.021 
Standard deviation of septal wall thickness mm/m2 2.67 ± 0.86 2.65 ± 1.03 0.94 
     
Stage II     
Myocardial mass gm /m2 91.7 ± 24.6 77.2 ± 33.7 0.11 
Length mm/m2 74.2 ± 8.6 78.9 ± 18.9 0.27 
Maximum ventricular cavity diameter mm/m2 50.3 ± 9.6 64.0 ± 16.3 0.001 
Maximum ventricular epicardial diameter mm/m2 67.5 ± 5.8 81.2 ± 21.6 0.003 
Sphericity ratio  1.52 ± 0.35 1.24 ± 0.19 0.006 
Maximum wall thickness mm/m2 8.4 ± 2.4 8.0 ± 2.8 0.64 
Standard deviation of septal wall thickness mm/m2 2.24 ± 0.56 2.97 ± 1.13 0.006 
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Functional Analysis
There were no differences in global systolic function between the MBT shunt
and the RVPA conduit groups. Initially EF was equivalent between groups at
Stage I surgery but after Stage II surgery was significantly lower in those
receiving a RVPA conduit (p =0.014), although the mean value was within the
normal range. 
Table 20 shows the results of the strain analysis using feature tracking.
Compared to the MBT shunt group, subjects from the RVPA conduit group had
reduced longitudinal systolic function (strain p =0.023, strain rate p <0.0001).
Furthermore, at the midventricular level, the RVPA conduit group displayed a
reduced circumferential strain (p <0.006) and radial strain (p <0.0001). Diastolic
strain rates in the RVPA conduit group were reduced on assessment of
longitudinal function (strain rate p <0.0001), midventricular radial function
(strain rate p =0.011), and apical radial function (p =0.029). Typical strain
curves are shown in Figure 34.
Reproducibility of ventricular volumes
Intra-class correlation (95% confidence interval) was 0.97 (0.80-0.99) for EDV,
0.95 (0.82-0.980) for ESV, 0.95 (0.82-0.98) for SV, and 0.89 (0.58-0.97) for EF.
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Table 20: Systolic and diastolic function of the systemic right ventricle
following either a modified Blalock-Taussig shunt or right ventricle to
pulmonary artery conduit.
	
 MBT shunt RVPA conduit P value 
Ejection fraction % 57.9 ±  8.3 56.5 ± 8.5 0.44 
    
Systolic Function    
Longitudinal    
Strain % -14.78 ± 5.68 -12.23 ± 4.52 0.023 
Strain rate % s-1 -1.37 ± 0.61 -0.92 ± 0.28 0.0001 
Circumferential    
Basal strain % -12.53 ± 4.80 -10.44 ± 3.56 0.15 
Basal strain rate % s-1 -0.82 ± 0.34 -0.73 ± 0.22 0.19 
Mid strain % -16.90 ± 5.14 -12.97 ± 4.63 0.006 
Mid strain rate % s-1 -1.17 ± 1.11 -0.94 ± 0.34 0.22 
Apical strain % -17.28 ± 9.54 -18.03 ± 6.98 0.070 
Apical strain rate % s-1 -1.30 ± 0.84 -1.38 ± 0.50 0.35 
Radial    
Basal strain % 16.11 ± 12.45 15.82 ± 7.47 0.38 
Basal strain rate % s-1 1.16 ± 0.52 1.10 ± 0.41 0.25 
Mid strain % 24.76 ± 11.89 16.22 ± 8.05 0.0001 
Mid strain rate % s-1 1.32 ± 0.69 1.17 ± 0.44 0.14 
Apical strain % 11.08 ± 8.32 9.95 ± 7.72 0.15 
Apical strain rate % s-1 1.31 ± 0.78 1.14 ± 0.75 0.12 
    
Diastolic Function    
Longitudinal    
Strain rate % s-1 1.82 ± 0.91 1.32 ± 0.61 0.0001 
Circumferential    
Basal strain rate % s-1 1.04 ± 0.40 0.99 ± 0.36 0.63 
Mid strain rate % s-1 1.46 ± 0.52 1.27 ± 0.50 0.054 
Apical strain rate % s-1 1.63 ± 1.10 1.94 ± 0.75 0.12 
Radial    
Basal strain rate % s-1 -1.22 ± 0.59 -1.11 ± 0.49 0.11 
Mid strain rate % s-1 -1.74 ± 0.94 -1.39 ± 0.68 0.011 
Apical strain rate % s-1 -1.42 ± 0.82 -1.24 ± 0.87 0.029 
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Figure 34:  Feature tracking derived MR strain. Top panel shows the feature
tracking for the mid ventricular short axis slice in diastole (left) and systole
(right). The strain curves are shown in the middle panel. Typical circumferential
strain for the MBT shunt is on the left and RVPA shunt is on the right.
Segmental analysis is represented by each colour and white is the mean global
strain. The bottom panel shows a box and whisker plot comparing
circumferential strain (left) and radial strain (right). Circumferential strain is a
negative value representing a shortening whilst radial strain is a positive value
representing a lengthening.
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5.1.3 Discussion
Interest in outcomes following a RVPA conduit is due to concern about the
impact of a residual scar at the site of the conduit insertion on the systemic RV.
Post-mortem studies have shown the scar remains stable in size irrespective of
patient age and consists of fibrosis and ventricle wall thinning. 96
Echocardiographic studies have found wall motion abnormalities localised to
the ventriculotomy site 95 with altered contractility occurring only after removal
of the conduit and formation of a scar. Recent studies have compared survival
rates, rates of intervention, and transplant free survival between the 2 types of
shunt used in Stage I operation. 41, 42 Survival at 3 years was comparable but
longer-term prognoses remain uncertain. We hypothesised that the focal
scarring following a RVPA conduit would adversely affect the shape and
motion of the RV and, through computational shape analysis and strain
analysis of MRI data, we would be able to detect differences between the
Norwood groups. The major results of this study demonstrated that those
receiving a RVPA conduit tend to have a more spherical-shaped and dilated
ventricle, and, despite preserved EF, have reduced longitudinal systolic and
diastolic strain values compared to those receiving a MBT shunt.
The use of computational modelling, 103 allowed the creation of a 3D
computational atlas of ventricular anatomy accounting for characteristic
variation in the HLHS population. Creating a cardiac atlas has the advantage of
not having to assume any typical shape or dimension. Instead variations in a
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structure are described and analysed in 3D terms rather than being subject to
the constraints of applying 2D measurements to try and describe a 3D space.
This is illustrated in Figure 33 where differences in the orientation of the apex
and shape at the base of the ventricle are seen but not easily measured.
Similar techniques have been used to study the LV in adults who were born
prematurely 105 and we were able to apply this to accurately capture the
geometry of the systemic RV. In this study, one of the ten cardiac modes
captured the shape remodelling differences between the RVPA conduit and
MBT shunt groups, and corresponded to increased sphericity and dilatation of
the heart. The formation of the fibrotic scar after Stage II surgery might cause
reduced regional growth in the scar region relative to the remote myocardial
wall, as previously described in echocardiographic and post-mortem studies, 96
leading to the observed change in the shape of the ventricle. The effects of
pulmonary regurgitation through a non-valved conduit may also contribute to
this difference in shape in comparison to those with mBT shunts where blood
is not able to regurgitate back into the ventricle.
The results demonstrated that those receiving RVPA conduits had more dilated
ventricles at Stage I than those receiving MBT shunts. This differs from that
reported in the literature using echocardiography 224 and may reflect that CMR
more accurately records ventricular volumes 71 without the echocardiographic
limitations of acoustic windows. EF has a prognostic value in those with HLHS
and a decline in EF has been shown in those with RVPA conduits compared to
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MBT shunts at 3 years of age. 42 We found EF was lower in the RVPA conduit
group compared to the MBT shunt group but still within normal range. This
might reflect the smaller sample size of this study but may also be influenced
by the method of assessment, as there is increased variability in measurement
between echocardiography techniques and the CMR used in this study. 71
Interestingly despite the preserved EF, comparison of feature tracking based
strain analysis between the 2 Norwood groups showed that the RVPA conduit
group had significantly reduced strain in multiple ventricular axes. The CMR
strain data is the first to be analysed for HLHS. As would be expected from the
altered RV geometry, systemic RV strain values were markedly different from
the healthy LV 105 and healthy RV. 102 Values were comparable to existing
measures taken in those with HLHS via echocardiography. 37 The altered strain
in the RVPA conduit group may represent dyskinesia caused by the scar,
though increased volume loading from pulmonary regurgitation through the
RVPA conduit may also play a role. Abnormal strain has been linked to an
increased risk of adverse events in adults with LV dysfunction 99 and correlates
to the risk of developing heart failure in adults with anatomically normal hearts.
As such, strain analysis in the systemic RV may be a useful early marker of
those that might have a poorer prognosis, particularly when the primary
benefits of feature tracking are considered, namely: it is able to rapidly extract
measures of strain from conventional MR imaging techniques; it is not limited
by acoustic windows and it does not require new sequences or time
consuming post-processing.
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5.1.4 Limitations
Differences in clinical management certainly exist between the two groups as
they were recruited from two centres. Some such as interventional coil
occlusion rate can be accounted for, but many subtle factors affecting the RV
shape cannot be fully quantified. This may lead to centre specific bias however
single centre recruitment would not remove this potential bias either. The RVPA
cohort undergoing primary CMR represented those with “best-physiology” as
patients with less than ideal physiology underwent primary cardiac
catheterisation. Despite this bias, marked differences in shape and function
existed between the two groups after Stage II surgery with those undergoing
BTS having better strain values across multiple axes.
The discrepancy in population size between the 2 groups is a consequence of
the development of surgical techniques. The MBT shunt has been the
standard approach for 30 years. The RVPA conduit has gained popularity
during the past 10 years. Recent refinements including a reduction in the size
of the ventriculotomy are becoming more commonplace. We advocate
increasing the database size to include more subjects as they become
available allowing improved sensitivity to abnormalities. Further work would
include an analysis of how the more recent limited ventriculotomy affects
growth and function. Prospectively collected data on serial MRI scans from the
same subject would make this a more powerful study. 
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Patients receiving a RVPA conduit were older when they underwent Stage I
CMR with consequent greater exposure to the effects of a higher Qp:Qs
through the shunt. Qp:Qs was not routinely measured in either centre. This
might have provided useful additional information on how the shunt affects
ventricular volume. There was no difference in age at which each group
underwent Stage II surgery with the continued presence of increased
ventricular dilatation in the RVPA group indicating a major proportion of the
volume loading may be a consequence of the type and size of shunt rather
than its duration.
The addition of catheterization pressure data would have added further
information on the loading effects on the ventricle. Unfortunately, this was not
comprehensively available to permit analysis. 
The construction of the computational atlas is limited to the available image
resolution. Full 3D resolution images would provide greater anatomical detail.
The automatic 3D mesh reconstruction of the systemic RV achieved a tolerable
accuracy compared to the adult healthy LV (average fitting error divided by
average length: 1.43mm/78mm vs. 1.28mm/95mm), 105 despite the greater
difficulty for manual segmentation and automatic reconstruction of a structure
with thinner walls and larger shape variability.  
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MRI feature tracking is susceptible to inter-user variability particularly for
longitudinal and radial regional segmental assessments. 98, 101 Comparison of
global circumferential strain to the gold standard of MR-tagged sequences
does show good correlation. Regional strain analysis in the right ventricular
outflow tract region would be desirable, but the current analysis technique
does not provide reliable data and requires further refinement.
5.1.5 Conclusions
Utilising computational tools to create a cardiac atlas of ventricular geometry
allows detection of subtle deviations in 3D shape that may not be adequately
captured using 2D measurements. Alterations in the shape of the ventricle fol-
lowing RVPA conduit palliation are associated with abnormal function, which
may have adverse effects on intra-ventricular blood flow energetics. Although
the current evidence on short-term outcomes is equivocal, the results of this
study warrant continued surveillance to assess the long-term outcomes in this
vulnerable group of patients.
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5.1.6 Summary
Background: The Norwood procedure for hypoplastic left heart syndrome
(HLHS) is performed either via a right ventricle-to-pulmonary artery (RVPA)
conduit or a modified Blalock-Taussig (MBT) shunt. The effects of the ven-
triculotomy associated with RVPA conduit on ventricular shape and function
are assessed.
Methods and Results: A retrospective analysis of 93 cardiac magnetic reso-
nance scans in subjects with HLHS was performed (59 MBT shunt, 34 RVPA
shunt) incorporating data from two congenital centres at varying stages of
surgery. Longitudinal and short-axis cine images were used to create a com-
putational cardiac atlas and assess global strain. Those receiving RVPA con-
duit had significant differences (p <0.0001) in the shape of the RV correspond-
ing to increased ventricular dilatation (p = 0.001) and increased sphericity (p =
0.006). Differences were evident only following completion of Stage II surgery.
Despite preserved ejection fraction in both groups, functional strain in the
RVPA shunt group compared to the MBT shunt group was reduced across
multiple ventricular axes, including reduced systolic longitudinal strain rate (p
< 0.0001), reduced diastolic longitudinal strain rate (p = 0.0001), and reduced
midventricular systolic circumferential strain (p < 0.0001). 
Conclusions: Computational modelling analysis reveals subtle differences in
ventricular remodelling in those with HLHS undergoing a RVPA conduit with fo-
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cal scarring potentially leading to altered functional markers of strain. Although
comparative early outcome data shows no differences in survival, the need for
continued surveillance is warranted, as deleterious effects may not become
apparent until later years.




The aim of this thesis was to use CMR to characterise the function of the sys-
temic RV in those with HLHS in terms of energy, shape and motion.
Chapter 3 described efforts to understand the external work performed by the
ventricle using multi-modality CMR imaging and to explore the constraints im-
posed on the systemic RV during simulated exertion. Although pharmacologi-
cal stimulation cannot mimic all of the physiological changes experienced dur-
ing true exercise, a literature review suggested that it might offer useful
insights. Surprisingly the load independent measures of contractility and relax-
ation of the ventricle were normal in this group of patients despite patients be-
ing symptomatic. Simultaneous measurements of volume and pressure
demonstrated a 50% fall in preload, unrelated to PVR, was found to contribute
to the plateau of cardiac index seen during pharmacological stress. The char-
acteristics of the ventricle were described in energetic terms and it was found
to be well coupled to the circulation although a dramatic increase in ventricular
work was noted due primarily to a heart rate mediated increase in cardiac out-
put. Determining the limitation to exercise in this group of patients provides im-
portant information on potential treatment strategies. Measures to improve
preload could be explored as ways to alleviate symptoms of reduced function-
al capacity whilst trying to modulate PVR in the younger age group is less likely
to be successful unless altered resistance is proven. Since this work was pub-
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lished the data has been useful in guiding clinical decision making for this
group of patients at Evelina. Seeing the translation of this work into the clinical
realm, albeit in highly specialised practice, has been particularly rewarding.
The energetic theme was then developed further by using MRI to non-invasive-
ly assess another energetic parameter of external work - kinetic work. The pro-
gression towards assessing kinetic work was described in Chapter 2.6. A
translational approach was used to answer the question "can a non-invasive
measure of kinetic work be used in the clinical environment?" As a collabora-
tion, a highly accelerated 4D flow MRI sequence was validated for clinical ap-
plicability and accuracy. Simultaneously, an approach to measuring intra-ven-
tricular kinetic energy was developed. Clinical acquisition of data then
completed the translation (Chapter 4). Kinetic energy profiles both in health
and through a range of ages, were described. These normal values were com-
pared to a cohort with established ventricular dysfunction and finally to a group
with single ventricle physiology. The KE profiles were unchanged from the
healthy RV. This was surprising as although the systemic RV demonstrates
both volume-loading and hypertrophy there were no KE adaptations. This is
also different to pressure-volume loops in patients with HLHS which show the
systemic RV loop resembles a healthy LV loop. It was noted that subjects with
larger and likely stiffer LV remnants had the greatest reductions in diastolic KE
profiles. This preliminary work demonstrated that KE appeared to be a sensi-
tive marker to pathology and led to the possibility of using markers based
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around KE as potential new measures of ventricular function. Novel markers of
systolic ventricular performance based on KE were developed and evaluated.
The remainder of the chapter set out to explore the impact of function and
morphology on KE EF and PE EF values. KE EF and PE EF in health had a very
narrow range. In those with LV dysfunction, they were both significantly de-
creased suggesting they might be useful as a marker of function. In those with
HLHS, KE EF and PE EF were also found to be decreased and additionally had
a broader range than in those with healthy LVs suggesting they measured a
spectrum of function. Comparatively VV EF remained within the very broad
range of what is considered normal. The interesting finding was that PE EF was
also associated with worsening AVVR and worsening NYHA status. These early
results indicate that PE EF appears to be a marker of systolic ventricular func-
tion and may even be useful in grading dysfunction. Comparing these to objec-
tive clinical measures of exercise tolerance would be a useful next step. Ex-
ploring the use of KE to assess diastology would also be interesting. Both
measuring total intra-ventricular KE and using the developed KE metrics pro-
vided some useful insights into the ventricle. However both were computation-
ally intensive and the magnitude of the values whilst seeming significant were
quite small. It will be interesting to see if other groups are able to reproduce
these findings in other subjects or if the computation can be sped up. For the
moment both methods will appear to be confined to the research realm.
In Chapter 6, a collaborative approach was used to bring the thesis to a con-
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clusion through characterisation of the shape, motion and function of the ven-
tricle following Norwood palliation. Single institution datasets for rare clinical
conditions such as HLHS may be statistically underpowered. Sharing exper-
tise, processing and datasets between institutions can allow important insights
to be made. In coǌunction with Boston Children's Hospital a retrospective
computational analysis of shape and motion of the systemic RV was undertak-
en using CMR. Those undergoing MBT shunts and RVPA conduits demonstrat-
ed distinct 3D differences in shape. The dilated shape in those receiving a
RVPA conduit was only partially captured using traditional metrics of length
and volume indicating the increased sensitivity for 3D shape analyses.
Measures of ventricular motion showed decreased strain indices in those un-
dergoing a RVPA conduit. Either the ventriculotomy scar on the systemic RV
or the effect of shunt regurgitation on the ventricle caused deleterious effects
on function. The results warrant further surveillance and support the need for
ongoing studies to assess the longer term impact in older patients.
The process of completing this thesis has raised and answered and then raised
further questions. Using pressure-volume loop analyses of the systemic single
RV allowed us to understand that preload is a major factor for symptoms. The
RV in HLHS appeared to adapt as a pressure loaded ventricle and the
pressure-volume loop resembled that of a healthy LV. The stroke work, a use-
ful measure of ventricular work, was seen to be grossly elevated during higher
heart rates. This led to the question of whether the work of the heart could be
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investigated non-invasively. A 4D flow sequence was used to measure kinetic
energy. Kinetic energy and stroke work are part of the useful work that the
heart performs in ejecting blood. Surprisingly the intra-cardiac KE profile re-
sembled a RV. There was no adaptation. It would have been useful to examine
and compare single RV to single LV datasets but unfortunately there were not
enough subjects available. Although the KE and PV loop results appear con-
trasting, one showing no energetic adaptation and the other showing a com-
plete adaptation I think these ideas complement each other. They measure
different aspects of the useful work the heart performs in pumping blood and
show how the adaptation that the RV undergoes in HLHS is not complete. It is
still inherently a morphological RV and as such when asked to pump at sys-
temic pressures it is less efficient and uses more energy. It is able to eject a
given volume at a set pressure however the work of pumping the blood and
transferring energy to the blood is altered. Over time this cumulative load could
be costly. Finally an investigation into the shape and motion of the ventricle
was performed confirming our thoughts about the RVPA conduit causing di-
latation and reduced motion presumably from scar and regurgitation. However
these values have not yet been shown to have any clinical impact. It would also
be useful in future to understand how shape and motion correlate to work. At
the end of this process some questions are answered and some unexpected
insights were gained but what is certain is that we are still only a small part of




Limitations to each study have been discussed at the end of the relevant chap-
ter. However three over-arching themes span the breadth of this work. The
first is that the majority of scans are performed on anaesthetised patients. The
second is the relatively small numbers in each study and the third is a sparsity
of clinical correlates. The effect these have on the context of this work will be
assessed in turn.
The majority of patients with HLHS within the institution where these studies
were performed are of a young age. Opportunistic scanning and ethical con-
siderations meant recruitment occurred at the time of scheduled clinical visits.
The majority of the CMR studies then represent pre-surgical scans. The age of
the recruited patients therefore tended to be between 3 to 10 years of age. In-
stitutional preference dictated scans be performed under a general anaesthetic
to facilitate acquisition of high quality clinical data. In those with a Fontan cir-
culation, positive pressure ventilation represents a reversal of respiratory physi-
ology. 206, 207 Furthermore those with Fontan circulations rely on the actions
peripheral muscle pump to contribute towards systemic venous return. Ethical
considerations did not allow younger patients to be scanned awake, and tech-
nological limitations prevented scanning in an upright or active position. How-
ever with the increasing population of patients with HLHS surviving into early
teenage years and beyond these may become available options in the future.




HLHS is a rare condition and the number of patients available and suitable for
study recruitment reflects this. The largest studies to-date have come from the
Single Ventricle Reconstruction trial involving the recruitment of 549 patients
through multiple North American centres. 41, 42, 218 Through similar collaborations
such as this, or smaller partnerships such as demonstrated in chapter 6, our
understanding of the limitations faced by the systemic RV can be advanced
more completely.
The population of subjects with HLHS remains skewed towards the younger
age range. This limits their ability to successfully complete objective measures
of function such as cardio-pulmonary exercise testing as they are often too
young or too small to run on a treadmill or reach the pedals on a bike. Subjec-
tive clinical correlates were used as a substitute where possible but these can-
not replace objective data. However the translational work performed in this
thesis does draw interesting preliminary conclusions that can be followed up
with robust objective measures of function in future studies.
6.3 Future directions
In better characterising the single RV, further questions emerge leading to new
avenues of research. The development of supine exercise bikes that can be
used whilst a patient is within the bore of the CMR scanner offer new opportu-
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nities for better understanding changes in physiology during exertion. 61 Dual
VENC 4D flow sequences are being developed and require validation. 225 These
will pave the way for improved flow data sampling particularly in low velocity
areas of the heart where a single higher VENC sequence can miss subtleties in
blood flow dynamics. Further work in the field of KE may include the develop-
ment of echocardiographic assessment of KE using 3D flow 119 or the applica-
tion of indices of KE to study other congenital cardiac conditions. The increas-
ing use of Lagrangian particle-by-particle based analysis offers the possibility
of understanding kinematics in new ways. 202, 213, 214, 226 The use of cardiac at-
lases offer the opportunity to understand and compare a wide variety of condi-
tions and could include, how the hybrid procedure can alter the shape of the
ventricle. This technique could also be applied to other forms of CHD to assess
the impact of different treatment strategies on the same cohort of patients. De-
veloping 3D CMR tagging would provide more robust measures of regional
ventricular wall motion.
This thesis focused on those with HLHS as they have the worst outcomes. Fu-
ture work could include expanding these techniques to incorporate other pa-
tients with single ventricle circulations to compare and contrast their
haemodynamics.
6.4 Final Conclusions
This thesis has sought to characterise distinctive features typical of the sys-
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temic RV in relation to energy, shape, motion and function. The objectives set
out in the introduction have been met but in doing so have raise new questions
for further investigation. Ultimately in trying to characterise the systemic RV,
the hope is that this thesis will provide some insights that lead to improve-
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